UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number | 811-08748 |
|
Wanger Advisors Trust |
(Exact name of registrant as specified in charter) |
|
227 W. Monroe Street Suite 3000 Chicago, IL | | 60606 |
(Address of principal executive offices) | | (Zip code) |
|
Mary C. Moynihan Perkins Coie LLP 700 13th Street, NW Suite 600 Washington, DC 20005 |
(Name and address of agent for service) |
|
Registrant’s telephone number, including area code: | 312-634-9200 | |
|
Date of fiscal year end: | December 31 | |
|
Date of reporting period: | June 30, 2013 | |
| | | | | | | | |
Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
Item 1. Reports to Stockholders.
Wanger International
2013 Semiannual Report
Not FDIC insured • No bank guarantee • May lose value
Columbia Wanger Asset Management, LLC (CWAM) is one of the leading global small- and mid-cap equity managers in the United States with over 40 years of small- and mid-cap investment experience. As of June 30, 2013, CWAM managed $34.9 billion in assets. CWAM is the investment manager to Wanger USA, Wanger International, Wanger Select and Wanger International Select (together, the Columbia Wanger Funds) and the Columbia Acorn Family of Funds.
Investors should consider the investment objectives, risks, charges and expenses of a mutual fund carefully before investing. For a free prospectus, which contains this and other important information about the Fund, contact your financial adviser, insurance company, qualified pension or retirement plan sponsor or call 1-888-4-WANGER. Read the prospectus carefully before investing.
An important note: Columbia Wanger Funds are available for purchase through variable annuity contracts and variable life insurance policies offered by the separate accounts of participating insurance companies and qualified pension or retirement plans.
Shares of the Fund may not be purchased or sold directly by individual owners of variable annuity contracts and/or variable life insurance policies (collectively, Contracts) or participants in qualified retirement or other plans (collectively, Qualified Plans). If you are the owner of a Contract or a participant in a Qualified Plan, please refer to the prospectus that describes your Contract or Qualified Plan for information about minimum investment requirements and how to purchase and redeem shares of the Fund.
The views expressed in "Health Care in the United States" and in the Performance Review reflect the current views of the respective authors. These views are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict so actual outcomes and results may differ significantly from those stated. These views are subject to change at any time based upon economic, market or other conditions and the respective parties disclaim any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Columbia Wanger Fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any particular Columbia Wanger Fund. References to specific company securities should not be construed as a recommendation or investment advice.
Wanger International
2013 Semiannual Report
Table of Contents
| 2 | | | Understanding Your Expenses | |
| 3 | | | Health Care in the United States | |
| 6 | | | Performance Review | |
| 8 | | | Statement of Investments | |
| 19 | | | Statement of Assets and Liabilities | |
| 19 | | | Statement of Operations | |
| 20 | | | Statement of Changes in Net Assets | |
| 21 | | | Financial Highlights | |
| 22 | | | Notes to Financial Statements | |
| 25 | | | Board Approval of the Advisory Agreement | |
Wanger International 2013 Semiannual Report
Understanding Your Expenses
As an investor, you incur two types of costs. There are transaction costs, which may include redemption fees or exchange fees charged under your contract or qualified plan. There are also ongoing costs, which generally include management fees and other Fund expenses. Lastly, there may be additional fees or charges imposed by the insurance company that sponsors your variable annuity and/or variable life insurance product. The following information is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to help you compare these costs with the ongoing costs of investing in other mutual funds.
Analyzing your Fund's expenses
To illustrate the ongoing costs, we have provided an example and calculated the expenses paid by investors in the Fund during the period. The actual and hypothetical information in the table below is based on an initial investment of $1,000 at the beginning of the period indicated and held for the entire period. Expense information is calculated two ways and each method provides you with different information. The amount listed in the "Actual" column is calculated using the Fund's actual operating expenses and total return for the period. You may use the Actual information, together with the amount invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the results by the expenses paid during the period under the Actual column. The amount listed in the "Hypothetical" column assumes a 5% annual rate of return before expenses (which is not the Fund's actual return) and then applies the Fund's actual expense ratio for the period to the hypothetical return. You should not use the hypothetical account values and expenses to estimate either your actual account balance at the end of the period or the expenses you paid during the period. See "Compare with other funds" below for details on how to use the hypothetical data.
Compare with other funds
Since all mutual funds are required to include the same hypothetical calculations about expenses in shareholder reports, you can use this information to compare the ongoing cost of investing in the Fund with other funds. To do so, compare the hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds. As you compare hypothetical examples of other funds, it is important to note that hypothetical examples are meant to highlight the ongoing cost of investing in a fund only and do not reflect any transaction costs, such as redemption or exchange fees. Therefore, the hypothetical calculations are useful in comparing ongoing costs only, and will not help you determine the relative total costs of investing in different funds. If transaction costs were included in these calculations, your costs would be higher.
January 1, 2013 - June 30, 2013
| | Account value at the beginning of the period ($) | | Account value at the end of the period ($) | | Expenses paid during period ($) | | Fund's annualized expense ratio (%)* | |
| | Actual | | Hypothetical | | Actual | | Hypothetical | | Actual | | Hypothetical | | | |
Wanger International | | | 1,000.00 | | | | 1,000.00 | | | | 1,057.70 | | | | 1,019.32 | | | | 5.35 | | | | 5.25 | | | | 1.06 | | |
*Expenses paid during the period are equal to the Fund's annualized expense ratio, multiplied by the average account value over the period, then multiplied by the number of days in the Fund's most recent fiscal half-year and divided by 365.
It is important to note that the expense amounts shown in the table are meant to highlight only ongoing costs of investing in the Fund. Expenses paid during the period do not include any insurance charges imposed by your insurance company's separate account.
2
Wanger International 2013 Semiannual Report
Health Care in the United States
Critics of the U.S. health care system note that the World Health Organization (WHO) ranked the United States thirtieth in the world in life expectancy1 despite the fact that the United States spends more money per capita on health care than any other country. They argue that health care in the United States is inferior to health care in many other developed countries.
Scott W. Atlas's book, In Excellent Health, Setting the Record Straight on America's Health Care,2 analyzes the consequences of poor lifestyle choices made by many Americans and how the U.S. health care system operates compared to health care systems elsewhere. His book cites numerous studies indicating the U.S. health care system does a great job addressing the health concerns of Americans and is likely the best system in the world.
Life Expectancy
The United States is much more violent and accident-prone than other developed countries. Homicide rates in the United States are ten times that of the United Kingdom and five times that of Canada.3 Death rates from transportation accidents in the United States are 250% that of the United Kingdom and 160% that of Canada.4 Murder and accidents account for the majority of deaths among young adults in the United States,5 and deaths at young ages substantially impact life expectancies.
Robert Ohsfeldt's and John Schneider's book, The Business of Health,6 attempts to quantify the impact of fatal injuries on life expectancy. Using linear regression, they calculate that after standardizing for fatal injuries alone, the United States would edge out Switzerland by 0.3 years and have the highest life expectancy of any country in the world.7
Other studies indicate that violence and accidents account for much, but not all, of the life expectancy shortfall in the United States. A National Academy of Sciences panel addressing cross-national health differences issued a paper that indicated 57% of the life expectancy gap for
males under age 50 and 38% for females under 50 is explained by higher violence and accidents in the United States.8
The United States has a much higher incidence of obesity than other developed countries. Atlas notes that in 2010 34% of people in the United States were obese compared to 15% in Canada, 17% in Western Europe and about 24% in the United Kingdom.9 The Organization for Economic Cooperation and Development (OECD) estimates that obesity reduces life spans by up to eight to ten years.10 Sadly, the worst is yet to come for the United States, as obesity rates have increased and there appears to be a 25-year time lag between becoming obese and suffering premature death.11
Cigarette use in the United States is down substantially; smoking rates are now lower than most other OECD countries.12 However, studies have found a time lag of roughly 25 to 30 years between smoking and lung cancer mortality.13 The United States had the highest rate of smoking in the developed world from the 1930s to the mid-1980s and, according to a 2007 study, 53% of Americans were current or former smokers, compared to 43% of Western Europeans.14 Clearly the United States' legacy of smoking continues to impact health. The Surgeon General estimates that cigarette smoking causes 443,000 deaths in the United States yearly, nearly one-fifth of all deaths.15
With respect to neonatal mortality, Atlas writes that the United States has stringent reporting requirements and definitions. Birth registrations in the United States are done by hospitals and health care professionals, while many other countries rely on reporting by families or surveys.16 In the United States, a live birth is tabulated should a newborn breathe, have a beating heart, move voluntary muscles or show any other evidence of life.17 According to WHO, countries representing only 13% of births worldwide had reliable data meeting this definition.18
Elsewhere, definitions for live births vary greatly. Some countries consider births as live only if 28 weeks gestation was achieved, if a baby is 30 centimeters long, or if a baby survives 24 hours.19 Otherwise, the baby is classified as stillborn and is not considered an infant mortality. Atlas states, "... considering that roughly half of all U.S. infant mortality occurs in the first twenty-four hours, the single criterion of omitting deaths within the first twenty-four hours by many European nations generates their falsely superior infant mortality rates."20
Data from 2004 indicated that the United States had 12% of births classified as preterm (under 32 weeks gestation), a rate 50% to 100% higher than most European countries.21 These figures are impacted by the fact the United States has more multiple gestation pregnancies. Since the early 1980s, the incidence of triplets in the United States has more than tripled to over 140 births per 100,000.22 Atlas notes that in 2007, 17% of twins and 40% of triplets in the United States were associated with fertility treatments.
The United States health care system should be applauded for its efforts to save premature babies rather than write them off as stillborn, as many other countries do. Except for a very limited number of abusive cases, fertility treatment should be considered a virtue of the U.S. health care system. Yet, coupled with superior record keeping, these efforts depress the country's life expectancy ranking.
Diagnosis, Treatment and Outcomes
The Centers for Disease Control and Prevention (CDC) lists heart disease as the top killer in the United States, accounting for 25% of deaths, followed by cancer at 23%, and stroke a distant third at 6%.23 Rather than judge a health care system on reported life expectancy, Atlas assesses health care quality in the United States based on actual medical care, especially diagnosis and treatment of important diseases, using objective data.
3
Wanger International 2013 Semiannual Report
Atlas notes the challenges facing the health care system due to the poor lifestyle choices of many Americans. The CDC estimates that 80% of diabetes, heart disease and stroke, and 40% of cancer, could be eliminated through reduction in obesity and smoking.24 The rate of diabetes in the United States is typically 33% to 100% higher than other developed countries.25 A 2007 study indicated that 12% of Americans over age 50 were diagnosed with cancer, compared to only 5% in a composite of 10 European countries.26
Atlas cites data showing more timely diagnosis and treatment in the United States as compared to other countries. He writes that, "... prolonged wait times are commonly found in health systems with government-controlled nationalized health insurance."27 Numerous countries with single payer systems had to create policies to address prolonged wait times, including Canada, England, Italy, Sweden and Spain.
The United States is among the world's leaders in per capita computerized tomography (CT) and magnetic resonance imaging (MRI) scanners,28 which are crucial to accurately diagnosing leading fatal diseases and guiding lower risk and more effective treatments. In the United States, referring doctors book CT and MRI appointments within days. In other countries, people wait. In 2010, the average wait time in Canada for a CT scan was 4 weeks and for an MRI, 10 weeks.29 A 2011 study in the United Kingdom indicated thousands of people waited over six weeks for an MRI scan. With respect to breast cancer biopsies, another survey indicated that only 1% of U.S. patients waited three weeks or more while 44% of Canadian and 20% of U.K. patients waited that long.30
Treatment of diseases also tends to be very timely in the United States. One study indicated that no elective (non-emergency) cardiac bypass patients in the United States were known to have waited more than three months, while 47% in Canada and 89% in the United Kingdom waited at least that long.31
Furthermore, treatments in the United States tend to be aggressive. A 2009 paper written by
University of Pennsylvania professor Samuel Preston and doctoral candidate Jessica Ho states that 88% of Americans with high cholesterol are being medicated versus 62% of Europeans. Likewise a higher percentage of Americans over age 50 with heart disease receive medication. Among those with hypertension in the United States, 66% were being successfully treated, versus 25% to 49% in other countries.32
With respect to cancer, Preston and Ho cite studies showing that the United States tends to have the highest percentage of screenings for breast, cervical, prostate and colon cancer.33 If cancer is detected, Americans tend to receive more surgery, chemotherapy and advanced cancer drugs. A 2008 study calculated five-year survival rates for breast, colorectal and prostate cancers. Patients in the United States lead the world with a 74% survival rate. Second-best Canada came in at 71% and the United Kingdom was a laggard at 52%.
Atlas adds that new oncology drugs are most often approved and first used in the United States.34 Some 80% of worldwide medical innovation originates in the United States and, since the mid-1970s, U.S. scientists have won more than half of Nobel Prize awards in medicine and physiology.
The statistics are clear. Sick Americans are more likely to receive timely and aggressive health care than citizens of other countries. Atlas writes, "Availability of state-of-the-art medical technology, timely access to specialists, the most effective screening, the shortest wait times for life-changing surgeries, the newest, most effective drugs for more accurate, safer diagnosis and for the most advanced treatment are all superior in the United States."35
Many people appear to agree. In 2008, a McKinsey & Company study estimated that up to 85,000 patients sought in-patient treatment outside their home country. Of that number, 87% traveled to the United States for advanced medical technology, better quality care or quicker access to care. In contrast, critics of the U.S.
health care system don't appear to be traveling to Cuba for treatment. Based on the facts, I agree with Atlas.
Health Care Economics and Investment Implications
Atlas states that the, "... only real crisis in America's health care today is the unsustainable and increasing burden of health care costs..."36 and recommends free market reforms. Health care costs are not the topic of this essay, but world-class health care clearly is expensive, and costs in the United States are exacerbated by detrimental lifestyle choices. I also believe that poor government policies result in few incentives for cost restraint.
Columbia Wanger Asset Management, the investment manager of the Columbia Wanger Funds, strives to provide Columbia Wanger Fund investors with investments in health care companies that are pursuing breakthrough drugs and devices, with the potential to transform treatment of serious and poorly managed diseases. For example, in pivotal studies Seattle Genetics' drug Adcetris delivered 80% response rates in advanced Hodgkin's lymphoma patients who had exhausted all other treatment options.37 In addition, we seek to invest in companies with products and services that we believe increase the cost effectiveness of health care delivery. We attempt to avoid investing in health care companies that may be more likely to be subject to cost cuts or price controls.
Charles P. McQuaid
President and Chief Investment Officer
Columbia Wanger Asset Management, LLC
4
Wanger International 2013 Semiannual Report
The information and data provided in this analysis are derived from sources that we deem to be reliable and accurate. These views are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict so actual outcomes and results may differ significantly from the views expressed. The views/opinions expressed here are those of the author and not of the Wanger Advisors Trust Board, are subject to change at any time based upon economic, market or other conditions, may differ from views expressed by other Columbia Management associates and the respective parties disclaim any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Columbia Wanger Fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any particular Columbia Wanger Fund.
1 Atlas, Scott W., In Excellent Health, Setting the Record Straight on American's Heath Care, (Stanford, California, Hoover Institution Press), p. 2.
2 Ibid.
3 Ohsfeldt, Robert L., and Schneider, John E., The Business of Health, The Role of Competition, Markets, and Regulation, (Washington, D.C., The AEI Press), p. 19.
4 Atlas, Scott W., op. cit., p. 28.
5 Ibid., p. 28.
6 Ohsfeldt, Robert L., and Schneider, John E., op. cit.
7 Ibid., p. 22.
8 Steven H. Woolf and Laudan Aron, Editors; Panel on Understanding Cross-National Health Differences Among High-Income Countries; Committee on Population; Division of Behavioral and Social Sciences and Education; National Research Council; Board on Population Health and Public Health Practice; Institute of Medicine, www.nap.edu.
9 Atlas, Scott W., op. cit., p. 105.
10 Ibid., p. 31.
11 Ibid., p. 107.
12 Ibid., p. 40.
13 Ibid., p. 41.
14 Ibid., p. 111.
15 Ibid., p. 108.
16 Ibid., p. 60.
17 Ibid., p. 67.
18 Ibid., p. 71.
19 Ibid., p. 68.
20 Ibid., p. 70.
21 Ibid., p. 73.
22 Ibid., p. 89.
23 Ibid., p. 119.
24 Ibid., p. 103.
25 Ibid., p. 113.
26 Preston, Samuel H., and Ho, Jessica Y., "Low Life Expectancy in the United States: Is the Health Care System at Fault?" University of Pennsylvania Scholarly Commons Working Paper Series, July 1, 2009, p. 4, http://repository.upenn.edu/psc_working_papers/13/. Accessed July 24, 2013.
27 Atlas, Scott W., op. cit., p. 159.
28 Ibid., p. 192-193.
29 Ibid., p. 194.
30 Ibid., p. 175.
31 Ibid., p. 187.
32 Preston, Samuel H., and Ho, Jessica Y., op. cit., p. 6.
33 Ibid., p. 3.
34 Atlas, Scott W., op. cit., p. 222.
35 Ibid., p. 233.
36 Ibid., p. 245.
37 Seattle Genetics is held in the following Columbia Wanger Funds: Wanger USA, 1.2%; Wanger Select, 1.3%.
5
Wanger International 2013 Semiannual Report
Performance Review Wanger International
| | | |
Louis J. Mendes III Co-Portfolio Manager | | Christopher J. Olson Co-Portfolio Manager | |
Performance data shown represents past performance and is not a guarantee of future results. The investment return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data shown. Please visit columbiamanagement.com for most recent month-end performance updates.
Wanger International gained 5.77% for the semiannual period ended June 30, 2013, outperforming the 1.95% return of its primary benchmark, the S&P Global Ex-U.S. Between $500M and $5B Index. For comparison, the large-cap, developed market MSCI EAFE Index (Net) rose 4.10% during the period.
Many bond markets experienced a sharp rise in mid-term interest rates following the mid-May remarks by U.S. Federal Reserve Bank Chairman Ben Bernanke that the Fed could "take a step down in our pace of purchase" of bonds, an unconventional practice that has supported low interest rates through the present financial crisis. How the Fed will manage this policy shift is of critical importance to investors globally, since many risk assets are priced off of U.S. government bonds. While Bernanke's remarks are grounded in signs of a normalizing U.S. economy—ostensibly good news—10-year bond rates rose on average 100 basis points in the ensuing weeks, which triggered a sell-off in international equities as investors discounted the impact more expensive money would have on economic activity and asset values in diverse markets. While the outlook for the U.S. economy may be brightening, things still appear grim in many parts of the world. In June, fears of stagflation in Brazil sent over one million people into the streets demanding more accountability from a government whose popularity has reached historic lows. Slowing economic growth in China upset already weak commodity markets and sent resources shares tumbling in the second quarter of 2013. Japanese stocks also took a breather in the second quarter as the initial euphoria of "Abenomics" began to fade following two prior quarters of sharply rising markets. Despite the ebb and flow of sentiment, many of the Fund's holdings have continued to post growth in earnings.
Up 111%, the Fund's top performer in the semiannual period was Start Today, a Japanese online apparel retailer. The company has successfully managed costs to return to strong profitability after a rough 2012, during which its shares declined roughly 60%. Siam Makro, a Thai-based cash and carry retailer of goods and produce, rose 76% following a takeover bid from fellow Thai retailer CP-ALL. In recent years, Thailand has had a strong domestic economy as government policies and foreign investment have continued to increase the purchasing power of the rising middle class outside of urban Bangkok. Taiwan's St. Shine Optical, the world's leading manufacturer of daily disposable contact lenses, rose 69% with continued
expansion of its overseas presence, and increasing penetration of daily-wear contact lenses, which have become more affordable with rising regional incomes.
Commodity-related holdings, namely in energy and basic materials, came under pressure as anxiety about the macroeconomic outlook rose. Coal miner Mongolian Mining fell 62% during the six-month period on disappointing volume throughput to China as logistic improvements continue to be delayed. Brazilian gold miner Beadell Resources and Australia's Regis Resources each fell over 50% in the first six months of 2013 as gold prices dropped over 25%. Imtech, a Dutch technical installation and maintenance services provider, was down 68%. It became clear that an earnings-dilutive rights issue was in the offing, following the news of fraud in its German and Polish operations. In Korea, Samsung Engineering fell 49% as the outlook for earnings declined amidst weakening overseas construction orders. We opted to sell the Fund's position in this stock.
Considerable uncertainties mar the international landscape. We expect continued high volatility in the second half of the year. We believe that, while unsettling, volatility provides opportunities to buy good companies at attractive prices.
International investing involves special risks, including foreign taxation, currency risks, risks associated with possible differences in financial standards, operational and settlement risks and other risks associated with future political and economic developments. Stocks of small- and mid-cap companies pose special risks, including possible illiquidity and greater price volatility than stocks of larger, more established companies. Investing in emerging markets may involve greater risks than investing in more developed countries. In addition, concentration of investments in a single region may result in greater volatility.
Portfolio holdings are subject to change periodically and may not be representative of current holdings.
Fund's Positions in Mentioned Holdings
As a percentage of net assets, as of 6/30/13
St. Shine Optical | | | 0.8 | % | |
Start Today | | | 0.8 | | |
Beadell Resources | | | 0.3 | | |
Regis Resources | | | 0.2 | | |
Imtech | | | 0.2 | | |
Mongolian Mining | | | 0.2 | | |
6
Wanger International 2013 Semiannual Report
Growth of a $10,000 Investment in Wanger International
May 3, 1995 (inception date) through June 30, 2013
Performance data shown represents past performance and is not a guarantee of future results. The investment return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data shown. Performance results reflect any fee waivers or reimbursements of Fund expenses by the investment manager and/or any of its affiliates. Absent these fee waivers and/or expense reimbursement arrangements, performance results would have been lower. For daily and most recent month-end performance updates, please call 1-888-4-WANGER.
This graph compares the results of $10,000 invested in Wanger International on May 3, 1995 (the date the Fund began operations) through June 30, 2013, to the S&P Global Ex-U.S. Between $500M and $5B Index with dividends and capital gains reinvested. Although the index is provided for use in assessing the Fund's performance, the Fund's holdings may differ significantly from those in the index.
Top 10 Holdings
As a percentage of net assets, as of 6/30/13
1. Far Eastone Telecom (Taiwan) Taiwan's Third Largest Mobile Operator | | | 1.4 | % | |
2. Coronation Fund Managers (South Africa) South African Fund Manager | | | 1.1 | | |
3. Hexagon (Sweden) Design, Measurement & Visualization Software & Equipment | | | 1.1 | | |
4. Melco Crown Entertainment — ADR* (Hong Kong) Macau Casino Operator | | | 1.1 | | |
5. CCL Industries (Canada) Largest Global Label Converter | | | 1.0 | | |
6. Partners Group (Switzerland) Private Markets Asset Management | | | 1.0 | | |
7. Eurofins Scientific (France) Food, Pharmaceuticals & Materials Screening & Testing | | | 0.9 | | |
8. Neopost (France) Postage Meter Machines | | | 0.9 | | |
9. Taiwan Mobile (Taiwan) Taiwan's Second Largest Mobile Operator | | | 0.9 | | |
10. Aalberts Industries (Netherlands) Flow Control & Heat Treatment | | | 0.9 | | |
* ADR = American Depository Receipts
Top 5 Countries
As a percentage of net assets, as of 6/30/13
Japan | | | 20.9 | % | |
United Kingdom | | | 9.7 | | |
Taiwan | | | 7.0 | | |
Hong Kong | | | 4.9 | | |
South Africa | | | 4.1 | | |
Results as of June 30, 2013
| | 2nd quarter* | | Year to date* | | 1 year | | 5 years | | 10 years | |
Wanger International | | | -1.08 | % | | | 5.77 | % | | | 18.35 | % | | | 4.27 | % | | | 13.90 | % | |
S&P Global Ex-U.S. Between $500M and $5B Index** | | | -3.46 | | | | 1.95 | | | | 15.91 | | | | 2.88 | | | | 12.36 | | |
MSCI EAFE Index (Net) | | | -0.98 | | | | 4.10 | | | | 18.62 | | | | -0.63 | | | | 7.67 | | |
Lipper Variable Underlying International Growth Funds Index | | | -1.78 | | | | 2.16 | | | | 15.59 | | | | 0.02 | | | | 7.88 | | |
*Not annualized.
**The Fund's primary benchmark.
NAV as of 6/30/13: $30.10
Performance numbers reflect all Fund expenses but do not include any fees and expenses imposed under your variable annuity or life insurance policy or qualified pension or retirement plan. If performance included the effect of these additional charges, it would be lower.
The Fund's annual operating expense ratio of 1.07% is stated as of the Fund's prospectus dated May 1, 2013, and differences in expense ratios disclosed elsewhere in this report may result from including fee waivers and expense reimbursements as well as different time periods used in calculating the ratios.
All results shown assume reinvestment of distributions.
The S&P Global Ex-U.S. Between $500M and $5B Index is a subset of the broad market selected by the index sponsor representing the mid- and small-cap developed and emerging markets, excluding the United States. The MSCI Europe, Australasia, Far East (EAFE) Index (Net) is a capitalization-weighted index that tracks the total return of common stocks in 22 developed-market countries within Europe, Australasia and the Far East. The returns of the MSCI EAFE Index (Net) are presented net of the withholding tax rate applicable to foreign non-resident institutional investors in the foreign companies included in the index who do not benefit from double taxation treaties. The performance of the MSCI EAFE Index (Net) is provided to show how the Fund's performance compares to a widely recognized broad-based index of foreign market performance. The Lipper Variable Underlying International Growth Funds Index is an equally weighted representation of the 30 largest variable insurance underlying funds in the Lipper Variable Underlying International Growth Funds Classification, and shows how the Fund's performance compares with returns of an index of funds with similar investment objectives. Indexes are not managed and do not incur fees or expenses. It is not possible to invest directly in an index.
Lipper Inc., a widely respected data provider in the industry, calculates an average total return (assuming reinvestment of distributions) for mutual funds with investment objectives similar to those of the Fund.
Portfolio characteristics and holdings are subject to change periodically and may not be representative of current characteristics and holdings.
7
Wanger International 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Equities – 97.7% | |
| | Asia – 46.7% | |
| | Japan – 20.9% | |
| 292,000
| | | Start Today Online Japanese Apparel Retailer | | $ | 5,717,824
| | |
| 514,600
| | | Wacom Computer Graphic Illustration Devices | | | 5,688,398
| | |
| 443,589
| | | Kansai Paint Paint Producer in Japan, India, China & Southeast Asia | | | 5,662,483
| | |
| 255,000
| | | NGK Spark Plug Automobile Parts | | | 5,103,796
| | |
| 1,339,000
| | | Seven Bank ATM Processing Services | | | 4,853,989
| | |
| 4,220
| | | Orix JREIT Diversified Real Estate Investment Trust | | | 4,816,670
| | |
| 339,900
| | | Kuraray Special Resin, Fine Chemical, Fibers & Textures | | | 4,763,767
| | |
| 125,000
| | | Hoshizaki Electric Commercial Kitchen Equipment | | | 4,003,054
| | |
| 30,299
| | | Nakanishi Dental Tools & Machinery | | | 3,862,053
| | |
| 238,000
| | | Japan Airport Terminal Airport Terminal Operator at Haneda | | | 3,766,951
| | |
| 88,541
| | | Kintetsu World Express Airfreight Logistics | | | 3,543,005
| | |
| 149,000
| | | Glory Currency Handling Systems & Related Equipment | | | 3,495,770
| | |
| 143,300
| | | Ariake Japan Manufacturer of Soup/Sauce Extracts for Business-to-business Use | | | 3,489,591
| | |
| 190,400
| | | Park24 Parking Lot Operator | | | 3,454,242
| | |
| 830
| | | Kenedix Realty Investment Tokyo Mid-size Office Real Estate Investment Trust | | | 3,304,040
| | |
| 170,000
| | | Daiseki (a) Waste Disposal & Recycling | | | 2,974,003
| | |
| 220,500
| | | Ushio Industrial Light Sources | | | 2,911,421
| | |
| 22,000
| | | Hirose Electric Electrical Connectors | | | 2,897,624
| | |
| 234,000
| | | NGK Insulators Ceramic Products for Auto, Power & Electronics | | | 2,891,671
| | |
| 62,000
| | | Sanrio Character Goods & Licensing | | | 2,876,044
| | |
Number of Shares | | | | Value | |
| 141,039
| | | Nihon Parkerizing Metal Surface Treatment Agents & Processing Service | | $ | 2,792,999
| | |
| 77,000
| | | Benesse Education Service Provider | | | 2,777,924
| | |
| 59,536
| | | Miraca Holdings Outsourced Lab Testing, Diagnostic Equipment & Reagents | | | 2,735,854
| | |
| 39,300
| | | Disco Semiconductor Dicing & Grinding Equipment | | | 2,710,634
| | |
| 206,500
| | | Nippon Kayaku (a) Functional Chemicals, Pharmaceuticals & Auto Safety Systems | | | 2,572,738
| | |
| 140,000
| | | Suruga Bank Regional Bank | | | 2,538,827
| | |
| 121,000
| | | Nabtesco Machinery Components | | | 2,512,294
| | |
| 35,000
| | | Rinnai Gas Appliances for Household & Commercial Use | | | 2,488,695
| | |
| 35,100
| | | FP Corporation Disposable Food Trays & Containers | | | 2,433,624
| | |
| 250
| | | Industrial & Infrastructure Fund Industrial Real Estate Investment Trust in Japan | | | 2,431,418
| | |
| 280
| | | Nippon Prologis REIT Logistics Real Estate Investment Trust in Japan | | | 2,429,631
| | |
| 58,000
| | | Itochu Techno-Science IT Network Equipment Sales & Services | | | 2,400,948
| | |
| 72,000
| | | Toyo Suisan Kaisha Instant Noodle Manufacturer | | | 2,395,637
| | |
| 65,500
| | | Hamamatsu Photonics Optical Sensors for Medical & Industrial Applications | | | 2,365,417
| | |
| 166,000
| | | Doshisha Wholesaler | | | 2,364,333
| | |
| 1,070
| | | Advance Residence Investment Residential REIT | | | 2,319,745
| | |
| 370
| | | Mori Hills REIT Investment Tokyo Centric Diversified Real Estate Investment Trust | | | 2,310,592
| | |
| 54,000
| | | Familymart Convenience Store Operator | | | 2,304,096
| | |
| 51,500
| | | Santen Pharmaceutical Specialty Pharma (Ophthalmic Medicine) | | | 2,228,652
| | |
| 109,100
| | | Aica Kogyo Laminated Sheets, Building Materials & Chemical Adhesives | | | 2,186,773
| | |
| 72,300
| | | Omron Electric Components for Factory Automation | | | 2,155,481
| | |
See accompanying notes to financial statements.
8
Wanger International 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Japan – 20.9% (cont) | |
| 48,711
| | | Ain Pharmaciez Dispensing Pharmacy/Drugstore Operator | | $ | 2,099,612
| | |
| 360
| | | Global One Real Estate Office Real Estate Investment Trust | | | 2,091,463
| | |
| 133,900
| | | OSG Consumable Cutting Tools | | | 2,003,206
| | |
| 80,000
| | | Icom Two Way Radio Communication Equipment | | | 1,940,519
| | |
| 197,000
| | | Asahi Diamond Industrial Consumable Diamond Tools | | | 1,862,077
| | |
| 21,000
| | | Shimano Bicycle Components & Fishing Tackle | | | 1,788,882
| | |
| 200,900
| | | Sintokogio Automated Casting Machines, Surface Treatment System & Consumables | | | 1,660,851
| | |
| 45,500
| | | Milbon Manufacturer of Hair Products for Business-to-business Use | | | 1,604,271
| | |
| 155,000
| | | Lifenet Insurance (a) (b) Online Life Insurance Company in Japan | | | 1,265,423
| | |
| 23,800
| | | Horiba Test & Measurement Instruments | | | 868,051
| | |
| 34,600
| | | MonotaRO (a) Online MRO (Maintenance, Repair, Operations) Goods Distributor in Japan | | | 842,437
| | |
| | | 149,559,500 | | |
| | Taiwan – 7.0% | |
| 3,714,000
| | | Far Eastone Telecom Taiwan's Third Largest Mobile Operator | | | 9,953,914
| | |
| 1,671,000
| | | Taiwan Mobile Taiwan's Second Largest Mobile Operator | | | 6,583,164
| | |
| 224,000
| | | St. Shine Optical World's Leading Disposable Contact Lens OEM (Original Equipment Manufacturer) | | | 5,790,303
| | |
| 2,115,000
| | | CTCI Corp International Engineering Firm | | | 3,835,911
| | |
| 717,000
| | | Delta Electronics Industrial Automation, Switching Power Supplies & Passive Components | | | 3,256,243
| | |
| 1,249,000
| | | Taiwan Hon Chuan Beverage Packaging (Bottles, Caps, Labels) Manufacturer | | | 2,914,612
| | |
| 603,000
| | | Advantech Industrial PC & Components | | | 2,859,993
| | |
Number of Shares | | | | Value | |
| 140,000
| | | Ginko International Largest Contact Lens Maker in China | | $ | 2,346,037
| | |
| 680,000
| | | Flexium Interconnect Flexible Printed Circuit for Mobile Electronics | | | 2,310,184
| | |
| 612,000
| | | Lung Yen Funeral Services & Columbaria | | | 1,987,842
| | |
| 262,000
| | | President Chain Store Taiwan's Number One Convenience Chain Store Operator | | | 1,712,647
| | |
| 894,000
| | | Lite-On Technology Mobile Device, LED & IT Component Supplier | | | 1,562,675
| | |
| 298,000
| | | PC Home Taiwanese Internet Retail Company | | | 1,553,938
| | |
| 543,181
| | | Chipbond Semiconductor Back-end Packaging Services | | | 1,321,751
| | |
| 695,000
| | | Chroma Ate Automatic Test Systems, Testing & Measurement Instruments | | | 1,176,137
| | |
| 404,000
| | | CHC Healthcare Medical Device Distributor | | | 1,069,383
| | |
| | | 50,234,734 | | |
| | Hong Kong – 4.9% | |
| 340,000
| | | Melco Crown Entertainment – ADR (b) Macau Casino Operator | | | 7,602,400
| | |
| 753,000
| | | AAC Technologies Miniature Acoustic Components | | | 4,224,687
| | |
| 1,531,750
| | | L'Occitane International Skin Care & Cosmetics Producer | | | 4,114,770
| | |
| 1,746,000
| | | Lifestyle International Mid to High-end Department Store Operator in Hong Kong & China | | | 3,644,230
| | |
| 1,835,000
| | | Melco International Macau Casino Operator | | | 3,443,084
| | |
| 2,888,000
| | | Sa Sa International Cosmetics Retailer | | | 2,851,958
| | |
| 3,600,000
| | | Mapletree Greater China Commercial Trust (b) Retail & Office Property Landlord | | | 2,675,693
| | |
| 917,800
| | | MGM China Holdings Macau Casino Operator | | | 2,435,526
| | |
| 1,700,000
| | | Vitasoy International Well Known Hong Kong Soy Food Brand Reinventing Brand | | | 2,046,360
| | |
| 162,300
| | | ASM Pacific Semi Backend & Surface Mounting Equipment | | | 1,781,690
| | |
| | | 34,820,398 | | |
See accompanying notes to financial statements.
9
Wanger International 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Singapore – 2.8% | |
| 3,850,000
| | | Mapletree Commercial Trust Retail & Office Property Landlord | | $ | 3,588,018
| | |
| 3,000,000
| | | Mapletree Logistics Trust Industrial Property Landlord | | | 2,600,109
| | |
| 2,500,000
| | | Mapletree Industrial Trust Industrial Property Landlord | | | 2,598,079
| | |
| 1,851,000
| | | CDL Hospitality Trust Hotel Owner/Operator | | | 2,476,842
| | |
| 1,239,000
| | | Ascendas REIT Industrial Property Landlord | | | 2,171,328
| | |
| 323,000
| | | Singapore Exchange Singapore Equity & Derivatives Market Operator | | | 1,785,349
| | |
| 473,000
| | | Super Group Instant Food & Beverages in Southeast Asia | | | 1,659,512
| | |
| 1,233,000
| | | Goodpack Limited International Bulk Container Leasing | | | 1,527,266
| | |
| 473,000
| | | Petra Foods Cocoa Processor & Chocolate Manufacturer | | | 1,412,156
| | |
| | | 19,818,659 | | |
| | Korea – 2.7% | |
| 76,570
| | | Coway Household Appliance Rental Service Provider | | | 3,720,862
| | |
| 148,377
| | | Paradise Co Korean 'Foreigner Only' Casino Operator | | | 2,994,929
| | |
| 46,952
| | | Kepco Plant Service & Engineering Power Plant & Grid Maintenance | | | 2,137,821
| | |
| 40,000
| | | LS Industrial Systems Manufacturer of Electrical & Automation Equipment | | | 1,998,998
| | |
| 6,865
| | | KCC Paint & Housing Material Manufacturer | | | 1,962,503
| | |
| 1,495
| | | Lotte Chilsung Beverage Beverages & Liquor Manufacturer | | | 1,800,465
| | |
| 89,014
| | | iMarketKorea Procurement, Distribution of MRO (Maintenance, Repair, Operations) Goods | | | 1,715,005
| | |
| 65,350
| | | Handsome High-end Apparel Company | | | 1,656,840
| | |
| 74,000
| | | Nexen Tire Tire Manufacturer | | | 1,052,067
| | |
| 14,260
| | | BS Financial Group Regional Bank in Busan (Korea's Second Largest City) | | | 179,447
| | |
| | | 19,218,937 | | |
Number of Shares | | | | Value | |
| | India – 2.2% | |
| 32,877
| | | Asian Paints India's Largest Paint Company | | $ | 2,558,332
| | |
| 185,000
| | | United Breweries India's Largest Brewer | | | 2,247,503
| | |
| 277,000
| | | Yes Bank Commercial Banking in India | | | 2,141,297
| | |
| 91,100
| | | Colgate Palmolive India Consumer Products in Oral Care | | | 2,081,059
| | |
| 694,809
| | | Adani Ports & Special Economic Zone Indian West Coast Shipping Port | | | 1,754,243
| | |
| 1,217,418
| | | Redington India Supply Chain Solutions for IT & Mobile Handsets in Emerging Markets | | | 1,469,813
| | |
| 556,967
| | | Bharti Infratel Communication Towers | | | 1,424,164
| | |
| 8,620
| | | Bosch Automotive Parts | | | 1,308,568
| | |
| 12,300
| | | TTK Prestige Branded Cooking Equipment | | | 651,686
| | |
| 199,131
| | | SKIL Ports and Logistics (b) Indian Container Port Project | | | 298,325
| | |
| | | 15,934,990 | | |
| | Indonesia – 1.8% | |
| 5,367,900
| | | Tower Bersama Infrastructure (b) Communications Towers | | | 2,803,150
| | |
| 3,249,542
| | | Archipelago Resources (b) Gold Mining Projects in Indonesia, Vietnam & the Philippines | | | 2,335,279
| | |
| 23,000,000
| | | Ace Indonesia Home Improvement Retailer | | | 1,710,651
| | |
| 509,000
| | | Mayora Indah Consumer Branded Food Manufacturer | | | 1,542,547
| | |
| 4,035,391
| | | Surya Citra Media Free to Air TV Station in Indonesia | | | 1,107,455
| | |
| 945,500
| | | Matahari Department Store (b) Largest Department Store Chain in Indonesia | | | 1,105,563
| | |
| 4,681,000
| | | MNC Skyvision (b) Largest Satellite Pay TV Operator in Indonesia | | | 1,104,040
| | |
| 1,589,500
| | | Arwana Citramulia Ceramic Tiles for Home Decoration | | | 511,580
| | |
| 636,500
| | | Mitra Adiperkasa Operator of Department Store & Specialty Retail Stores | | | 446,875
| | |
See accompanying notes to financial statements.
10
Wanger International 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Indonesia – 1.8% (cont) | |
| 780,500
| | | Southern Arc Minerals (b) Gold & Copper Exploration in Indonesia | | $ | 89,056
| | |
| | | 12,756,196 | | |
| | China – 1.4% | |
| 209,348
| | | WuXi PharmaTech — ADR (b) Largest Contract Research Organization Business in China | | | 4,396,308
| | |
| 1,640,000
| | | Want Want Chinese Branded Consumer Food Company | | | 2,298,694
| | |
| 19,000,000
| | | RexLot Holdings Lottery Equipment Supplier in China | | | 1,246,006
| | |
| 3,002,000
| | | AMVIG Holdings Chinese Tobacco Packaging Material Supplier | | | 1,161,158
| | |
| 136,000
| | | Biostime Pediatric Nutrition & Baby Care Products Provider | | | 760,523
| | |
| 435,000
| | | Digital China IT Distribution & Systems Integration Services | | | 517,069
| | |
| | | 10,379,758 | | |
| | Thailand – 1.1% | |
| 9,174,600
| | | Home Product Center Home Improvement Retailer | | | 3,387,702
| | |
| 400,000
| | | Airports of Thailand Airport Operator of Thailand | | | 2,161,669
| | |
| 882,000
| | | Robinson's Department Store Mass-market Department Store Operator in Thailand | | | 1,723,725
| | |
| 924,300
| | | Samui Airport Property Fund Thai Airport Operator | | | 523,335
| | |
| | | 7,796,431 | | |
| | Philippines – 0.9% | |
| 6,165,000
| | | SM Prime Holdings Shopping Mall Operator | | | 2,315,950
| | |
| 777,540
| | | Int'l Container Terminal Container Handling Terminals & Port Management | | | 1,558,525
| | |
| 1,795,000
| | | Manila Water Company Water Utility Company in Philippines | | | 1,344,880
| | |
| 5,500,000
| | | Melco Crown (Philippines) Resorts (b) Integrated Resort Operator in Manila | | | 1,056,713
| | |
| | | 6,276,068 | | |
Number of Shares | | | | Value | |
| | Cambodia – 0.6% | |
| 5,774,000
| | | Nagacorp Casino/Entertainment Complex in Cambodia | | $ | 4,487,842
| | |
| | Mongolia – 0.4% | |
| 118,952 | | | Turquoise Hill Resources (a) (b) | | | 705,772 | | |
| 108,951
| | | Turquoise Hill Resources (a) (b) (c) Copper Mine Project in Mongolia | | | 646,079
| | |
| 7,204,500
| | | Mongolian Mining (b) Coking Coal Mining in Mongolia | | | 1,336,578
| | |
| | | 2,688,429 | | |
| | | | Total Asia | | | 333,971,942 | | |
| | Europe – 31.5% | |
| | United Kingdom – 9.7% | |
| 448,000
| | | Jardine Lloyd Thompson Group International Business Insurance Broker | | | 6,205,356
| | |
| 2,000,000
| | | Charles Taylor Insurance Services | | | 5,718,770
| | |
| 350,000
| | | Telecity European Data Center Provider | | | 5,393,523
| | |
| 110,920
| | | Spirax Sarco Steam Systems for Manufacturing & Process Industries | | | 4,545,925
| | |
| 92,700
| | | Whitbread The UK's Leading Hotelier & Coffee Shop | | | 4,312,373
| | |
| 353,326
| | | Domino's Pizza UK & Ireland Pizza Delivery in UK, Ireland & Germany | | | 3,601,921
| | |
| 113,000
| | | Rightmove Internet Real Estate Listings | | | 3,582,445
| | |
| 317,959
| | | WH Smith (a) Newsprint, Books & General Stationery Retailer | | | 3,472,359
| | |
| 356,000
| | | Shaftesbury London Prime Retail Real Estate Investment Trust | | | 3,225,596
| | |
| 270,000
| | | Smith & Nephew Medical Equipment & Supplies | | | 3,023,962
| | |
| 78,000
| | | CRODA Oleochemicals & Industrial Chemicals | | | 2,941,388
| | |
| 572,355
| | | BBA Aviation Aviation Support Services | | | 2,437,634
| | |
| 347,000
| | | Abcam Online Sales of Antibodies | | | 2,393,435
| | |
See accompanying notes to financial statements.
11
Wanger International 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | United Kingdom – 9.7% (cont) | |
| 715,966
| | | Elementis Clay-based Additives | | $ | 2,389,042
| | |
| 451,000
| | | Halford's The UK's Leading Retailer for Leisure Goods & Auto Parts | | | 2,169,127
| | |
| 3,455,000
| | | Cable and Wireless Leading Telecoms Service Provider in the Caribbean | | | 2,150,718
| | |
| 80,731
| | | Aggreko Temporary Power & Temperature Control Services | | | 2,017,829
| | |
| 117,771
| | | Babcock International Public Sector Outsourcer | | | 1,977,482
| | |
| 831,000
| | | Smiths News Newspaper & Magazine Distributor | | | 1,911,662
| | |
| 274,715
| | | PureCircle (a) (b) Natural Sweeteners | | | 1,462,397
| | |
| 48,186
| | | Fidessa Group Software for Financial Trading Systems | | | 1,413,230
| | |
| 31,000
| | | Intertek Group Testing, Inspection & Certification Services | | | 1,377,999
| | |
| 189,615
| | | Ocado (a) (b) Leading Online Grocery Retailer | | | 860,282
| | |
| 36,815
| | | Tullow Oil Oil & Gas Producer | | | 560,428
| | |
| 5,708
| | | Telecom Plus UK Multi Utility | | | 108,346
| | |
| | | 69,253,229 | | |
| | Netherlands – 3.5% | |
| 291,319
| | | Aalberts Industries Flow Control & Heat Treatment | | | 6,510,913
| | |
| 145,741
| | | UNIT4 Business Software Development | | | 4,723,461
| | |
| 113,383
| | | TKH Group Dutch Industrial Conglomerate | | | 2,915,475
| | |
| 51,818
| | | Fugro Subsea Oilfield Services | | | 2,815,600
| | |
| 98,582
| | | Arcadis Engineering Consultants | | | 2,654,553
| | |
| 14,197
| | | Core Labs Oil & Gas Reservoir Consulting | | | 2,153,117
| | |
| 27,926
| | | Vopak World's Largest Operator of Petroleum & Chemical Storage Terminals | | | 1,648,288
| | |
Number of Shares | | | | Value | |
| 207,240
| | | Imtech (a) (b) Technical Installation & Maintenance | | $ | 1,525,500
| | |
| | | 24,946,907 | | |
| | France – 3.2% | |
| 32,020
| | | Eurofins Scientific (b) Food, Pharmaceuticals & Materials Screening & Testing | | | 6,756,949
| | |
| 100,921
| | | Neopost Postage Meter Machines | | | 6,682,153
| | |
| 44,200
| | | Gemalto (a) Digital Security Solutions | | | 4,001,989
| | |
| 30,533
| | | Norbert Dentressangle Leading European Logistics & Transport Group | | | 2,483,954
| | |
| 96,450
| | | Saft Niche Battery Manufacturer | | | 2,291,754
| | |
| 220,933
| | | Hi-Media (b) Online Advertiser in Europe | | | 480,526
| | |
| | | 22,697,325 | | |
| | Switzerland – 2.9% | |
| 25,741
| | | Partners Group Private Markets Asset Management | | | 6,967,544
| | |
| 20,880
| | | Geberit Plumbing Supplies | | | 5,172,470
| | |
| 1,505
| | | Sika Chemicals for Construction & Industrial Applications | | | 3,891,537
| | |
| 22,965
| | | Dufry Group (b) Operates Airport Duty Free & Duty Paid Shops | | | 2,781,903
| | |
| 37,840
| | | Zehnder Radiators & Heat Recovery Ventilation Systems | | | 1,686,585
| | |
| | | 20,500,039 | | |
| | Germany – 2.7% | |
| 183,492
| | | Wirecard Online Payment Processing & Risk Management | | | 4,992,808
| | |
| 14,270
| | | Rational Commercial Ovens | | | 4,777,346
| | |
| 68,400
| | | NORMA Group Clamps for Automotive & Industrial Applications | | | 2,473,788
| | |
| 213,000
| | | TAG Immobilien Owner of Residential Properties in Germany | | | 2,321,552
| | |
| 47,000
| | | Elringklinger (a) Automobile Components | | | 1,566,231
| | |
See accompanying notes to financial statements.
12
Wanger International 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Germany – 2.7% (cont) | |
| 57,879
| | | Aurelius European Turnaround Investor | | $ | 1,390,743
| | |
| 11,343
| | | Pfeiffer Vacuum Vacuum Pumps | | | 1,174,599
| | |
| 26,200
| | | Deutsche Beteiligungs Private Equity Investment Management | | | 630,276
| | |
| | | 19,327,343 | | |
| | Sweden – 2.1% | |
| 289,727
| | | Hexagon Design, Measurement & Visualization Software & Equipment | | | 7,744,803
| | |
| 399,345
| | | Sweco Engineering Consultants | | | 4,540,651
| | |
| 83,593
| | | Unibet European Online Gaming Operator | | | 2,798,441
| | |
| | | 15,083,895 | | |
| | Denmark – 1.8% | |
| 169,677
| | | SimCorp Software for Investment Managers | | | 5,043,189
| | |
| 128,911
| | | Novozymes Industrial Enzymes | | | 4,129,047
| | |
| 102,481
| | | Jyske Bank (b) Danish Bank | | | 3,854,718
| | |
| | | 13,026,954 | | |
| | Italy – 0.9% | |
| 351,999
| | | Pirelli (a) Global Tire Supplier | | | 4,069,158
| | |
| 833,343
| | | Geox (a) Apparel & Shoe Maker | | | 2,071,373
| | |
| | | 6,140,531 | | |
| | Finland – 0.8% | |
| 56,294
| | | Vacon Leading Independent Manufacturer of Variable Speed Alternating Current Drives | | | 3,733,364
| | |
| 106,000
| | | Tikkurila Decorative & Industrial Paint in Scandinavia & Central & Eastern Europe | | | 2,392,275
| | |
| | | 6,125,639 | | |
Number of Shares | | | | Value | |
| | Norway – 0.7% | |
| 324,911
| | | Atea Leading Nordic IT Hardware/Software Reseller & Installation Company | | $ | 3,276,202
| | |
| 90,000
| | | Subsea 7 (b) Offshore Subsea Contractor | | | 1,577,947
| | |
| | | 4,854,149 | | |
| | Spain – 0.6% | |
| 587,190
| | | Dia Leading Hard Discounter in Spain, Latin America & the Eastern Mediterranean | | | 4,435,793
| | |
| | Russia – 0.6% | |
| 112,297
| | | Yandex (b) Search Engine for Russian & Turkish Languages | | | 3,102,766
| | |
| 43,200
| | | QIWI — ADR Electronic Payments Network Serving Russia & the Commonwealth of Independent States | | | 1,002,240
| | |
| | | 4,105,006 | | |
| | Iceland – 0.5% | |
| 2,644,101 | | | Marel (d) | | | 1,891,740 | | |
| 1,700,000
| | | Marel (d) Largest Manufacturer of Poultry & Fish Processing Equipment | | | 1,798,506
| | |
| | | 3,690,246 | | |
| | Kazakhstan – 0.5% | |
| 494,896
| | | Halyk Savings Bank of Kazakhstan - GDR Largest Retail Bank & Insurer in Kazakhstan | | | 3,652,333
| | |
| | Belgium – 0.4% | |
| 42,233
| | | EVS Broadcast Equipment Digital Live Mobile Production Software & Systems | | | 2,928,071
| | |
| | Portugal – 0.3% | |
| 854,881
| | | Redes Energéticas Nacionais Portuguese Power Transmission & Gas Transportation | | | 2,451,400
| | |
| | Turkey – 0.3% | |
| 130,830
| | | Bizim Toptan Cash & Carry Stores in Turkey | | | 2,129,964
| | |
| | | | Total Europe | | | 225,348,824 | | |
See accompanying notes to financial statements.
13
Wanger International 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Other Countries – 14.0% | |
| | South Africa – 4.1% | |
| 1,278,520
| | | Coronation Fund Managers South African Fund Manager | | $ | 8,116,614
| | |
| 83,713
| | | Naspers Media in Africa, China, Russia & Other Emerging Markets | | | 6,178,997
| | |
| 1,872,183
| | | Rand Merchant Insurance Directly Sold Property & Casualty Insurance; Holdings in Other Insurers | | | 4,767,359
| | |
| 218,654
| | | Massmart Holdings General Merchandise, Food & Home Improvement Stores; Wal-Mart Subsidiary | | | 3,966,056
| | |
| 254,433
| | | Mr. Price South African Retailer of Apparel, Household & Sporting Goods | | | 3,468,107
| | |
| 835,245
| | | Northam Platinum (b) Platinum Mining in South Africa | | | 2,697,175
| | |
| | | 29,194,308 | | |
| | Canada – 3.8% | |
| 120,663
| | | CCL Industries (b) Largest Global Label Converter | | | 7,443,773
| | |
| 106,322
| | �� | ShawCor Oil & Gas Pipeline Products | | | 4,201,524
| | |
| 313,128
| | | CAE Flight Simulator Equipment & Training Centers | | | 3,248,290
| | |
| 62,856
| | | Onex Capital Private Equity | | | 2,852,038
| | |
| 158,516 | | | DeeThree Exploration (b) (e) | | | 1,122,589 | | |
| 119,569
| | | DeeThree Exploration (b) Canadian Oil & Gas Producer | | | 864,053
| | |
| 58,433
| | | AG Growth Leading Manufacturer of Augers & Grain Handling Equipment | | | 1,896,836
| | |
| 65,101
| | | Black Diamond Group Provides Accommodations/Equipment for Oil Sands Development | | | 1,383,481
| | |
| 90,834
| | | Alliance Grain Traders Global Leader in Pulse Processing & Distribution | | | 1,265,302
| | |
| 202,168
| | | Horizon North Logistics (a) Diversified Oil Services Offering in Northern Canada | | | 1,220,659
| | |
| 26,123
| | | Baytex Oil & Gas Producer in Canada | | | 941,392
| | |
Number of Shares | | | | Value | |
| 53,000
| | | Athabasca Oil Sands (b) Oil Sands & Unconventional Oil Development | | $ | 328,069
| | |
| 195,271
| | | Pan Orient Asian Oil & Gas Explorer | | | 302,645
| | |
| 42,800
| | | Crew Energy (b) Canadian Oil & Gas Producer | | | 210,805
| | |
| 35,542
| | | Americas Petrogas (a) (b) Oil & Gas Exploration in Argentina, Potash in Peru | | | 30,077
| | |
| | | 27,311,533 | | |
| | United States – 2.8% | |
| 124,722
| | | Textainer Group Holdings (a) Top International Container Leasor | | | 4,794,314
| | |
| 91,616
| | | Atwood Oceanics (b) Offshore Drilling Contractor | | | 4,768,613
| | |
| 96,600
| | | Rowan (b) Contract Offshore Driller | | | 3,291,162
| | |
| 57,853
| | | FMC Technologies (b) Oil & Gas Well Head Manufacturer | | | 3,221,255
| | |
| 43,084
| | | Hornbeck Offshore (b) Supply Vessel Operator in U.S. Gulf of Mexico | | | 2,304,994
| | |
| 41,979
| | | World Fuel Services Global Fuel Broker | | | 1,678,320
| | |
| | | 20,058,658 | | |
| | Australia – 2.6% | |
| 1,089,000
| | | Challenger Financial Largest Annuity Provider | | | 3,971,065
| | |
| 3,658,000
| | | Commonwealth Property Office Fund Australia Prime Office Real Estate Investment Trust | | | 3,666,096
| | |
| 571,000
| | | IAG General Insurance Provider | | | 2,834,273
| | |
| 780,001
| | | SAI Global Publishing, Certification & Compliance Services | | | 2,583,865
| | |
| 251,000
| | | Domino's Pizza Enterprises Domino's Pizza Operator in Australia/New Zealand & France/Benelux | | | 2,566,279
| | |
| 651,000
| | | Regis Resources (b) Gold Mining in Australia | | | 1,723,286
| | |
| 94,269
| | | Austbrokers Local Australian Small Business Insurance Broker | | | 935,240
| | |
| | | 18,280,104 | | |
See accompanying notes to financial statements.
14
Wanger International 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Israel – 0.7% | |
| 302,685
| | | Israel Chemicals Producer of Potash, Phosphates, Bromine & Specialty Chemicals | | $ | 2,972,498
| | |
| 78,000
| | | Caesarstone (b) Quartz Countertops | | | 2,123,940
| | |
| | | 5,096,438 | | |
| | | | Total Other Countries | | | 99,941,041 | | |
| | Latin America – 5.5% | |
| | Brazil – 2.2% | |
| 320,000
| | | Localiza Rent A Car Car Rental | | | 4,524,615
| | |
| 5,037,276
| | | Beadell Resources (b) Gold Mining in Brazil | | | 2,350,101
| | |
| 173,209
| | | Arcos Dorados (a) McDonald's Master Franchise for Latin America | | | 2,023,081
| | |
| 130,000
| | | Multiplus Loyalty Program Operator in Brazil | | | 1,920,855
| | |
| 461,400
| | | Odontoprev Dental Insurance | | | 1,900,314
| | |
| 100,000
| | | Linx Retail Management Software in Brazil | | | 1,673,427
| | |
| 111,800
| | | Mills Estruturas e Servicos de Engenharia Civil Engineering & Construction | | | 1,515,151
| | |
| | | 15,907,544 | | |
| | Mexico – 1.8% | |
| 1,722,600
| | | Genomma Lab Internacional (b) Develops, Markets & Distributes Consumer Products | | | 3,402,007
| | |
| 28,000
| | | Grupo Aeroportuario del Sureste – ADR Mexican Airport Operator | | | 3,114,720
| | |
| 600,222
| | | Gruma (b) Tortilla Producer & Distributor | | | 2,728,398
| | |
| 816,000
| | | Bolsa Mexicana de Valores Mexico's Stock Exchange | | | 2,029,066
| | |
| 641,824
| | | Qualitas Leading Auto Insurer in Mexico & Central America | | | 1,535,529
| | |
| | | 12,809,720 | | |
Number of Shares | | | | Value | |
| | Chile – 0.6% | |
| 65,995
| | | Sociedad Quimica y Minera de Chile — ADR Producer of Specialty Fertilizers, Lithium & Iodine | | $ | 2,666,198
| | |
| 2,300,000
| | | Grupo Hites Mass Retailer for the Lower Income Strata | | | 1,806,771
| | |
| | | 4,472,969 | | |
| | Uruguay – 0.3% | |
| 230,870
| | | Union Agriculture Group (b) (e) (f) Farmland Operator in Uruguay | | | 2,389,504
| | |
| | Colombia – 0.3% | |
| 1,503,000
| | | Isagen (b) Leading Colombian Electricity Provider | | | 2,013,975
| | |
| | Guatemala – 0.3% | |
| 132,362
| | | Tahoe Resources (b) Silver Project in Guatemala | | | 1,876,502
| | |
| | Argentina – —% | |
| 459,000
| | | Madalena Ventures (b) Oil & Gas Exploration in Argentina | | | 122,202
| | |
| | | | Total Latin America | | | 39,592,416 | | |
Total Equities (Cost: $525,131,728) – 97.7% | | | 698,854,223 | (g) | |
Short-Term Investments – 1.4% | | | |
| 6,773,346
| | | JPMorgan U.S. Government Money Market Fund, Capital Shares (7 day yield of 0.01%) | | | 6,773,346 | | |
| 3,334,246
| | | JPMorgan U.S. Government Money Market Fund, Agency Shares (7 day yield of 0.01%) | | | 3,334,246 | | |
Total Short-Term Investments (Cost: $10,107,592) – 1.4% | | | 10,107,592 | | |
See accompanying notes to financial statements.
15
Wanger International 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
Securities Lending Collateral – 2.0% | |
| 14,168,673 | | | Dreyfus Government Cash Management Fund, Institutional Shares (7 day yield of 0.01%) (h) | | $ | 14,168,673 | | |
Total Securities Lending Collateral (Cost: $14,168,673) | | | 14,168,673 | | |
Total Investments (Cost: $549,407,993) (i) – 101.1% | | | 723,130,488 | | |
Obligation to Return Collateral for Securities Loaned – (2.0)% | | | (14,168,673 | ) | |
Cash and Other Assets Less Liabilities – 0.9% | | | 6,398,936 | | |
Net Assets – 100.0% | | $ | 715,360,751 | | |
ADR = American Depositary Receipts
GDR = Global Depositary Receipts
REIT = Real Estate Investment Trust
Notes to Statement of Investments
(a) All or a portion of this security was on loan at June 30, 2013. The total market value of securities on loan at June 30, 2013 was $13,479,204.
(b) Non-income producing security.
(c) Security is traded on a U.S. exchange.
(d) The common stock equity holdings of Marel are stated separately on the Statement of Investments due to the application of the onshore or offshore foreign currency exchange rate. The appropriate exchange rate is applied to each purchased security lot based on the applicable registration obtained from Marel's regulatory governing body, the Icelandic Central Bank.
(e) Denotes a restricted security, which is subject to restrictions on resale under federal securities laws. These securities are valued at fair value determined in good faith under consistently applied procedures established by the Board of Trustees. At June 30, 2013, the market value of these securities amounted to $3,512,093, which represented 0.49% of total net assets. Additional information on these securities is as follows:
Security | | Acquisition Dates | | Shares | | Cost | | Value | |
Union Agriculture Group | | 12/8/10- 6/27/12 | | | 230,870 | | | $ | 2,649,999 | | | $ | 2,389,504 | | |
DeeThree Exploration | | 9/7/10 | | | 158,516 | | | | 413,939 | | | | 1,122,589 | | |
| | | | | | $ | 3,063,938 | | | $ | 3,512,093 | | |
(f) Illiquid security.
(g) On June 30, 2013, the Fund's total investments were denominated in currencies as follows:
Currency | | Value | | Percentage of Net Assets | |
Japanese Yen | | $ | 149,559,500 | | | | 20.9 | | |
Euro | | | 86,899,892 | | | | 12.2 | | |
British Pound | | | 71,886,833 | | | | 10.0 | | |
United States Dollar | | | 54,931,345 | | | | 7.7 | | |
Taiwan Dollar | | | 50,234,734 | | | | 7.0 | | |
Hong Kong Dollar | | | 36,350,175 | | | | 5.1 | | |
Other currencies less than 5% of total net assets | | | 248,991,744 | | | | 34.8 | | |
Total Equities | | $ | 698,854,223 | | | | 97.7 | | |
(h) Investment made with cash collateral received from securities lending activity.
(i) At June 30, 2013, for federal income tax purposes, the cost of investments was $549,407,993 and net unrealized appreciation was $173,722,495 consisting of gross unrealized appreciation of $209,309,639 and gross unrealized depreciation of $35,587,144.
Fair Value Measurements
Various inputs are used in determining the value of the Fund's investments, following the input prioritization hierarchy established by accounting principles generally accepted in the United States of America (GAAP). These inputs are summarized in the three broad levels listed below:
• Level 1 – quoted prices in active markets for identical securities
• Level 2 – prices determined using other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others)
• Level 3 – prices determined using significant unobservable inputs where quoted prices or observable inputs are unavailable or less reliable (including management's own assumptions about the factors market participants would use in pricing an investment)
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
Examples of the types of securities in which the Fund would typically invest and how they are classified within this hierarchy are as follows. Typical Level 1 securities include exchange traded domestic equities, mutual funds whose NAVs are published each day and exchange traded foreign equities that are not statistically fair valued. Typical Level 2 securities include exchange traded foreign equities that are statistically fair valued, forward foreign currency exchange contracts and short-term investments valued at amortized cost. Additionally, securities fair valued by the Valuation Committee (the Committee) of the Fund's Board of Trustees (the Board) that rely on significant observable inputs are also included in Level 2. Typical Level 3 securities include any security fair valued by the Committee that relies on significant unobservable inputs.
Under the direction of the Board, the Committee is responsible for carrying out the valuation procedures approved by the Board.
The Committee meets as necessary, and no less frequently than quarterly, to determine fair values for securities for which market quotations are not readily available or for which the investment manager believes that available market quotations are unreliable, to review the appropriateness of the Trust's Portfolio Pricing Policy and the pricing procedures of the investment manager (the Policies), and to review the continuing
See accompanying notes to financial statements.
16
Wanger International 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
appropriateness of the current value of any security subject to the Policies. The Policies address, among other things: circumstances under which market quotations will be deemed readily available; selection of third party pricing vendors; appropriate pricing methodologies; events that require fair valuation and fair value techniques; and circumstances under which securities will be deemed to pose a potential for stale pricing, including when securities are illiquid, restricted, or in default. The Committee may also meet to discuss additional valuation matters, which may include review of back-testing results, review of time-sensitive information or approval of other valuation related actions, and to review the appropriateness of the Policies.
For investments categorized as Level 3, the significant unobservable inputs used in the fair value measurement of the Funds' securities may include: (i) data specific to the issuer or comparable issuers, (ii) general market or specific sector news and (iii) quoted prices and specific or similar security transactions. The Committee considers this data and any changes from prior periods in order to assess the reasonableness of observable and unobservable inputs, any assumptions or internal models used to value those securities and changes in fair value. Significant changes in any of these factors could result in lower or higher fair value measurements. Various factors impact the frequency of monitoring (which may occur as often as daily), however the Committee may determine that changes to inputs, assumptions and models are not required with the same frequency.
The following table summarizes the inputs used, as of June 30, 2013, in valuing the Fund's assets:
Investment Type | |
Quoted Prices (Level 1) | | Other Significant Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | |
Total | |
Equities | |
Asia | | $ | 13,439,615 | | | $ | 320,532,327 | | | $ | — | | | $ | 333,971,942 | | |
Europe | | | 6,258,123 | | | | 219,090,701 | | | | — | | | | 225,348,824 | | |
Other Countries | | | 48,371,542 | | | | 51,569,499 | | | | — | | | | 99,941,041 | | |
Latin America | | | 34,852,811 | | | | 2,350,101 | | | | 2,389,504 | | | | 39,592,416 | | |
Total Equities | | | 102,922,091 | | | | 593,542,628 | | | | 2,389,504 | | | | 698,854,223 | | |
Total Short-Term Investments | | | 10,107,592 | | | | — | | | | — | | | | 10,107,592 | | |
Total Securities Lending Collateral | | | 14,168,673 | | | | — | | | | — | | | | 14,168,673 | | |
Total Investments | | $ | 127,198,356 | | | $ | 593,542,628 | | | $ | 2,389,504 | | | $ | 723,130,488 | | |
The Fund's assets assigned to the Level 2 input category are generally valued using a market approach, in which a security's value is determined through its correlation to prices and information from observable market transactions for similar or identical assets. Foreign equities are generally valued at the last sale price on the foreign exchange or market on which they trade. The Fund may use a statistical fair valuation model, in accordance with the policy adopted by the Board, provided by an independent third party to value securities principally traded in foreign markets in order to adjust for possible stale pricing that may occur between the close of the foreign exchanges and the time for valuation. These models take into account available market data including intraday index, ADR, and ETF movements. Securities acquired via private placement that have a holding period or an extended settlement period are valued at a discount to the same shares that are trading freely on the market. These discounts are determined by the investment manager's experience with similar securities or situations. Factors may include, but are not limited to, trade volume, shares outstanding and stock price.
There were no transfers of financial assets between levels 1 and 2 during the period.
The Fund does not hold any significant investments categorized as Level 3.
Certain common stock classified as Level 3 are valued at fair value, using a market approach, as determined in good faith under consistently applied procedures established by and under the general supervision of the Board. To determine fair value for these securities, for which no market exists, the Committee utilizes the valuation technique it deems most appropriate in the circumstances, using some unobservable inputs, which may include, but are not limited to, trades of similar securities, estimated earnings of the company, market multiples derived from a set of comparable companies, and the position of the security within the company's capital structure. Significant increases or decreases to any of these inputs could result in a significantly lower or higher fair value measurement.
See accompanying notes to financial statements.
17
Wanger International 2013 Semiannual Report
Portfolio Diversification (Unaudited) June 30, 2013
At June 30, 2013, the Fund's portfolio investments as a percentage of net assets were diversified as follows:
| | Value | | Percentage of Net Assets | |
Industrial Goods & Services | |
Industrial Materials & Specialty Chemicals | | $ | 52,468,786 | | | | 7.3 | | |
Machinery | | | 42,086,712 | | | | 5.9 | | |
Other Industrial Services | | | 40,725,614 | | | | 5.7 | | |
Electrical Components | | | 18,880,313 | | | | 2.6 | | |
Conglomerates | | | 10,817,130 | | | | 1.5 | | |
Construction | | | 10,523,531 | | | | 1.5 | | |
Outsourcing Services | | | 4,115,303 | | | | 0.6 | | |
Industrial Distribution | | | 4,084,709 | | | | 0.6 | | |
| | | 183,702,098 | | | | 25.7 | | |
Consumer Goods & Services | |
Retail | | | 52,580,997 | | | | 7.4 | | |
Food & Beverage | | | 27,787,719 | | | | 3.9 | | |
Casinos & Gaming | | | 26,064,941 | | | | 3.6 | | |
Other Durable Goods | | | 16,840,868 | | | | 2.4 | | |
Nondurables | | | 16,564,821 | | | | 2.3 | | |
Restaurants | | | 10,480,573 | | | | 1.5 | | |
Other Consumer Services | | | 9,352,934 | | | | 1.3 | | |
Consumer Goods Distribution | | | 7,826,867 | | | | 1.1 | | |
Travel | | | 4,524,615 | | | | 0.6 | | |
Apparel | | | 3,728,214 | | | | 0.5 | | |
Educational Services | | | 2,777,924 | | | | 0.4 | | |
Furniture & Textiles | | | 2,123,940 | | | | 0.3 | | |
| | | 180,654,413 | | | | 25.3 | | |
Information | |
Computer Hardware & Related Equipment | | | 24,522,056 | | | | 3.4 | | |
Mobile Communications | | | 22,704,911 | | | | 3.2 | | |
Business Software | | | 20,598,109 | | | | 2.9 | | |
Internet Related | | | 12,864,208 | | | | 1.8 | | |
Computer Services | | | 11,070,674 | | | | 1.5 | | |
Semiconductors & Related Equipment | | | 8,124,259 | | | | 1.1 | | |
Financial Processors | | | 7,780,397 | | | | 1.1 | | |
Instrumentation | | | 4,409,605 | | | | 0.6 | | |
Telephone & Data Services | | | 2,150,718 | | | | 0.3 | | |
TV Broadcasting | | | 1,107,455 | | | | 0.2 | | |
Satellite Broadcasting & Services | | | 1,104,040 | | | | 0.2 | | |
Electronics Distribution | | | 517,069 | | | | 0.1 | | |
Advertising | | | 480,526 | | | | 0.1 | | |
| | | 117,434,027 | | | | 16.5 | | |
| | Value | | Percentage of Net Assets | |
Finance | |
Insurance | | $ | 29,133,329 | | | | 4.0 | | |
Banks | | | 17,220,610 | | | | 2.4 | | |
Brokerage & Money Management | | | 15,714,434 | | | | 2.2 | | |
Finance Companies | | | 7,646,352 | | | | 1.1 | | |
Specialized Finance | | | 2,029,066 | | | | 0.3 | | |
| | | 71,743,791 | | | | 10.0 | | |
Other Industries | |
Real Estate | | | 47,342,822 | | | | 6.6 | | |
Transportation | | | 13,728,949 | | | | 1.9 | | |
Regulated Utilities | | | 5,918,600 | | | | 0.8 | | |
| | | 66,990,371 | | | | 9.3 | | |
Energy & Minerals | |
Oil Services | | | 24,785,235 | | | | 3.5 | | |
Mining | | | 15,912,946 | | | | 2.2 | | |
Oil & Gas Producers | | | 4,482,261 | | | | 0.6 | | |
Agricultural Commodities | | | 3,654,806 | | | | 0.5 | | |
Oil Refining, Marketing & Distribution | | | 1,648,288 | | | | 0.2 | | |
| | | 50,483,536 | | | | 7.0 | | |
Health Care | |
Medical Supplies | | | 10,529,774 | | | | 1.5 | | |
Medical Equipment & Devices | | | 7,955,399 | | | | 1.1 | | |
Pharmaceuticals | | | 6,624,960 | | | | 0.9 | | |
Health Care Services | | | 2,735,854 | | | | 0.4 | | |
| | | 27,845,987 | | | | 3.9 | | |
Total Equities: | | | 698,854,223 | | | | 97.7 | | |
Short-Term Investments: | | | 10,107,592 | | | | 1.4 | | |
Securities Lending Collateral: | | | 14,168,673 | | | | 2.0 | | |
Total Investments: | | | 723,130,488 | | | | 101.1 | | |
Obligation to Return Collateral for Securities Loaned: | | | (14,168,673 | ) | | | (2.0 | ) | |
Cash and Other Assets Less Liabilities: | | | 6,398,936 | | | | 0.9 | | |
Net Assets: | | | 715,360,751 | | | | 100.0 | % | |
See accompanying notes to financial statements.
18
Wanger International 2013 Semiannual Report
Statement of Assets and Liabilities
June 30, 2013 (Unaudited)
Assets: | |
Investments, at cost | | $ | 549,407,993 | | |
Investments, at value (including securities on loan of $13,479,204) | | $ | 723,130,488 | | |
Foreign currency (cost of $1,437,918) | | | 1,422,563 | | |
Receivable for: | |
Investments sold | | | 7,204,801 | | |
Fund shares sold | | | 32,768 | | |
Securities lending income | | | 23,808 | | |
Dividends | | | 747,885 | | |
Foreign tax reclaims | | | 664,103 | | |
Trustees' deferred compensation plan | | | 114,527 | | |
Prepaid expenses | | | 3,962 | | |
Total Assets | | | 733,344,905 | | |
Liabilities: | |
Collateral on securities loaned | | | 14,168,673 | | |
Payable for: | |
Investments purchased | | | 2,964,395 | | |
Fund shares redeemed | | | 500,981 | | |
Investment advisory fee | | | 17,733 | | |
Administration fee | | | 975 | | |
Transfer agent fee | | | 1 | | |
Trustees' fees | | | 849 | | |
Custody fee | | | 47,087 | | |
Reports to shareholders | | | 133,491 | | |
Trustees' deferred compensation plan | | | 114,527 | | |
Other liabilities | | | 35,442 | | |
Total Liabilities | | | 17,984,154 | | |
Net Assets | | $ | 715,360,751 | | |
Composition of Net Assets: | |
Paid-in capital | | $ | 498,670,591 | | |
Overdistributed net investment income | | | (14,776,742 | ) | |
Accumulated net realized gain | | | 57,769,383 | | |
Net unrealized appreciation (depreciation) on: | | | | | |
Investments | | | 173,722,495 | | |
Foreign currency translations | | | (24,976 | ) | |
Net Assets | | $ | 715,360,751 | | |
Fund Shares Outstanding | | | 23,766,233 | | |
Net asset value, offering price and redemption price per share | | $ | 30.10 | | |
Statement of Operations
For the Six Months Ended June 30, 2013 (Unaudited)
Investment Income: | |
Dividend income (net foreign taxes withheld of $989,525) | | $ | 8,933,261 | | |
Interest income | | | 10 | | |
Securities lending income, net | | | 175,192 | | |
Total Investment Income | | | 9,108,463 | | |
Expenses: | |
Investment advisory fee | | | 3,242,942 | | |
Administration fee | | | 178,930 | | |
Transfer agent fees | | | 247 | | |
Trustees' fees | | | 15,003 | | |
Custody fees | | | 182,006 | | |
Reports to shareholders | | | 96,309 | | |
Audit fees | | | 23,546 | | |
Legal fees | | | 22,885 | | |
Chief compliance officer expenses (See Note 4) | | | 10,110 | | |
Commitment fee for line of credit (See Note 5) | | | 2,040 | | |
Other expenses | | | 25,123 | | |
Net Expenses | | | 3,799,141 | | |
Net Investment Income | | | 5,309,322 | | |
Net Realized and Unrealized Gain (Loss) on Investments: | |
Net realized gain (loss) on: | |
Investments | | | 61,679,342 | | |
Foreign currency translations | | | (255,221 | ) | |
Net realized gain | | | 61,424,121 | | |
Net change in unrealized appreciation (depreciation) on: | | | | | |
Investments | | | (26,610,042 | ) | |
Foreign currency translations | | | (626 | ) | |
Net change in unrealized depreciation | | | (26,610,668 | ) | |
Net realized and unrealized gain | | | 34,813,453 | | |
Net Increase in Net Assets from Operations | | $ | 40,122,775 | | |
See accompanying notes to financial statements.
19
Wanger International 2013 Semiannual Report
Statements of Changes in Net Assets
Increase (Decrease) in Net Assets | | (Unaudited) Six Months Ended June 30, 2013 | | Year Ended December 31, 2012 | |
Operations: | |
Net investment income | | $ | 5,309,322 | | | $ | 10,657,545 | | |
Net realized gain (loss) on: | |
Investments | | | 61,679,342 | | | | 59,347,239 | | |
Foreign currency translations | | | (255,221 | ) | | | (293,590 | ) | |
Forward foreign currency exchange contracts | | | — | | | | 536,207 | | |
Net change in unrealized appreciation (depreciation) on: | |
Investments | | | (26,610,042 | ) | | | 63,222,289 | | |
Affiliated investments | | | — | | | | 4,709,968 | | |
Foreign currency translations | | | (626 | ) | | | (3,456 | ) | |
Forward foreign currency exchange contracts | | | — | | | | (447,630 | ) | |
Foreign capital gains tax | | | — | | | | 299,433 | | |
Net Increase in Net Assets from Operations | | | 40,122,775 | | | | 138,028,005 | | |
Distributions to Shareholders From: | |
Net investment income | | | (13,530,998 | ) | | | (8,399,015 | ) | |
Net realized gains | | | (50,758,012 | ) | | | (64,994,967 | ) | |
Total Distributions to Shareholders | | | (64,289,010 | ) | | | (73,393,982 | ) | |
Share Transactions: | |
Subscriptions | | | 21,633,933 | | | | 19,075,946 | | |
Distributions reinvested | | | 64,289,010 | | | | 73,393,982 | | |
Redemptions | | | (49,062,620 | ) | | | (136,654,538 | ) | |
Net Increase (Decrease) from Share Transactions | | | 36,860,323 | | | | (44,184,610 | ) | |
Total Increase in Net Assets | | | 12,694,088 | | | | 20,449,413 | | |
Net Assets: | |
Beginning of period | | | 702,666,663 | | | | 682,217,250 | | |
End of period | | $ | 715,360,751 | | | $ | 702,666,663 | | |
Overdistributed net investment income | | $ | (14,776,742 | ) | | $ | (6,555,066 | ) | |
See accompanying notes to financial statements.
20
Wanger International 2013 Semiannual Report
The following table is intended to help you understand the Fund's financial performance. Certain information reflects financial results for a single share held for the periods shown. Per share net investment income (loss) amounts are calculated based on average shares outstanding during the period. Total return assumes reinvestment of all dividends and distributions. Total return does not reflect payment of the expenses that apply to the variable accounts or contract charges, if any, and are not annualized for periods of less than one year.
| | (Unaudited) Six Months Ended June 30, | | Year Ended December 31, | |
Selected data for a share outstanding throughout each period | | 2013 | | 2012 | | 2011 | | 2010 | | 2009 | | 2008 | |
Net Asset Value, Beginning of Period | | $ | 31.19 | | | $ | 28.79 | | | $ | 36.16 | | | $ | 29.68 | | | $ | 20.69 | | | $ | 44.04 | | |
Income from Investment Operations: | |
Net investment income | | | 0.24 | | | | 0.46 | | | | 0.42 | | | | 0.35 | | | | 0.30 | | | | 0.52 | | |
Net realized and unrealized gain (loss) | | | 1.61 | | | | 5.27 | | | | (5.31 | ) | | | 6.93 | | | | 9.61 | | | | (18.37 | ) | |
Reimbursement from affiliate | | | — | | | | — | | | | 0.00 | (a) | | | — | | | | — | | | | — | | |
Total from Investment Operations | | | 1.85 | | | | 5.73 | | | | (4.89 | ) | | | 7.28 | | | | 9.91 | | | | (17.85 | ) | |
Less Distributions to Shareholders: | |
Net investment income | | | (0.62 | ) | | | (0.38 | ) | | | (1.64 | ) | | | (0.80 | ) | | | (0.93 | ) | | | (0.34 | ) | |
Net realized gains | | | (2.32 | ) | | | (2.95 | ) | | | (0.84 | ) | | | — | | | | — | | | | (5.16 | ) | |
Total Distributions to Shareholders | | | (2.94 | ) | | | (3.33 | ) | | | (2.48 | ) | | | (0.80 | ) | | | (0.93 | ) | | | (5.50 | ) | |
Increase from regulatory settlements | | | — | | | | — | | | | — | | | | — | | | | 0.01 | | | | — | | |
Net Asset Value, End of Period | | $ | 30.10 | | | $ | 31.19 | | | $ | 28.79 | | | $ | 36.16 | | | $ | 29.68 | | | $ | 20.69 | | |
Total Return | | | 5.77 | % | | | 21.56 | %(b) | | | (14.62 | )%(b) | | | 24.92 | %(b) | | | 49.78 | % | | | (45.60 | )% | |
Ratios to Average Net Assets/Supplemental Data: | |
Total gross expenses | | | 1.06 | %(c)(d) | | | 1.08 | %(d) | | | 1.06 | %(d) | | | 1.07 | %(d) | | | 1.05 | %(d) | | | 1.02 | % | |
Total net expenses | | | 1.06 | %(c)(d) | | | 1.05 | %(d)(e) | | | 1.00 | %(d)(e) | | | 1.04 | %(d)(e) | | | 1.05 | %(d)(e) | | | 1.02 | %(e) | |
Net investment income | | | 1.48 | %(c) | | | 1.51 | % | | | 1.25 | % | | | 1.12 | % | | | 1.23 | % | | | 1.67 | % | |
Portfolio turnover rate | | | 26 | % | | | 34 | % | | | 36 | % | | | 32 | % | | | 37 | % | | | 36 | % | |
Net assets, end of period (000s) | | $ | 715,361 | | | $ | 702,667 | | | $ | 682,217 | | | $ | 925,761 | | | $ | 1,442,428 | | | $ | 972,860 | | |
Notes to Financial Highlights
(a) Rounds to zero.
(b) Had the investment manager and/or its affiliates not waived a portion of expenses, total return would have been reduced.
(c) Annualized.
(d) In addition to the fees and expenses which the Fund bears directly, the Fund indirectly bears a pro rata share of the fees and expenses of the underlying funds in which it invests. Such indirect expenses are not included in the reported expense ratios.
(e) The benefits derived from custody fees paid indirectly had an impact of less than 0.01%.
See accompanying notes to financial statements.
21
Wanger International 2013 Semiannual Report
Notes to Financial Statements (Unaudited)
1. Nature of Operations
Wanger International (the Fund), a series of Wanger Advisors Trust (the Trust), is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The investment objective of the Fund is to seek long-term capital appreciation. The Fund is available only for allocation to certain life insurance company separate accounts established for the purpose of funding participating variable annuity contracts and variable life insurance policies and may also be offered directly to certain qualified pension and retirement plans.
2. Significant Accounting Policies
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (GAAP) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Security valuation
Securities of the Fund are valued at market value or, if a market quotation for a security is not readily available or is deemed not to be reliable because of events or circumstances that have occurred between the market quotation and the time as of which the security is to be valued, the security is valued at its fair value determined in good faith under consistently applied procedures established by the Board of Trustees (the Board). A security traded on a securities exchange or in an over-the-counter market in which transaction prices are reported is valued at the last sales price at the time of valuation. A security traded principally on NASDAQ is valued at the NASDAQ official closing price. Mutual funds and exchange traded funds are valued at their closing net asset value as reported to the applicable exchange. A security for which there is no reported sale on the valuation date is valued at the mean of the latest bid and ask quotations.
Short-term investments maturing in 60 days or less are valued at amortized cost, which approximates market value.
A security for which a market quotation is not readily available and any other assets are valued at their fair value determined in good faith under consistently applied procedures established by the Board. The Trust has retained an independent statistical fair value pricing service that employs a systematic methodology to assist in the fair valuation process for securities principally traded in a foreign market in order to adjust for possible changes in value that may occur between the close of the foreign market and the time as of which the securities are to be valued. If a security is valued at a fair value, that value may be different from the last quoted market price for the security.
Foreign currency translations
Values of investments denominated in foreign currencies are converted into U.S. dollars using the New York spot market rate of exchange at the time of valuation. Purchases and sales of investments and dividend and interest income are translated into U.S. dollars using the spot market rate of exchange prevailing on the respective dates of such transactions. The gain or loss resulting from changes in foreign exchange rates is included with net realized and unrealized gain or loss from investments, as appropriate.
Restricted securities
Restricted securities are securities that may only be resold upon registration under federal securities laws or in transactions exempt from registration. In some cases, the issuer of restricted securities has agreed to register such securities for resale at the
issuer's expense either upon demand by the Fund or in connection with another registered offering of the securities. Many restricted securities may be resold in the secondary market in transactions exempt from registration. Such restricted securities may be determined to be liquid under criteria established by the Board.
Security transactions and investment income
Security transactions are accounted for on the trade date (date the order to buy or sell is executed) and dividend income is recorded on the ex-dividend date, except that certain dividends from foreign securities are recorded as soon as the information is available to the Fund. Interest income is recorded on the accrual basis and includes amortization of discounts on debt obligations when required for federal income tax purposes. Realized gains and losses from security transactions are recorded on an identified cost basis.
Awards, if any, from class action litigation related to securities owned may be recorded as a reduction of cost of those securities. If the applicable securities are no longer owned, the proceeds are recorded as realized gains.
The Fund estimates the tax character of distributions from real estate investment trusts (REITs). Distributions received in excess of income are recorded as a reduction of the cost of the related investments. If the applicable securities are no longer owned, any distributions received in excess of income are recorded as realized gains.
Expenses
General expenses of the Trust are allocated to the Fund and the other series of the Trust based upon relative net assets or other expense allocation methodologies determined by the nature of the expense. Expenses directly attributable to the Fund are charged to the Fund.
Fund share valuation
Fund shares are sold and redeemed on a continuing basis at net asset value. Net asset value per share is determined daily as of the close of trading on the New York Stock Exchange (the Exchange) on each day the Exchange is open for trading by dividing the total value of the Fund's investments and other assets, less liabilities, by the number of Fund shares outstanding.
Securities lending
The Fund may lend securities up to one-third of the value of its total assets to certain approved brokers, dealers and other financial institutions to earn additional income. The Fund retains the benefits of owning the securities, including receipt of dividends or interest generated by the security. The Fund also receives a fee for the loan. The Fund has the ability to recall the loans at any time and could do so in order to vote proxies or to sell the loaned securities. Each loan is collateralized by cash that exceeded the value of the securities on loan. The market value of the loaned securities is determined daily at the close of business of the Fund and any additional required collateral is delivered to each Fund on the next business day. The Fund has elected to invest the cash collateral in the Dreyfus Government Cash Management Fund and the income earned is paid to the Fund, net of any fees remitted to Goldman Sachs Agency Lending, the Fund's lending agent and borrower rebates. The Fund's investment manager, Columbia Wanger Asset Management, LLC (CWAM), does not retain any fees earned by the lending program. Generally, in the event of borrower default, the Fund has the right to use the collateral to offset any losses incurred. In the event the Fund is delayed or prevented from exercising its right to dispose of the collateral, there may be a potential loss to the Fund. Some of these losses may be indemnified by the lending agent. The Fund bears the risk of loss with respect to the investment of collateral. The net lending income earned by the Fund as of June 30, 2013, is included in the Statement of Operations.
22
Wanger International 2013 Semiannual Report
Notes to Financial Statements, continued (Unaudited)
The following table presents the Fund's gross and net amount of assets available for offset under a securities lending agreement as well as the related collateral received by the Fund as of June 30, 2013:
| | Gross Amounts of | | Gross Amounts Offset in the | | Net Amounts of Assets Presented in the | | Gross Amounts Not Offset in the Statement of Assets and Liabilities | | | |
| | Recognized Assets | | Statement of Assets and Liabilities | | Statement of Assets and Liabilities | | Financial Instruments (a) | | Cash Collateral Received | | Securities Collateral Received | | Net Amount (b) | |
Securities loaned | | $ | 13,479,204 | | | $ | — | | | $ | 13,479,204 | | | $ | — | | | $ | 13,479,204 | | | $ | — | | | $ | — | | |
(a) Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar agreements that management elects not to offset on the Statement of Assets and Liabilities.
(b) Represents the net amount due from counterparties in the event of default.
Federal income taxes
The Fund has complied with the provisions of the Internal Revenue Code available to regulated investment companies and, in the manner provided therein, distributes substantially all its taxable income, as well as any net realized gain on sales of investments and foreign currency transactions reportable for federal income tax purposes. Accordingly, the Fund paid no federal income taxes and no federal income tax provision was required.
Foreign capital gains taxes
Gains in certain countries may be subject to foreign taxes at the fund level. The Fund accrues for such foreign taxes on realized and unrealized gains at the appropriate rate for each jurisdiction. The amount, if any, is disclosed as a liability on the Statement of Assets and Liabilities.
Distributions to shareholders
Distributions to shareholders are recorded on the ex-dividend date.
Indemnification
In the normal course of business, the Trust on behalf of the Fund enters into contracts that contain a variety of representations and warranties and that provide general indemnities. The Fund's maximum exposure under these arrangements is unknown, as this would involve future claims against the Fund. Also under the Trust's organizational documents, the trustees and officers of the Trust are indemnified against certain liabilities that may arise out of their duties to the Trust. However based on experience, the Fund expects the risk of loss due to these warranties and indemnities to be remote.
3. Federal Tax Information
The timing and character of income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. Reclassifications are made to the Fund's capital accounts for permanent tax differences to reflect income and gains available for distribution (or available capital loss carryforwards) under income tax regulations.
Management is required to determine whether a tax position of the Fund is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized by the Fund is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Management is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. However, management's conclusions may be subject to review and adjustment at a later date based on factors including, but not limited to, new tax laws, regulations, and administrative interpretations (including relevant court decisions). The Fund's federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
4. Transactions With Affiliates
CWAM is a wholly owned subsidiary of Columbia Management Investment Advisers, LLC (Columbia Management), which in turn is a wholly owned subsidiary of Ameriprise
Financial, Inc. (Ameriprise Financial). CWAM furnishes continuing investment supervision to the Fund and is responsible for the overall management of the Fund's business affairs.
CWAM receives a monthly advisory fee based on the Fund's average daily net assets at the following annual rates:
Average Daily Net Assets | | Annual Fee Rate | |
Up to $100 million | | | 1.10 | % | |
$100 million to $250 million | | | 0.95 | % | |
$250 million to $500 million | | | 0.90 | % | |
$500 million to $1billion | | | 0.80 | % | |
$1 billion and over | | | 0.72 | % | |
For the six months ended June 30, 2013, the annualized effective investment advisory fee rate was 0.91% of the Fund's average daily net assets.
CWAM provides administrative services and receives an administration fee from the Fund at the following annual rates:
Wanger Advisors Trust Aggregate Average Daily Net Assets of the Trust | | Annual Fee Rate | |
Up to $4 billion | | | 0.05 | % | |
$4 billion to $6 billion | | | 0.04 | % | |
$6 billion to $8 billion | | | 0.03 | % | |
$8 billion and over | | | 0.02 | % | |
For the six months ended June 30, 2013, the annualized effective administration fee rate was 0.05% of the Fund's average daily net assets. Columbia Management provides certain sub-administrative services to the Fund.
Columbia Management Investment Distributors, Inc. (CMID), a wholly owned subsidiary of Ameriprise Financial, serves as the Fund's distributor and principal underwriter.
Columbia Management Investment Services Corp. (CMIS), a wholly owned subsidiary of Ameriprise Financial, is the transfer agent to the Fund. For its services, the Fund pays CMIS a monthly fee at the annual rate of $21.00 per open account. CMIS also receives reimbursement from the Fund for certain out-of-pocket expenses.
Certain officers and trustees of the Trust are also officers of CWAM. The Trust makes no direct payments to its officers and trustees who are affiliated with CWAM.
The Board has appointed a Chief Compliance Officer of the Trust in accordance with federal securities regulations. The Fund, along with other affiliated funds, pays its pro-rata share of the expenses associated with the Office of the Chief Compliance Officer. These expenses are disclosed separately as "Chief compliance officer expenses" in the Statement of Operations.
The Trust offers a deferred compensation plan for its independent trustees. Under that plan, a trustee may elect to defer all or a portion of his or her compensation. Amounts deferred are retained by the Trust and may represent an unfunded obligation of the Trust. The value of amounts deferred is determined by reference to the change in value of Class Z shares of one or more series of Columbia Acorn Trust or a money market fund as specified by the trustee. Benefits under the deferred compensation plan are payable in accordance with the plan.
23
Wanger International 2013 Semiannual Report
Notes to Financial Statements, continued (Unaudited)
For the six months ended June 30, 2013, the Fund engaged in purchase and sales transactions with funds that have a common investment manager (or affiliated investment managers), common directors/trustees, and/or common officers. Those sale transactions complied with provisions of Rule 17a-7 under the Investment Company Act of 1940 and were $121,931.
5. Borrowing Arrangements
During the six months ended June 30, 2013, the Trust participated in a credit facility with JPMorgan Chase Bank, N.A., along with Columbia Acorn Trust, another trust managed by CWAM, in the amount of $150 million prior to January 11, 2013, and in the amount of $200 million thereafter. The credit facility was entered into to facilitate portfolio liquidity. Under the facility, interest is charged to each participating fund based on its borrowings at a rate per annum equal to the Federal Funds Rate plus 1.00%. In addition, a commitment fee of 0.08% per annum of the unutilized line of credit is accrued and apportioned among the participating funds based on their relative net assets. The commitment fee is disclosed separately as "Commitment fee for line of credit" in the Statement of Operations. The Trust renewed the line of credit in July in the amount of $150 million, and will continue to do so each year, at then current market rates and terms.
No amounts were borrowed for the benefit of the Fund during the six months ended June 30, 2013.
6. Fund Share Transactions
Proceeds and payments on Fund shares as shown in the Statement of Changes in Net Assets are in respect of the following numbers of shares:
| | (Unaudited) Six months ended June 30, 2013 | | Year ended December 31, 2012 | |
Shares sold | | | 644,036 | | | | 635,020 | | |
Shares issued in reinvestment of dividend distributions | | | 2,098,205 | | | | 2,667,193 | | |
Less shares redeemed | | | (1,502,652 | ) | | | (4,471,543 | ) | |
Net increase (decrease) in shares outstanding | | | 1,239,589 | | | | (1,169,330 | ) | |
7. Investment Transactions
The aggregate cost of purchases and proceeds from sales other than short-term obligations for the six months ended June 30, 2013, were $186,965,946 and $210,546,483, respectively.
8. Shareholder Concentration
At June 30, 2013, one unaffiliated shareholder account owned 19.9% of the outstanding shares of the Fund. The Fund has no knowledge about whether any portion of those shares was owned beneficially by such account. Affiliated shareholder accounts owned 56.2% of the outstanding shares of the Fund. Subscription and redemption activity by concentrated accounts may have a significant effect on the operations of the Fund.
9. Subsequent Events
Management has evaluated the events and transactions that have occurred through the date the financial statements were issued and noted no items requiring adjustment of the financial statements or additional disclosure.
10. Information Regarding Pending and Settled Legal Proceedings
Ameriprise Financial and certain of its affiliates have historically been involved in a number of legal, arbitration and regulatory proceedings, including routine litigation, class actions, and governmental actions, concerning matters arising in connection with the conduct of their business activities. Ameriprise Financial believes that the Funds are not currently the subject of, and that neither Ameriprise Financial nor any of its affiliates are the subject of, any pending legal, arbitration or regulatory proceedings that are likely to have a material adverse effect on the Funds or the ability of
Ameriprise Financial or its affiliates to perform under their contracts with the Funds. Ameriprise Financial is required to make 10-Q, 10-K and, as necessary, 8-K filings with the Securities and Exchange Commission on legal and regulatory matters that relate to Ameriprise Financial and its affiliates. Copies of these filings may be obtained by accessing the SEC website at www.sec.gov.
There can be no assurance that these matters, or the adverse publicity associated with them, will not result in increased fund redemptions, reduced sale of fund shares or other adverse consequences to the Funds. Further, although we believe proceedings are not likely to have a material adverse effect on the Funds or the ability of Ameriprise Financial or its affiliates to perform under their contracts with the Funds, these proceedings are subject to uncertainties and, as such, we are unable to estimate the possible loss or range of loss that may result. An adverse outcome in one or more of these proceedings could result in adverse judgments, settlements, fines, penalties or other relief that could have a material adverse effect on the consolidated financial condition or results of operations of Ameriprise Financial.
24
Wanger International 2013 Semiannual Report
Board Approval of the Advisory Agreement
Wanger Advisors Trust (the "Trust") has an investment advisory agreement (the "Advisory Agreement") with Columbia Wanger Asset Management, LLC ("Columbia WAM") under which Columbia WAM manages Wanger International (the "Fund"). More than 75% of the trustees of the Trust (the "Trustees") are persons who have no direct or indirect interest in the Advisory Agreement and are not "interested persons" (as defined in the Investment Company Act of 1940, as amended (the "1940 Act")) of the Trust (the "Independent Trustees"). The Trustees oversee the management of the Fund and, as required by law, determine at least annually whether to continue the Advisory Agreement for the Fund.
The Contract Committee (the "Committee") of the Board of Trustees (the "Board"), which is comprised solely of Independent Trustees, makes recommendations to the Board regarding any proposed continuation of the Advisory Agreement. After the Committee has made its recommendations, the full Board determines whether to approve continuation of the Advisory Agreement. The Board also considers matters bearing on the Advisory Agreement at its various meetings throughout the year, meets at least quarterly with Columbia WAM's portfolio managers (the Board's Investment Performance Analysis Committee meets frequently with them as well), and receives monthly reports from Columbia WAM on the performance of the Fund.
In connection with their most recent consideration of the Advisory Agreement for the Fund, the Committee and all Trustees received and reviewed a substantial amount of information provided by Columbia WAM, Columbia Management Investment Advisers, LLC ("Columbia Management") and Ameriprise Financial, Inc. ("Ameriprise") in response to written requests from the Independent Trustees and their independent legal counsel. In addition, the Trustees reviewed the Management Fee Evaluation dated June 2013 (the "Fee Evaluation") prepared by the Trust's chief compliance officer, senior vice president and general counsel, at the request of the Board. Throughout the process, the Trustees had numerous opportunities to ask questions of and request additional materials from Columbia WAM, Columbia Management and Ameriprise.
During each meeting at which the Committee or the Independent Trustees considered the Advisory Agreement, they met in executive session with their independent legal counsel. The Committee also met with representatives of Columbia WAM, Columbia Management and Ameriprise on several occasions. In all, the Committee convened formally on four separate occasions to consider the continuation of the Advisory Agreement. The Board and/or some or all of the Independent Trustees met on other occasions to receive the Committee's status reports, receive presentations from Columbia WAM, Columbia Management and Ameriprise representatives, and to discuss outstanding issues. In addition, the Investment Performance Analysis Committee of the Board, also comprised exclusively of Independent Trustees, reviewed the performance of the Fund, met in a joint meeting with the Committee, and presented its findings to the Board and the Committee throughout the year. The Compliance Committee of the Board also provided information to the Committee with respect to relevant matters.
The materials reviewed by the Committee and the Trustees included, among other items, (i) information on the investment performance of the Fund and of independently selected peer groups of funds and of the Fund's performance benchmark over various time periods, (ii) information on the Fund's advisory fees and other expenses, including information comparing the Fund's fees and expenses to those of peer groups of funds and information about any applicable expense limitations and fee breakpoints, (iii) data on sales and redemptions of Fund shares, and (iv) information on the profitability to Columbia WAM and Ameriprise, as well as potential "fall-out" or ancillary benefits that Columbia WAM and its affiliates may receive as a result of their relationships with the Fund. The Trustees also considered other information such as (i) Columbia WAM's financial condition, (ii) the Fund's investment objective and strategy, (iii) the size, education and experience of Columbia WAM's investment staff and its use of technology, external research and trading cost measurement tools, (iv) the portfolio manager compensation framework, (v) the allocation of the Fund's brokerage, and the use of "soft" commission dollars to pay for research products and services, (vi) Columbia WAM's risk management program, and (vii) the resources devoted to, and the record of compliance with, the Fund's
investment policies and restrictions, policies on personal securities transactions and other compliance policies.
At a meeting held on June 5, 2013, upon the recommendation of the Committee, the Board unanimously approved the continuation of the Advisory Agreement.
In considering the continuation of the Advisory Agreement, the Trustees reviewed and analyzed various factors that they determined were relevant, none of which by itself was considered dispositive. The material factors and conclusions that formed the basis for the Trustees' determination to approve the continuation of the Advisory Agreement are discussed below.
Nature, quality and extent of services. The Trustees reviewed the nature, quality and extent of the services provided by Columbia WAM and its affiliates to the Fund under the Advisory Agreement, taking into account the investment objective and strategy of the Fund, its shareholder base, and knowledge gained from meetings with management, which were held on at least a quarterly basis. In addition, the Trustees reviewed the available resources and key personnel of Columbia WAM and its affiliates, especially those providing investment management services to the Fund. The Trustees also considered other services provided to the Fund by Columbia WAM and its affiliates, including: managing the execution of portfolio transactions and selecting broker-dealers for those transactions; monitoring adherence to the Fund's investment restrictions; producing shareholder reports; providing support services for the Board and committees of the Board; managing the Fund's securities lending program; communicating with shareholders; serving as the Fund's administrator; and overseeing the activities of the Fund's other service providers, including monitoring for compliance with various policies and procedures as well as applicable securities laws and regulations.
The Trustees concluded that the nature, quality and extent of the services provided by Columbia WAM and its affiliates to the Fund under the Advisory Agreement were appropriate for the Fund and that the Fund was likely to benefit from the continued provision of those services by Columbia WAM. They also concluded that Columbia WAM currently had sufficient personnel, with appropriate education and experience, to serve the Fund effectively, and that the firm had demonstrated its continuing ability to attract and retain well-qualified personnel. In addition, they considered the quality of Columbia WAM's compliance record.
Performance of the Fund. The Trustees received and considered detailed performance information at various meetings of the Board, the Committee and the Investment Performance Analysis Committee of the Board throughout the year. They reviewed information comparing the Fund's performance with that of its benchmark(s) and with the performance of comparable funds and peer groups as identified by Lipper Inc. ("Lipper") and Morningstar, Inc. ("Morningstar"). The Trustees evaluated the performance of the Fund over various time periods, including over the one-, three- and five-year periods ending December 31, 2012. The Trustees also considered peer performance rankings for similar time periods, although they generally focused more on the five-year period.
The Trustees considered that the Fund's returns were excellent versus its peer group and benchmark over the five-year period ending December 31, 2012. The Trustees noted that the Fund underperformed its Morningstar peers but not its Lipper peers for the one- and three-year periods and had outperformed its benchmark for both periods. They also considered that the Fund exposed shareholders to less risk than its peers.
The Trustees noted that the Fund's performance was satisfactory over the longer term but that the decline in recent performance was being monitored closely by the Board and the Investment Performance Analysis Committee.
Costs of Services and Profits Realized by Columbia WAM. At various Committee and Board meetings, the Trustees examined detailed information on the fees and expenses of the Fund in comparison to information for comparable funds provided by Lipper and Morningstar. The Trustees noted that the Fund's net expenses were higher than the Lipper peer group expenses, but lower than the Morningstar peer group. The Trustees also took into account that the actual advisory fees paid by the Fund were lower than the Morningstar median but higher than Lipper peers.
The Trustees also reviewed the advisory fee rates charged by Columbia WAM for managing other investment companies, sub-advised funds and other institutional
25
Wanger International 2013 Semiannual Report
Board Approval of the Advisory Agreement, continued
separate accounts, as detailed in materials provided to the Committee by Columbia WAM and in the Fee Evaluation. The Trustees noted that the Fund's advisory fees were generally comparable to Columbia Acorn International's advisory fees at the same asset levels. The Trustees also examined Columbia WAM's institutional separate account fees for parallel investment strategies and determined that institutional account advisory fees tended to be lower than or equal to the Fund. The Trustees noted that Columbia WAM performs significant additional services for the Fund that it does not provide to sub-advised funds or non-mutual fund clients, including administrative services, oversight of the Fund's other service providers, Trustee support, regulatory compliance and numerous other services, and that, in servicing the Fund, Columbia WAM assumes many legal and business risks that it does not assume in servicing many of its non-fund clients.
The Trustees concluded that the rate of advisory fees payable to Columbia WAM were reasonable in relation to the nature and quality of the services to be provided and the investment performance of the Fund, taking into account Columbia WAM's recent steps to improve performance of the Fund.
The Trustees reviewed the analysis of the historic profitability of Columbia WAM in serving as the Fund's investment manager and of Columbia WAM and its affiliates in their relationships with the Fund. The Committee and Trustees met with representatives from Ameriprise to discuss its methodologies for calculating profitability and allocating costs. They considered that Ameriprise calculated profitability and allocated costs on a contract-by-contract and Fund-by-Fund basis. The Trustees also considered the methodology used by Columbia WAM and Ameriprise in determining compensation payable to portfolio managers and the competitive market for investment management talent. The Trustees were also provided with profitability information from Lipper, which compared Columbia WAM's profitability to other similar investment managers in the mutual fund industry. The Trustees concluded that Columbia WAM's and its affiliates' profits were within a reasonable range of those of competitors with similar business models. The Trustees discussed, however, that profitability comparisons among fund managers may not always be meaningful due to the lack of consistency in data, small number of publicly-owned managers, and the fact that profitability of any investment manager is affected by numerous factors, including its particular organizational structure, the types of funds and other accounts managed, other lines of business, expense allocation methodology, capital structure and other factors.
Economies of Scale. At various Committee and Board meetings and other informal meetings, the Trustees considered information about the extent to which Columbia WAM realizes economies of scale in connection with an increase in Fund assets. The Trustees noted that the advisory fee schedule for the Fund includes breakpoints in the rate of fees at various asset levels. The Trustees concluded that the fee structure of the Fund was reflective of a sharing of economies of scale between Columbia WAM and the Fund.
Other Benefits to Columbia WAM. The Trustees also reviewed benefits that accrue to Columbia WAM and its affiliates from their relationships with the Fund, based upon information provided to them by Ameriprise and as outlined in the Fee Evaluation. They noted that the Fund's transfer agency services are performed by Columbia Management Investment Services Corp., an affiliate of Ameriprise, which receives compensation from the Fund for its services provided. They considered that an affiliate of Ameriprise, Columbia Management Investment Distributors, Inc. ("CMID"), serves as the Fund's distributor under an underwriting agreement but receives no fees for its services to the Fund. In addition, Columbia Management provides sub-administration services to the Fund. The Committee received information regarding the profitability of the Fund agreement with Columbia WAM affiliates. The Committee and the Board also reviewed information about and discussed the capabilities of each affiliated entity in performing its duties.
The Trustees considered other ways that the Fund and Columbia WAM may potentially benefit from their relationship with each other. For example, the Trustees considered Columbia WAM's use of commissions paid by the Fund on its portfolio brokerage transactions to obtain research products and services benefiting the Fund and/or other clients of Columbia WAM. The Committee reviewed Columbia WAM's annual "soft dollar" report and met with representatives from Columbia WAM to review
Columbia WAM's soft dollar spending. The Committee also considered that the Compliance Committee of the Board regularly reviewed third-party prepared reports that evaluated the quality of Columbia WAM's execution of the Fund's portfolio transactions. The Trustees noted that these reports showed that Columbia WAM's execution capabilities were generally better than industry peers. The Trustees determined that Columbia WAM's use of the Fund's "soft" commission dollars to obtain research products and services was consistent with current regulatory requirements and guidance. They also concluded that Columbia WAM benefits from the receipt of proprietary research products and services acquired through commissions paid on portfolio transactions of the Fund, and that the Fund benefitted from Columbia WAM's receipt of those products and services as well as research products and services acquired through commissions paid by other clients of Columbia WAM.
After full consideration of the above factors, as well as other factors that were instructive in evaluating the Advisory Agreement, the Trustees, including the Independent Trustees by separate vote, concluded that the continuation of the Advisory Agreement was in the best interest of the Fund. On June 5, 2013, the Trustees approved continuation of the Advisory Agreement through July 31, 2014.
26
Wanger International 2013 Semiannual Report
This page intentionally left blank.
27
Wanger International 2013 Semiannual Report
This page intentionally left blank.
28
Wanger International 2013 Semiannual Report
Trustees
Laura M. Born
Chair of the Board
Steven N. Kaplan
Vice Chair of the Board
Michelle L. Collins
Maureen M. Culhane
Margaret M. Eisen
John C. Heaton
Charles P. McQuaid
David J. Rudis
David B. Small
Ralph Wanger (Trustee Emeritus)
Officers
Charles P. McQuaid
President
Robert A. Chalupnik
Vice President
Michael G. Clarke
Assistant Treasurer
Joseph F. DiMaria
Assistant Treasurer
P. Zachary Egan
Vice President
Fritz Kaegi
Vice President
John M. Kunka
Assistant Treasurer
Stephen Kusmierczak
Vice President
Joseph C. LaPalm
Vice President
Bruce H. Lauer
Vice President, Secretary and Treasurer
Louis J. Mendes III
Vice President
Robert A. Mohn
Vice President
Christopher J. Olson
Vice President
Christopher O. Petersen
Assistant Secretary
Scott R. Plummer
Assistant Secretary
Linda K. Roth-Wiszowaty
Assistant Secretary
Robert P. Scales
Chief Compliance Officer, Chief Legal Officer, Senior Vice President and
General Counsel
Andreas Waldburg-Wolfegg
Vice President
Investment Manager
Columbia Wanger Asset Management, LLC
227 West Monroe Street, Suite 3000
Chicago, Illinois 60606
1-888-4-WANGER
(1-888-492-6437)
Transfer Agent,
Dividend Disbursing Agent
Columbia Management Investment Services Corp.
P.O. Box 8081
Boston, Massachusetts
02266-8081
Distributor
Columbia Management Investment Distributors, Inc.
225 Franklin Street
Boston, Massachusetts
02110
Legal Counsel to the Funds
Perkins Coie LLP
Washington, DC
Legal Counsel to the Independent Trustees
Drinker Biddle & Reath LLP
Philadelphia, Pennsylvania
Independent Registered Public Accounting Firm
PricewaterhouseCoopers LLP
Chicago, Illinois
This document contains Global Industry Classification Standard data. The Global Industry Classification Standard ("GICS") was developed by and is the exclusive property and a service mark of MSCI Inc. ("MSCI") and Standard & Poor's Financial Services LLC ("S&P") and is licensed for use by Columbia Wanger Asset Management, LLC ("CWAM"). Neither MSCI, S&P, nor any other party involved in making or compiling the GICS or any GICS classifications makes any express or implied warranties or representations with respect to such standard or classification (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability and fitness for a particular purpose with respect to any of such standard or classification. Without limiting any of the foregoing, in no event shall MSCI, S&P, any of their affiliates or any third party involved in making or compiling the GICS or any GICS classifications have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages.
This report, including the schedules of investments and financial statements, is submitted for the general information of the shareholders of the Wanger Advisors Trust.
A description of the Fund's proxy voting policies and procedures and a copy of the Fund's voting record for the most recent 12-month period ended June 30 are available (i) on our website, columbiamanagement.com, (ii) on the Securities and Exchange Commission's website at www.sec.gov, and (iii) without charge, upon request, by calling 888-492-6437.
The Fund files a complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q. The Fund's Form N-Q is available on the SEC's website at www.sec.gov and may be reviewed and copied at the SEC's Public Reference Room in Washington, D.C. Information on the operation of the Pubic Reference Room may be obtained by calling 800-SEC-0330. The Fund's complete portfolio holdings are disclosed at www.columbiamanagement.com approximately 30 to 40 days after each month-end.
29
© 2013 Columbia Management Investment Advisers, LLC. All rights reserved.
Wanger International Select
2013 Semiannual Report
Not FDIC insured • No bank guarantee • May lose value
Columbia Wanger Asset Management, LLC (CWAM) is one of the leading global small- and mid-cap equity managers in the United States with over 40 years of small- and mid-cap investment experience. As of June 30, 2013, CWAM managed $34.9 billion in assets. CWAM is the investment manager to Wanger USA, Wanger International, Wanger Select and Wanger International Select (together, the Columbia Wanger Funds) and the Columbia Acorn Family of Funds.
Investors should consider the investment objectives, risks, charges and expenses of a mutual fund carefully before investing. For a free prospectus, which contains this and other important information about the Fund, contact your financial adviser, insurance company, qualified pension or retirement plan sponsor or call 1-888-4-WANGER. Read the prospectus carefully before investing.
An important note: Columbia Wanger Funds are available for purchase through variable annuity contracts and variable life insurance policies offered by the separate accounts of participating insurance companies and qualified pension or retirement plans.
Shares of the Fund may not be purchased or sold directly by individual owners of variable annuity contracts and/or variable life insurance policies (collectively, Contracts) or participants in qualified retirement or other plans (collectively, Qualified Plans). If you are the owner of a Contract or a participant in a Qualified Plan, please refer to the prospectus that describes your Contract or Qualified Plan for information about minimum investment requirements and how to purchase and redeem shares of the Fund.
The views expressed in "Health Care in the United States" and in the Performance Review reflect the current views of the respective authors. These views are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict so actual outcomes and results may differ significantly from those stated. These views are subject to change at any time based upon economic, market or other conditions and the respective parties disclaim any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Columbia Wanger Fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any particular Columbia Wanger Fund. References to specific company securities should not be construed as a recommendation or investment advice.
Wanger International Select
2013 Semiannual Report
Table of Contents
| 2 | | | Understanding Your Expenses | |
| 3 | | | Health Care in the United States | |
| 6 | | | Performance Review | |
| 8 | | | Statement of Investments | |
| 13 | | | Statement of Assets and Liabilities | |
| 13 | | | Statement of Operations | |
| 14 | | | Statement of Changes in Net Assets | |
| 15 | | | Financial Highlights | |
| 16 | | | Notes to Financial Statements | |
| 20 | | | Board Approval of the Advisory Agreement | |
Wanger International Select 2013 Semiannual Report
Understanding Your Expenses
As an investor, you incur two types of costs. There are transaction costs, which may include redemption fees or exchange fees charged under your contract or qualified plan. There are also ongoing costs, which generally include management fees and other Fund expenses. Lastly, there may be additional fees or charges imposed by the insurance company that sponsors your variable annuity and/or variable life insurance product. The following information is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to help you compare these costs with the ongoing costs of investing in other mutual funds.
Analyzing your Fund's expenses
To illustrate the ongoing costs, we have provided an example and calculated the expenses paid by investors in the Fund during the period. The actual and hypothetical information in the table below is based on an initial investment of $1,000 at the beginning of the period indicated and held for the entire period. Expense information is calculated two ways and each method provides you with different information. The amount listed in the "Actual" column is calculated using the Fund's actual operating expenses and total return for the period. You may use the Actual information, together with the amount invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the results by the expenses paid during the period under the Actual column. The amount listed in the "Hypothetical" column assumes a 5% annual rate of return before expenses (which is not the Fund's actual return) and then applies the Fund's actual expense ratio for the period to the hypothetical return. You should not use the hypothetical account values and expenses to estimate either your actual account balance at the end of the period or the expenses you paid during the period. See "Compare with other funds" below for details on how to use the hypothetical data.
Compare with other funds
Since all mutual funds are required to include the same hypothetical calculations about expenses in shareholder reports, you can use this information to compare the ongoing cost of investing in the Fund with other funds. To do so, compare the hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds. As you compare hypothetical examples of other funds, it is important to note that hypothetical examples are meant to highlight the ongoing cost of investing in a fund only and do not reflect any transaction costs, such as redemption or exchange fees. Therefore, the hypothetical calculations are useful in comparing ongoing costs only, and will not help you determine the relative total costs of investing in different funds. If transaction costs were included in these calculations, your costs would be higher.
January 1, 2013 – June 30, 2013
| | Account value at the beginning of the period ($) | | Account value at the end of the period ($) | | Expenses paid during period ($) | | Fund's annualized expense ratio (%)* | |
| | Actual | | Hypothetical | | Actual | | Hypothetical | | Actual | | Hypothetical | | | |
Wanger International Select | | | 1,000.00 | | | | 1,000.00 | | | | 1,017.80 | | | | 1,017.41 | | | | 7.17 | | | | 7.17 | | | | 1.45 | | |
* Expenses paid during the period are equal to the Fund's annualized expense ratio, multiplied by the average account value over the period, then multiplied by the number of days in the Fund's most recent fiscal half-year and divided by 365.
It is important to note that the expense amounts shown in the table are meant to highlight only ongoing costs of investing in the Fund. Expenses paid during the period do not include any insurance charges imposed by your insurance company's separate account.
2
Wanger International Select 2013 Semiannual Report
Health Care in the United States
Critics of the U.S. health care system note that the World Health Organization (WHO) ranked the United States thirtieth in the world in life expectancy1 despite the fact that the United States spends more money per capita on health care than any other country. They argue that health care in the United States is inferior to health care in many other developed countries.
Scott W. Atlas's book, In Excellent Health, Setting the Record Straight on America's Health Care,2 analyzes the consequences of poor lifestyle choices made by many Americans and how the U.S. health care system operates compared to health care systems elsewhere. His book cites numerous studies indicating the U.S. health care system does a great job addressing the health concerns of Americans and is likely the best system in the world.
Life Expectancy
The United States is much more violent and accident-prone than other developed countries. Homicide rates in the United States are ten times that of the United Kingdom and five times that of Canada.3 Death rates from transportation accidents in the United States are 250% that of the United Kingdom and 160% that of Canada.4 Murder and accidents account for the majority of deaths among young adults in the United States,5 and deaths at young ages substantially impact life expectancies.
Robert Ohsfeldt's and John Schneider's book, The Business of Health,6 attempts to quantify the impact of fatal injuries on life expectancy. Using linear regression, they calculate that after standardizing for fatal injuries alone, the United States would edge out Switzerland by 0.3 years and have the highest life expectancy of any country in the world.7
Other studies indicate that violence and accidents account for much, but not all, of the life expectancy shortfall in the United States. A National Academy of Sciences panel addressing cross-national health differences issued a paper that indicated 57% of the life expectancy gap for
males under age 50 and 38% for females under 50 is explained by higher violence and accidents in the United States.8
The United States has a much higher incidence of obesity than other developed countries. Atlas notes that in 2010 34% of people in the United States were obese compared to 15% in Canada, 17% in Western Europe and about 24% in the United Kingdom.9 The Organization for Economic Cooperation and Development (OECD) estimates that obesity reduces life spans by up to eight to ten years.10 Sadly, the worst is yet to come for the United States, as obesity rates have increased and there appears to be a 25-year time lag between becoming obese and suffering premature death.11
Cigarette use in the United States is down substantially; smoking rates are now lower than most other OECD countries.12 However, studies have found a time lag of roughly 25 to 30 years between smoking and lung cancer mortality.13 The United States had the highest rate of smoking in the developed world from the 1930s to the mid-1980s and, according to a 2007 study, 53% of Americans were current or former smokers, compared to 43% of Western Europeans.14 Clearly the United States' legacy of smoking continues to impact health. The Surgeon General estimates that cigarette smoking causes 443,000 deaths in the United States yearly, nearly one-fifth of all deaths.15
With respect to neonatal mortality, Atlas writes that the United States has stringent reporting requirements and definitions. Birth registrations in the United States are done by hospitals and health care professionals, while many other countries rely on reporting by families or surveys.16 In the United States, a live birth is tabulated should a newborn breathe, have a beating heart, move voluntary muscles or show any other evidence of life.17 According to WHO, countries representing only 13% of births worldwide had reliable data meeting this definition.18
Elsewhere, definitions for live births vary greatly. Some countries consider births as live only if 28 weeks gestation was achieved, if a baby is 30 centimeters long, or if a baby survives 24 hours.19 Otherwise, the baby is classified as stillborn and is not considered an infant mortality. Atlas states, "... considering that roughly half of all U.S. infant mortality occurs in the first twenty-four hours, the single criterion of omitting deaths within the first twenty-four hours by many European nations generates their falsely superior infant mortality rates."20
Data from 2004 indicated that the United States had 12% of births classified as preterm (under 32 weeks gestation), a rate 50% to 100% higher than most European countries.21 These figures are impacted by the fact the United States has more multiple gestation pregnancies. Since the early 1980s, the incidence of triplets in the United States has more than tripled to over 140 births per 100,000.22 Atlas notes that in 2007, 17% of twins and 40% of triplets in the United States were associated with fertility treatments.
The United States health care system should be applauded for its efforts to save premature babies rather than write them off as stillborn, as many other countries do. Except for a very limited number of abusive cases, fertility treatment should be considered a virtue of the U.S. health care system. Yet, coupled with superior record keeping, these efforts depress the country's life expectancy ranking.
Diagnosis, Treatment and Outcomes
The Centers for Disease Control and Prevention (CDC) lists heart disease as the top killer in the United States, accounting for 25% of deaths, followed by cancer at 23%, and stroke a distant third at 6%.23 Rather than judge a health care system on reported life expectancy, Atlas assesses health care quality in the United States based on actual medical care, especially diagnosis and treatment of important diseases, using objective data.
3
Wanger International Select 2013 Semiannual Report
Atlas notes the challenges facing the health care system due to the poor lifestyle choices of many Americans. The CDC estimates that 80% of diabetes, heart disease and stroke, and 40% of cancer, could be eliminated through reduction in obesity and smoking.24 The rate of diabetes in the United States is typically 33% to 100% higher than other developed countries.25 A 2007 study indicated that 12% of Americans over age 50 were diagnosed with cancer, compared to only 5% in a composite of 10 European countries.26
Atlas cites data showing more timely diagnosis and treatment in the United States as compared to other countries. He writes that, "... prolonged wait times are commonly found in health systems with government-controlled nationalized health insurance."27 Numerous countries with single payer systems had to create policies to address prolonged wait times, including Canada, England, Italy, Sweden and Spain.
The United States is among the world's leaders in per capita computerized tomography (CT) and magnetic resonance imaging (MRI) scanners,28 which are crucial to accurately diagnosing leading fatal diseases and guiding lower risk and more effective treatments. In the United States, referring doctors book CT and MRI appointments within days. In other countries, people wait. In 2010, the average wait time in Canada for a CT scan was 4 weeks and for an MRI, 10 weeks.29 A 2011 study in the United Kingdom indicated thousands of people waited over six weeks for an MRI scan. With respect to breast cancer biopsies, another survey indicated that only 1% of U.S. patients waited three weeks or more while 44% of Canadian and 20% of U.K. patients waited that long.30
Treatment of diseases also tends to be very timely in the United States. One study indicated that no elective (non-emergency) cardiac bypass patients in the United States were known to have waited more than three months, while 47% in Canada and 89% in the United Kingdom waited at least that long.31
Furthermore, treatments in the United States tend to be aggressive. A 2009 paper written by
University of Pennsylvania professor Samuel Preston and doctoral candidate Jessica Ho states that 88% of Americans with high cholesterol are being medicated versus 62% of Europeans. Likewise a higher percentage of Americans over age 50 with heart disease receive medication. Among those with hypertension in the United States, 66% were being successfully treated, versus 25% to 49% in other countries.32
With respect to cancer, Preston and Ho cite studies showing that the United States tends to have the highest percentage of screenings for breast, cervical, prostate and colon cancer.33 If cancer is detected, Americans tend to receive more surgery, chemotherapy and advanced cancer drugs. A 2008 study calculated five-year survival rates for breast, colorectal and prostate cancers. Patients in the United States lead the world with a 74% survival rate. Second-best Canada came in at 71% and the United Kingdom was a laggard at 52%.
Atlas adds that new oncology drugs are most often approved and first used in the United States.34 Some 80% of worldwide medical innovation originates in the United States and, since the mid-1970s, U.S. scientists have won more than half of Nobel Prize awards in medicine and physiology.
The statistics are clear. Sick Americans are more likely to receive timely and aggressive health care than citizens of other countries. Atlas writes, "Availability of state-of-the-art medical technology, timely access to specialists, the most effective screening, the shortest wait times for life-changing surgeries, the newest, most effective drugs for more accurate, safer diagnosis and for the most advanced treatment are all superior in the United States."35
Many people appear to agree. In 2008, a McKinsey & Company study estimated that up to 85,000 patients sought in-patient treatment outside their home country. Of that number, 87% traveled to the United States for advanced medical technology, better quality care or quicker access to care. In contrast, critics of the U.S.
health care system don't appear to be traveling to Cuba for treatment. Based on the facts, I agree with Atlas.
Health Care Economics and Investment Implications
Atlas states that the, "... only real crisis in America's health care today is the unsustainable and increasing burden of health care costs..."36 and recommends free market reforms. Health care costs are not the topic of this essay, but world-class health care clearly is expensive, and costs in the United States are exacerbated by detrimental lifestyle choices. I also believe that poor government policies result in few incentives for cost restraint.
Columbia Wanger Asset Management, the investment manager of the Columbia Wanger Funds, strives to provide Columbia Wanger Fund investors with investments in health care companies that are pursuing breakthrough drugs and devices, with the potential to transform treatment of serious and poorly managed diseases. For example, in pivotal studies Seattle Genetics' drug Adcetris delivered 80% response rates in advanced Hodgkin's lymphoma patients who had exhausted all other treatment options.37 In addition, we seek to invest in companies with products and services that we believe increase the cost effectiveness of health care delivery. We attempt to avoid investing in health care companies that may be more likely to be subject to cost cuts or price controls.
Charles P. McQuaid
President and Chief Investment Officer
Columbia Wanger Asset Management, LLC
4
Wanger International Select 2013 Semiannual Report
The information and data provided in this analysis are derived from sources that we deem to be reliable and accurate. These views are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict so actual outcomes and results may differ significantly from the views expressed. The views/opinions expressed here are those of the author and not of the Wanger Advisors Trust Board, are subject to change at any time based upon economic, market or other conditions, may differ from views expressed by other Columbia Management associates and the respective parties disclaim any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Columbia Wanger Fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any particular Columbia Wanger Fund.
1 Atlas, Scott W., In Excellent Health, Setting the Record Straight on American's Heath Care, (Stanford, California, Hoover Institution Press), p. 2.
2 Ibid.
3 Ohsfeldt, Robert L., and Schneider, John E., The Business of Health, The Role of Competition, Markets, and Regulation, (Washington, D.C., The AEI Press), p. 19.
4 Atlas, Scott W., op. cit., p. 28.
5 Ibid., p. 28.
6 Ohsfeldt, Robert L., and Schneider, John E., op. cit.
7 Ibid., p. 22.
8 Steven H. Woolf and Laudan Aron, Editors; Panel on Understanding Cross-National Health Differences Among High-Income Countries; Committee on Population; Division of Behavioral and Social Sciences and Education; National Research Council; Board on Population Health and Public Health Practice; Institute of Medicine, www.nap.edu.
9 Atlas, Scott W., op. cit., p. 105.
10 Ibid., p. 31.
11 Ibid., p. 107.
12 Ibid., p. 40.
13 Ibid., p. 41.
14 Ibid., p. 111.
15 Ibid., p. 108.
16 Ibid., p. 60.
17 Ibid., p. 67.
18 Ibid., p. 71.
19 Ibid., p. 68.
20 Ibid., p. 70.
21 Ibid., p. 73.
22 Ibid., p. 89.
23 Ibid., p. 119.
24 Ibid., p. 103.
25 Ibid., p. 113.
26 Preston, Samuel H., and Ho, Jessica Y., "Low Life Expectancy in the United States: Is the Health Care System at Fault?" University of Pennsylvania Scholarly Commons Working Paper Series, July 1, 2009, p. 4, http://repository.upenn.edu/psc_working_papers/13/. Accessed July 24, 2013.
27 Atlas, Scott W., op. cit., p. 159.
28 Ibid., p. 192-193.
29 Ibid., p. 194.
30 Ibid., p. 175.
31 Ibid., p. 187.
32 Preston, Samuel H., and Ho, Jessica Y., op. cit., p. 6.
33 Ibid., p. 3.
34 Atlas, Scott W., op. cit., p. 222.
35 Ibid., p. 233.
36 Ibid., p. 245.
37 Seattle Genetics is held in the following Columbia Wanger Funds: Wanger USA, 1.2%; Wanger Select, 1.3%.
5
Wanger International Select 2013 Semiannual Report
Performance Review Wanger International Select
Christopher J. Olson
Portfolio Manager
Performance data shown represents past performance and is not a guarantee of future results. The investment return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data shown. Please visit columbiamanagement.com for most recent month-end performance updates.
Wanger International Select finished the semiannual period ended June 30, 2013, up 1.78%. This compares to a 4.30% gain by its primary benchmark, the S&P Developed Ex-U.S. Between $2B and $10B Index. Overall, the Fund's very strong stock performance in Japan was more than offset by an overweight in the underperforming materials sector.
Start Today, a Japanese online apparel retailer, was the top contributor to Fund gains for the first half of 2013. Up 114%, the company continued to benefit from improved marketing and cost cutting, combined with strong revenue growth. NGK Spark Plug, a Japanese auto parts manufacturer, ended the half year up 53%, as exporters continued to benefit from a weaker yen. Rounding out the Japanese winners, Seven Bank, a provider of ATM processing services, enjoyed a 39% year-to-date gain as the company continued expansion of ATMs in the 7-11 store network in Japan. Far EasTone Telecom, Taiwan's third largest mobile operator, and Taiwan Mobile, its second largest, rebounded from early declines in the period to end the six months up 5% and 7%, respectively. Both companies continue to report very steady earnings growth driven by increasing smartphone usage and subsequent data growth.
As mentioned, the Fund's performance during the period was dampened by its overweight in the materials sector. Eight of the ten greatest detractors from performance during the six-month period were mining stocks. The list included Brazilian gold miner Beadell Resources, Fresnillo, a silver and metal byproduct miner in Mexico, and Australian gold miner Regis Resources. Each fell more than 50% during the half year period. Falling gold and silver prices drove the sector's underperformance despite individual companies' reports of good operating results. The Fund cut back on its exposure in the materials sector early in the period, but we believe that historically low valuations at this point argue for leaving its current weighting in place.
Real estate stocks pulled back late in the period on fears of higher interest rates. Singaporean industrial property landlords Ascendas REIT and Mapletree Logistics Trust fell 8% and 5%, respectively. Operationally, these REITs continue to perform well.
Monetary policy has been one of the main drivers of stock market performance and those countries with significant easing programs (Japan and the United States, for example) have reported strong returns while those countries that do not have similar programs (Hong Kong, Korea, many emerging markets) have been decidedly weak. Fund holdings reflected this trend with strength coming from Japanese names, while those listed in emerging markets struggled during the period. The Fund will continue to focus on companies with strong fundamentals but will seek to be mindful of the impact that government policies are having on the investment environment.
International investing involves special risks, including foreign taxation, currency risks, risks associated with possible differences in financial standards, operational and settlement risks and other risks associated with future political and economic developments. Stocks of small- and mid-cap companies pose special risks, including possible illiquidity and greater price volatility than stocks of larger, more established companies. The Fund has potentially greater price volatility due to its concentration in a limited number of stocks of small- and mid-size companies. Investing in emerging markets may involve greater risks than investing in more developed countries.
Portfolio holdings are subject to change periodically and may not be representative of current holdings.
Fund's Positions in Mentioned Holdings
As a percentage of net assets, as of 6/30/13
Far EasTone Telecom | | | 7.3 | % | |
Taiwan Mobile | | | 5.3 | | |
NGK Spark Plug | | | 4.6 | | |
Start Today | | | 4.6 | | |
Ascendas REIT | | | 4.6 | | |
Seven Bank | | | 2.9 | | |
Mapletree Logistics Trust | | | 2.6 | | |
Beadell Resources | | | 1.6 | | |
Regis Resources | | | 1.3 | | |
Fresnillo | | | 0.9 | | |
6
Wanger International Select 2013 Semiannual Report
Growth of a $10,000 Investment in Wanger International Select
February 1, 1999 (inception date) through June 30, 2013
Performance data shown represents past performance and is not a guarantee of future results. The investment return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data shown. Performance results reflect any fee waivers or reimbursements of Fund expenses by the investment manager and/or any of its affiliates. Absent these fee waivers and/or expense reimbursement arrangements, performance results would have been lower. For daily and most recent month-end performance updates, please call 1-888-4-WANGER.
This graph compares the results of $10,000 invested in Wanger International Select on February 1, 1999 (the date the Fund began operations) through June 30, 2013, to the S&P Developed Ex-U.S. Between $2B and $10B Index, with dividends and capital gains reinvested. Although the index is provided for use in assessing the Fund's performance, the Fund's holdings may differ significantly from those in the index.
Top 10 Holdings
As a percentage of net assets, as of 6/30/13
1. Far EasTone Telecom (Taiwan) Taiwan's Third Largest Mobile Operator | | | 7.3 | % | |
2. Taiwan Mobile (Taiwan) Taiwan's Second Largest Mobile Operator | | | 5.3 | | |
3. NGK Spark Plug (Japan) Automobile Parts | | | 4.6 | | |
4. Start Today (Japan) Online Japanese Apparel Retailer | | | 4.6 | | |
5. Ascendas REIT (Singapore) Industrial Property Landlord | | | 4.6 | | |
6. CCL Industries (Canada) Largest Global Label Converter | | | 3.9 | | |
7. Jardine Lloyd Thompson Group (United Kingdom) International Business Insurance Broker | | | 3.7 | | |
8. Seven Bank (Japan) ATM Processing Services | | | 2.9 | | |
9. Mapletree Logistics Trust (Singapore) Industrial Property Landlord | | | 2.6 | | |
10. Archipelago Resources (Indonesia) Gold Mining Projects in Indonesia, Vietnam & the Philippines | | | 2.4 | | |
Top 5 Countries
As a percentage of net assets, as of 6/30/13
Japan | | | 20.8 | % | |
Taiwan | | | 14.5 | | |
Singapore | | | 9.6 | | |
United Kingdom | | | 9.1 | | |
Australia | | | 4.3 | | |
Results as of June 30, 2013
| | 2nd quarter* | | Year to date* | | 1 year | | 5 years | | 10 years | |
Wanger International Select | | | -1.30 | % | | | 1.78 | % | | | 12.97 | % | | | 0.89 | % | | | 11.98 | % | |
S&P Developed Ex-U.S. Between $2B and $10B Index** | | | -1.05 | | | | 4.30 | | | | 17.71 | | | | 1.17 | | | | 10.30 | | |
MSCI EAFE Index (Net) | | | -0.98 | | | | 4.10 | | | | 18.62 | | | | -0.63 | | | | 7.67 | | |
Lipper Variable Underlying International Growth Funds Index | | | -1.78 | | | | 2.16 | | | | 15.59 | | | | 0.02 | | | | 7.88 | | |
*Not annualized.
**The Fund's primary benchmark.
NAV as of 6/30/13: $18.39
Performance numbers reflect all Fund expenses but do not include any fees and expenses imposed under your variable annuity or life insurance policy or qualified pension or retirement plan. If performance included the effect of these additional charges, it would be lower.
The Fund's annual operating expense ratio of 1.42% is stated as of the Fund's prospectus dated May 1, 2013, and differences in expense ratios disclosed elsewhere in this report may result from including fee waivers and expense reimbursements as well as different time periods used in calculating the ratios.
All results shown assume reinvestment of distributions.
The S&P Developed Ex-U.S. Between $2B and $10B Index is a subset of the broad market selected by the index sponsor representing the mid-cap developed market, excluding the United States. The MSCI Europe, Australasia, Far East (EAFE) Index (Net) is a capitalization-weighted index that tracks the total return of common stocks in 22 developed-market countries within Europe, Australasia and the Far East. The returns of the MSCI EAFE Index (Net) are presented net of the withholding tax rate applicable to foreign non-resident institutional investors in the foreign companies included in the index who do not benefit from double taxation treaties. The performance of the MSCI EAFE Index (Net) is provided to show how the Fund's performance compares to a widely recognized broad-based index of foreign market performance. The Lipper Variable Underlying International Growth Funds Index is an equally weighted representation of the 30 largest variable insurance underlying funds in the Lipper Variable Underlying International Growth Funds Classification, and shows how the Fund's performance compares with returns of an index of funds with similar investment objectives. Indexes are not managed and do not incur fees or expenses. It is not possible to invest directly in an index.
Lipper Inc., a widely respected data provider in the industry, calculates an average total return (assuming reinvestment of distributions) for mutual funds with investment objectives similar to those of the Fund.
Portfolio characteristics and holdings are subject to change periodically and may not be representative of current characteristics and holdings.
7
Wanger International Select 2013 Semiannual Report
Wanger International Select
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Equities – 90.6% | |
| | Asia – 51.7% | |
| | Japan – 20.8% | |
| 55,000
| | | NGK Spark Plug Automobile Parts | | $ | 1,100,819
| | |
| 55,500
| | | Start Today Online Japanese Apparel Retailer | | | 1,086,778
| | |
| 192,000
| | | Seven Bank ATM Processing Services | | | 696,016
| | |
| 7,200
| | | Rinnai Gas Appliances for Household & Commercial Use | | | 511,960
| | |
| 56
| | | Nippon Prologis REIT (a) Logistics Real Estate Investment Trust in Japan | | | 485,926
| | |
| 9,000
| | | Toyo Suisan Kaisha Instant Noodle Manufacturer | | | 299,455
| | |
| 6,400
| | | Familymart Convenience Store Operator | | | 273,078
| | |
| 223
| | | Orix JREIT Diversified Real Estate Investment Trust | | | 254,530
| | |
| 13,000
| | | Park24 Parking Lot Operator | | | 235,847
| | |
| | | 4,944,409 | | |
| | Taiwan – 14.5% | |
| 647,000
| | | Far EasTone Telecom Taiwan's Third Largest Mobile Operator | | | 1,734,029
| | |
| 318,000
| | | Taiwan Mobile Taiwan's Second Largest Mobile Operator | | | 1,252,810
| | |
| 261,000
| | | CTCI Corp International Engineering Firm | | | 473,368
| | |
| | | 3,460,207 | | |
| | Singapore – 9.6% | |
| 618,000
| | | Ascendas REIT Industrial Property Landlord | | | 1,083,035
| | |
| 704,000
| | | Mapletree Logistics Trust Industrial Property Landlord | | | 610,159
| | |
| 384,000
| | | Mapletree Industrial Trust Industrial Property Landlord | | | 399,065
| | |
| 197,000
| | | Mapletree Commercial Trust Retail & Office Property Landlord | | | 183,595
| | |
| | | 2,275,854 | | |
Number of Shares | | | | Value | |
| | Indonesia – 2.4% | |
| 783,000 | | | Archipelago Resources (b) Gold Mining Projects in Indonesia, Vietnam & the Philippines | | $ | 562,702 | | |
| | Korea – 2.3% | |
| 6,350
| | | Coway Household Appliance Rental Service Provider | | | 308,573
| | |
| 5,330
| | | Kepco Plant Service & Engineering Power Plant & Grid Maintenance | | | 242,686
| | |
| | | 551,259 | | |
| | Hong Kong – 2.1% | |
| 157,000
| | | Melco International Macau Casino Operator | | | 294,585
| | |
| 278,000
| | | Mapletree Greater China Commercial Trust (b) Retail & Office Property Landlord | | | 206,623
| | |
| | | 501,208 | | |
| | | | Total Asia | | | 12,295,639 | | |
| | Europe – 20.2% | |
| | United Kingdom – 9.1% | |
| 64,000
| | | Jardine Lloyd Thompson Group International Business Insurance Broker | | | 886,479
| | |
| 46,000
| | | Smith & Nephew Medical Equipment & Supplies | | | 515,194
| | |
| 6,000
| | | Whitbread The UK's Leading Hotelier & Coffee Shop | | | 279,118
| | |
| 17,500
| | | Telecity European Data Center Provider | | | 269,676
| | |
| 13,086
| | | Babcock International Public Sector Outsourcer | | | 219,726
| | |
| | | 2,170,193 | | |
| | Denmark – 3.4% | |
| 10,000
| | | SimCorp Software for Investment Managers | | | 297,223
| | |
| 7,500
| | | Jyske Bank (b) Danish Bank | | | 282,105
| | |
| 7,000
| | | Novozymes Industrial Enzymes | | | 224,211
| | |
| | | 803,539 | | |
See accompanying notes to financial statements.
8
Wanger International Select 2013 Semiannual Report
Wanger International Select
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | France – 2.2% | |
| 8,000
| | | Neopost Postage Meter Machines | | $ | 529,694
| | |
| | Switzerland – 1.8% | |
| 1,570
| | | Partners Group Private Markets Asset Management | | | 424,966
| | |
| | Germany – 1.1% | |
| 9,800
| | | Wirecard Online Payment Processing & Risk Management | | | 266,658
| | |
| | Iceland – 1.1% | |
| 252,000 | | | Marel Largest Manufacturer of Poultry & Fish Processing Equipment | | | 266,602 | | |
| | Sweden – 1.1% | |
| 9,700 | | | Hexagon Design, Measurement & Visualization Software & Equipment | | | 259,294 | | |
| | Netherlands – 0.4% | |
| 11,496
| | | Imtech (a) (b) Technical Installation & Maintenance | | | 84,622
| | |
| | | | Total Europe | | | 4,805,568 | | |
| | Other Countries – 13.3% | |
| | Australia – 4.3% | |
| 130,500
| | | Challenger Financial Largest Annuity Provider | | | 475,872
| | |
| 117,000
| | | Regis Resources (b) Gold Mining in Australia | | | 309,715
| | |
| 47,000
| | | IAG General Insurance Provider | | | 233,294
| | |
| | | 1,018,881 | | |
| | Canada – 4.0% | |
| 15,000
| | | CCL Industries Largest Global Label Converter | | | 925,359
| | |
| 1,400
| | | Goldcorp Gold Mining | | | 34,622
| | |
| | | 959,981 | | |
| | South Africa – 2.5% | |
| 55,451
| | | Coronation Fund Managers South African Fund Manager | | | 352,027
| | |
Number of Shares | | | | Value | |
| 3,400 | | | Naspers Media in Africa, China, Russia & Other Emerging Markets | | $ | 250,960 | | |
| | | 602,987 | | |
| | United States – 2.5% | |
| 6,000
| | | Atwood Oceanics (b) Offshore Drilling Contractor | | | 312,300
| | |
| 4,600
| | | SM Energy Oil & Gas Producer | | | 275,908
| | |
| | | 588,208 | | |
| | | | Total Other Countries | | | 3,170,057 | | |
| | Latin America – 5.4% | |
| | Guatemala – 2.3% | |
| 39,000
| | | Tahoe Resources (b) Silver Project in Guatemala | | | 552,905
| | |
| | Brazil – 1.6% | |
| 797,500
| | | Beadell Resources (b) Gold Mining in Brazil | | | 372,067
| | |
| | Mexico – 0.9% | |
| 16,000
| | | Fresnillo Silver & Metal Byproduct Mining in Mexico | | | 216,013
| | |
| | Uruguay – 0.6% | |
| 13,068
| | | Union Agriculture Group (b) (c) (d) Farmland Operator in Uruguay | | | 135,254
| | |
| | Colombia – % | |
| 120,000
| | | Santa Maria Petroleum (b) (c) Explores for Oil & Gas in Latin America | | | 2,995
| | |
| | | | Total Latin America | | | 1,279,234 | | |
Total Equities (Cost: $18,589,083) – 90.6% | | | 21,550,498 | (e) | |
Short-Term Investments – 9.4% | | | |
| 2,251,865
| | | JPMorgan U.S. Government Money Market Fund, Capital Shares (7 day yield of 0.01%) | | | 2,251,865 | | |
Total Short-Term Investments (Cost: $2,251,865) – 9.4% | | | 2,251,865 | | |
See accompanying notes to financial statements.
9
Wanger International Select 2013 Semiannual Report
Wanger International Select
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
Securities Lending Collateral – 2.1% | |
| 491,226 | | | Dreyfus Government Cash Management Fund, Institutional Shares (7 day yield of 0.01%) (f) | | $ | 491,226 | | |
Total Securities Lending Collateral (Cost: $491,226) | | | 491,226 | | |
Total Investments (Cost: $21,332,174) (g) – 102.1% | | | 24,293,589 | | |
Obligation to Return Collateral for Securities Loaned – (2.1)% | | | (491,226 | ) | |
Cash and Other Assets Less Liabilities – —% | | | (9,464 | ) | |
Net Assets – 100.0% | | $ | 23,792,899 | | |
REIT = Real Estate Investment Trust
Notes to Statement of Investments
(a) All or a portion of this security was on loan at June 30, 2013. The total market value of securities on loan at June 30, 2013 was $466,218.
(b) Non-income producing security.
(c) Denotes a restricted security, which is subject to restrictions on resale under federal securities laws. These securities are valued at fair value determined in good faith under consistently applied procedures established by the Board of Trustees. At June 30, 2013, the market value of these securities amounted to $138,249, which represented 0.58% of total net assets. Additional information on these securities is as follows:
Security | | Acquisition Dates | | Shares | | Cost | | Value | |
Union Agriculture Group | | 12/8/10- 6/27/12 | | | 13,068 | | | $ | 150,000 | | | $ | 135,254 | | |
Santa Maria Petroleum | | 1/14/11 | | | 120,000 | | | | 151,653 | | | | 2,995 | | |
| | | | | | $ | 301,653 | | | $ | 138,249 | | |
(d) Illiquid security.
(e) On June 30, 2013, the Fund's total investments were denominated in currencies as follows:
Currency | | Value | | Percentage of Net Assets | |
Japanese Yen | | $ | 4,944,409 | | | | 20.8 | | |
Taiwan Dollar | | | 3,460,207 | | | | 14.5 | | |
British Pound | | | 2,948,908 | | | | 12.4 | | |
Hong Kong Dollar | | | 2,482,477 | | | | 10.4 | | |
Canadian Dollar | | | 1,481,259 | | | | 6.2 | | |
Australian Dollar | | | 1,390,948 | | | | 5.9 | | |
Other currencies less than 5% of total net assets | | | 4,842,290 | | | | 20.4 | | |
Total Equities | | $ | 21,550,498 | | | | 90.6 | | |
(f) Investment made with cash collateral received from securities lending activity.
(g) At June 30, 2013, for federal income tax purposes, the cost of investments was $21,332,174 and net unrealized appreciation was $2,961,415 consisting of gross unrealized appreciation of $4,380,067 and gross unrealized depreciation of $1,418,652.
At June 30, 2013, the Fund had entered into the following forward foreign currency exchange contracts:
Forward Foreign Currency Exchange Contracts to Buy | | Forward Foreign Currency Exchange Contracts to Sell | |
Principal Amount in Foreign Currency | |
Principal Amount in U.S. Dollar | |
Settlement Date | |
Unrealized Appreciation (Depreciation) | |
USD | | | | ZAR | | | | | 5,977,020 | | | $ | 600,000 | | | 7/15/13 | | $ | (3,474 | ) | |
The counterparty for all forward foreign currency exchange contracts is State Street Bank and Trust Company.
USD = United States Dollar
ZAR = South African Rand
Fair Value Measurements
Various inputs are used in determining the value of the Fund's investments, following the input prioritization hierarchy established by accounting principles generally accepted in the United States of America (GAAP). These inputs are summarized in the three broad levels listed below:
• Level 1 – quoted prices in active markets for identical securities
• Level 2 – prices determined using other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others)
• Level 3 – prices determined using significant unobservable inputs where quoted prices or observable inputs are unavailable or less reliable (including management's own assumptions about the factors market participants would use in pricing an investment)
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
Examples of the types of securities in which the Fund would typically invest and how they are classified within this hierarchy are as follows. Typical Level 1 securities include exchange traded domestic equities, mutual funds whose NAVs are published each day and exchange traded foreign equities that are not statistically fair valued. Typical Level 2 securities include exchange traded foreign equities that are statistically fair valued, forward foreign currency exchange contracts and short-term investments valued at amortized cost. Additionally, securities fair valued by the Valuation Committee (the Committee) of the Fund's Board of Trustees (the Board) that rely on significant observable inputs are also included in Level 2. Typical Level 3 securities include any security fair valued by the Committee that relies on significant unobservable inputs.
Under the direction of the Board, the Committee is responsible for carrying out the valuation procedures approved by the Board.
The Committee meets as necessary, and no less frequently than quarterly, to determine fair values for securities for which market quotations are not readily available or for which the investment manager believes that available market quotations are unreliable, to review the appropriateness of the Trust's Portfolio Pricing Policy and the pricing procedures of the investment manager (the Policies), and to review the continuing
See accompanying notes to financial statements.
10
Wanger International Select 2013 Semiannual Report
Wanger International Select
Statement of Investments (Unaudited), June 30, 2013
appropriateness of the current value of any security subject to the Policies. The Policies address, among other things: circumstances under which market quotations will be deemed readily available; selection of third party pricing vendors; appropriate pricing methodologies; events that require fair valuation and fair value techniques; and circumstances under which securities will be deemed to pose a potential for stale pricing, including when securities are illiquid, restricted, or in default. The Committee may also meet to discuss additional valuation matters, which may include review of back-testing results, review of time-sensitive information or approval of other valuation related actions, and to review the appropriateness of the Policies.
For investments categorized as Level 3, the significant unobservable inputs used in the fair value measurement of the Funds' securities may include: (i) data specific to the issuer or comparable issuers, (ii) general market or specific sector news and (iii) quoted prices and specific or similar security transactions. The Committee considers this data and any changes from prior periods in order to assess the reasonableness of observable and unobservable inputs, any assumptions or internal models used to value those securities and changes in fair value. Significant changes in any of these factors could result in lower or higher fair value measurements. Various factors impact the frequency of monitoring (which may occur as often as daily), however the Committee may determine that changes to inputs, assumptions and models are not required with the same frequency.
The following table summarizes the inputs used, as of June 30, 2013, in valuing the Fund's assets:
Investment Type | |
Quoted Prices (Level 1) | | Other Significant Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Total | |
Equities | |
Asia | | $ | — | | | $ | 12,295,639 | | | $ | — | | | $ | 12,295,639 | | |
Europe | | | — | | | | 4,805,568 | | | | — | | | | 4,805,568 | | |
Other Countries | | | 1,548,189 | | | | 1,621,868 | | | | — | | | | 3,170,057 | | |
Latin America | | | 552,905 | | | | 591,075 | | | | 135,254 | | | | 1,279,234 | | |
Total Equities | | | 2,101,094 | | | | 19,314,150 | | | | 135,254 | | | | 21,550,498 | | |
Total Short-Term Investments | | | 2,251,865 | | | | — | | | | — | | | | 2,251,865 | | |
Total Securities Lending Collateral | | | 491,226 | | | | — | | | | — | | | | 491,226 | | |
Total Investments | | $ | 4,844,185 | | | $ | 19,314,150 | | | $ | 135,254 | | | $ | 24,293,589 | | |
Unrealized Depreciation on Forward Foreign Currency Exchange Contracts | | | — | | | | (3,474 | ) | | | — | | | | (3,474 | ) | |
Total | | $ | 4,844,185 | | | $ | 19,310,676 | | | $ | 135,254 | | | $ | 24,290,115 | | |
The Fund's assets assigned to the Level 2 input category are generally valued using a market approach, in which a security's value is determined through its correlation to prices and information from observable market transactions for similar or identical assets. Foreign equities are generally valued at the last sale price on the foreign exchange or market on which they trade. The Fund may use a statistical fair valuation model, in accordance with the policy adopted by the Board, provided by an independent third party to value securities principally traded in foreign markets in order to adjust for possible stale pricing that may occur between the close of the foreign exchanges and the time for valuation. These models take into account available market data including intraday index, ADR, and ETF movements. Forward foreign currency exchange contracts are valued at the prevailing forward exchange rate of the
underlying currencies. Securities acquired via private placement that have a holding period or an extended settlement period are valued at a discount to the same shares that are trading freely on the market. These discounts are determined by the investment manager's experience with similar securities or situations. Factors may include, but are not limited to, trade volume, shares outstanding and stock price.
There were no transfers of financial assets between levels 1 and 2 during the period.
The Fund does not hold any significant investments categorized as Level 3.
Certain common stock classified as Level 3 are valued at fair value, using a market approach, as determined in good faith under consistently applied procedures established by and under the general supervision of the Board. To determine fair value for these securities, for which no market exists, the Committee utilizes the valuation technique it deems most appropriate in the circumstances, using some unobservable inputs, which may include, but are not limited to, trades of similar securities, estimated earnings of the company, market multiples derived from a set of comparable companies, and the position of the security within the company's capital structure. Significant increases or decreases to any of these inputs could result in a significantly lower or higher fair value measurement.
See accompanying notes to financial statements.
11
Wanger International Select 2013 Semiannual Report
Wanger International Select
Portfolio Diversification (Unaudited) June 30, 2013
At June 30, 2013, the Fund's portfolio investments as a percentage of net assets were diversified as follows:
| | Value | | Percentage of Net Assets | |
Consumer Goods & Services | |
Other Durable Goods | | $ | 1,612,779 | | | | 6.8 | | |
Retail | | | 1,359,856 | | | | 5.7 | | |
Nondurables | | | 925,359 | | | | 3.9 | | |
Other Consumer Services | | | 308,573 | | | | 1.3 | | |
Food & Beverage | | | 299,455 | | | | 1.2 | | |
Casinos & Gaming | | | 294,585 | | | | 1.2 | | |
Restaurants | | | 279,118 | | | | 1.2 | | |
| | | 5,079,725 | | | | 21.3 | | |
Information | |
Mobile Communications | | | 2,986,839 | | | | 12.6 | | |
Business Software | | | 556,517 | | | | 2.3 | | |
Computer Services | | | 269,676 | | | | 1.1 | | |
Financial Processors | | | 266,658 | | | | 1.1 | | |
Internet Related | | | 250,960 | | | | 1.1 | | |
| | | 4,330,650 | | | | 18.2 | | |
Finance | |
Insurance | | | 1,595,645 | | | | 6.7 | | |
Banks | | | 978,121 | | | | 4.1 | | |
Brokerage & Money Management | | | 776,993 | | | | 3.3 | | |
| | | 3,350,759 | | | | 14.1 | | |
Other Industries | |
Real Estate | | | 3,222,933 | | | | 13.5 | | |
| | | 3,222,933 | | | | 13.5 | | |
Energy & Minerals | |
Mining | | | 2,048,024 | | | | 8.6 | | |
Oil Services | | | 312,300 | | | | 1.3 | | |
Oil & Gas Producers | | | 278,903 | | | | 1.2 | | |
Agricultural Commodities | | | 135,254 | | | | 0.6 | | |
| | | 2,774,481 | | | | 11.7 | | |
| | Value | | Percentage of Net Assets | |
Industrial Goods & Services | |
Machinery | | $ | 796,296 | | | | 3.4 | | |
Construction | | | 473,368 | | | | 2.0 | | |
Outsourcing Services | | | 462,412 | | | | 1.9 | | |
Other Industrial Services | | | 320,469 | | | | 1.4 | | |
Industrial Materials & Specialty Chemicals | | | 224,211 | | | | 0.9 | | |
| | | 2,276,756 | | | | 9.6 | | |
Health Care | |
Medical Equipment & Devices | | | 515,194 | | | | 2.2 | | |
| | | 515,194 | | | | 2.2 | | |
Total Equities: | | | 21,550,498 | | | | 90.6 | | |
Short-Term Investments: | | | 2,251,865 | | | | 9.4 | | |
Securities Lending Collateral: | | | 491,226 | | | | 2.1 | | |
Total Investments: | | | 24,293,589 | | | | 102.1 | | |
Obligation to Return Collateral for Securities Loaned: | | | (491,226 | ) | | | (2.1 | ) | |
Cash and Other Assets Less Liabilities: | | | (9,464 | ) | | | (0.0 | )* | |
Net Assets: | | $ | 23,792,899 | | | | 100.0 | % | |
* Rounds to zero.
See accompanying notes to financial statements.
12
Wanger International Select 2013 Semiannual Report
Statement of Assets and Liabilities
June 30, 2013 (Unaudited)
Assets: | |
Investments, at cost | | $ | 21,332,174 | | |
Investments, at value (including securities on loan of $466,218) | | $ | 24,293,589 | | |
Foreign currency (cost of $5,814) | | | 5,814 | | |
Receivable for: | |
Investments sold | | | 115,939 | | |
Fund shares sold | | | 11,569 | | |
Securities lending income | | | 1,755 | | |
Dividends | | | 4,941 | | |
Foreign tax reclaims | | | 13,099 | | |
Expense reimbursement due from investment advisor | | | 97 | | |
Prepaid expenses | | | 143 | | |
Total Assets | | | 24,446,946 | | |
Liabilities: | |
Collateral on securities loaned | | | 491,226 | | |
Unrealized depreciation on forward foreign currency exchange contracts | | | 3,474 | | |
Payable for: | |
Investments purchased | | | 121,364 | | |
Fund shares redeemed | | | 2,550 | | |
Investment advisory fee | | | 606 | | |
Administration fee | | | 32 | | |
Trustees' fees | | | 7,017 | | |
Custody fee | | | 4,389 | | |
Reports to shareholders | | | 2,284 | | |
Other liabilities | | | 21,105 | | |
Total Liabilities | | | 654,047 | | |
Net Assets | | $ | 23,792,899 | | |
Composition of Net Assets: | |
Paid-in capital | | $ | 20,914,502 | | |
Overdistributed net investment income | | | (1,257,765 | ) | |
Accumulated net realized gain | | | 1,178,964 | | |
Net unrealized appreciation (depreciation) on: | |
Investments | | | 2,961,415 | | |
Foreign currency translations | | | (743 | ) | |
Forward foreign currency exchange contracts | | | (3,474 | ) | |
Net Assets | | $ | 23,792,899 | | |
Fund Shares Outstanding | | | 1,293,683 | | |
Net asset value, offering price and redemption price per share | | $ | 18.39 | | |
Statement of Operations
For the Six Months Ended June 30, 2013 (Unaudited)
Investment Income: | |
Dividend income (net foreign taxes withheld of $27,240) | | $ | 239,920 | | |
Interest income | | | 7 | | |
Securities lending income, net | | | 7,465 | | |
Total Investment Income | | | 247,392 | | |
Expenses: | |
Investment advisory fee | | | 113,774 | | |
Administration fee | | | 6,052 | | |
Transfer agent fees | | | 82 | | |
Trustees' fees | | | 1,366 | | |
Custody fees | | | 28,651 | | |
Reports to shareholders | | | 12,191 | | |
Audit fees | | | 16,550 | | |
Legal fees | | | 815 | | |
Chief compliance officer expenses (See Note 4) | | | 358 | | |
Commitment fee for line of credit (See Note 5) | | | 73 | | |
Other expenses | | | 967 | | |
Total Expenses | | | 180,879 | | |
Advisory fee waiver (See Note 4) | | | (5,377 | ) | |
Net Expenses | | | 175,502 | | |
Net Investment Income | | | 71,890 | | |
Net Realized and Unrealized Gain (Loss) on Investments: | |
Net realized gain (loss) on: | |
Investments | | | 1,124,130 | | |
Foreign currency translations | | | 2,164 | | |
Forward foreign currency exchange contracts | | | 88,919 | | |
Net realized gain | | | 1,215,213 | | |
Net change in unrealized appreciation (depreciation) on: | |
Investments | | | (856,485 | ) | |
Foreign currency translations | | | (461 | ) | |
Forward foreign currency exchange contracts | | | 25,349 | | |
Net change in unrealized depreciation | | | (831,597 | ) | |
Net realized and unrealized gain | | | 383,616 | | |
Net Increase in Net Assets from Operations | | $ | 455,506 | | |
See accompanying notes to financial statements.
13
Wanger International Select 2013 Semiannual Report
Statements of Changes in Net Assets
Increase (Decrease) in Net Assets | | (Unaudited) Six Months Ended June 30, 2013 | | Year Ended December 31, 2012 | |
Operations: | |
Net investment income | | $ | 71,890 | | | $ | 394,578 | | |
Net realized gain (loss) on: | |
Investments | | | 1,124,130 | | | | 2,993,706 | | |
Foreign currency translations | | | 2,164 | | | | (10,501 | ) | |
Forward foreign currency exchange contracts | | | 88,919 | | | | (13,334 | ) | |
Net change in unrealized appreciation (depreciation) on: | |
Investments | | | (856,485 | ) | | | 1,544,427 | | |
Foreign currency translations | | | (461 | ) | | | 549 | | |
Forward foreign currency exchange contracts | | | 25,349 | | | | 37,539 | | |
Net Increase in Net Assets from Operations | | | 455,506 | | | | 4,946,964 | | |
Distributions to Shareholders From: | |
Net investment income | | | (1,269,064 | ) | | | (278,945 | ) | |
Net realized gains | | | (876,210 | ) | | | — | | |
Total Distributions to Shareholders | | | (2,145,274 | ) | | | (278,945 | ) | |
Share Transactions: | |
Subscriptions | | | 982,122 | | | | 1,426,353 | | |
Distributions reinvested | | | 2,145,274 | | | | 278,945 | | |
Redemptions | | | (2,460,926 | ) | | | (5,575,629 | ) | |
Net Increase (Decrease) from Share Transactions | | | 666,470 | | | | (3,870,331 | ) | |
Total Increase (Decrease) in Net Assets | | | (1,023,298 | ) | | | 797,688 | | |
Net Assets: | |
Beginning of period | | | 24,816,197 | | | | 24,018,509 | | |
End of period | | $ | 23,792,899 | | | $ | 24,816,197 | | |
Overdistributed net investment income | | $ | (1,257,765 | ) | | $ | (60,591 | ) | |
See accompanying notes to financial statements.
14
Wanger International Select 2013 Semiannual Report
The following table is intended to help you understand the Fund's financial performance. Certain information reflects financial results for a single share held for the periods shown. Per share net investment income (loss) amounts are calculated based on average shares outstanding during the period. Total return assumes reinvestment of all dividends and distributions. Total return does not reflect payment of the expenses that apply to the variable accounts or contract charges, if any, and are not annualized for periods of less than one year.
| | (Unaudited) Six Months Ended June 30, | | Year Ended December 31, | |
Selected data for a share outstanding throughout each period | | 2013 | | 2012 | | 2011 | | 2010 | | 2009 | | 2008 | |
Net Asset Value, Beginning of Period | | $ | 19.83 | | | $ | 16.44 | | | $ | 18.57 | | | $ | 15.42 | | | $ | 12.01 | | | $ | 28.07 | | |
Income from Investment Operations: | |
Net investment income | | | 0.06 | | | | 0.29 | | | | 0.14 | | | | 0.09 | | | | 0.10 | | | | 0.21 | | |
Net realized and unrealized gain (loss) | | | 0.31 | | | | 3.32 | | | | (1.99 | ) | | | 3.28 | | | | 3.71 | | | | (10.31 | ) | |
Total from Investment Operations | | | 0.37 | | | | 3.61 | | | | (1.85 | ) | | | 3.37 | | | | 3.81 | | | | (10.10 | ) | |
Less Distributions to Shareholders: | |
Net investment income | | | (1.07 | ) | | | (0.22 | ) | | | (0.28 | ) | | | (0.22 | ) | | | (0.40 | ) | | | (0.09 | ) | |
Net realized gains | | | (0.74 | ) | | | — | | | | — | | | | — | | | | — | | | | (5.87 | ) | |
Total Distributions to Shareholders | | | (1.81 | ) | | | (0.22 | ) | | | (0.28 | ) | | | (0.22 | ) | | | (0.40 | ) | | | (5.96 | ) | |
Net Asset Value, End of Period | | $ | 18.39 | | | $ | 19.83 | | | $ | 16.44 | | | $ | 18.57 | | | $ | 15.42 | | | $ | 12.01 | | |
Total Return | | | 1.78 | %(a) | | | 22.00 | % | | | (10.11 | )%(a) | | | 22.09 | % | | | 32.92 | %(a) | | | (44.35 | )% | |
Ratios to Average Net Assets/Supplemental Data: | |
Total gross expenses | | | 1.49 | %(b)(c) | | | 1.43 | %(c) | | | 1.45 | %(c) | | | 1.38 | %(c) | | | 1.49 | % | | | 1.24 | % | |
Total net expenses | | | 1.45 | %(b)(c) | | | 1.42 | %(c)(d) | | | 1.40 | %(c)(d) | | | 1.38 | %(c)(d) | | | 1.45 | %(d) | | | 1.24 | %(d) | |
Net investment income | | | 0.59 | %(b) | | | 1.57 | % | | | 0.77 | % | | | 0.57 | % | | | 0.75 | % | | | 1.10 | % | |
Portfolio turnover rate | | | 49 | % | | | 58 | % | | | 44 | % | | | 37 | % | | | 62 | % | | | 68 | % | |
Net assets, end of period (000s) | | $ | 23,793 | | | $ | 24,816 | | | $ | 24,019 | | | $ | 31,669 | | | $ | 31,454 | | | $ | 29,604 | | |
Notes to Financial Highlights
(a) Had the investment manager and/or its affiliates not waived a portion of expenses, total return would have been reduced.
(b) Annualized.
(c) In addition to the fees and expenses which the Fund bears directly, the Fund indirectly bears a pro rata share of the fees and expenses of the underlying funds in which it invests. Such indirect expenses are not included in the reported expense ratios.
(d) The benefits derived from custody fees paid indirectly had an impact of less than 0.01%.
See accompanying notes to financial statements.
15
Wanger International Select 2013 Semiannual Report
Notes to Financial Statements (Unaudited)
1. Nature of Operations
Wanger International Select (the Fund), a series of Wanger Advisors Trust (the Trust), is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The investment objective of the Fund is to seek long-term capital appreciation. The Fund is available only for allocation to certain life insurance company separate accounts established for the purpose of funding participating variable annuity contracts and variable life insurance policies and may also be offered directly to certain qualified pension and retirement plans.
2. Significant Accounting Policies
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (GAAP) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Security valuation
Securities of the Fund are valued at market value or, if a market quotation for a security is not readily available or is deemed not to be reliable because of events or circumstances that have occurred between the market quotation and the time as of which the security is to be valued, the security is valued at its fair value determined in good faith under consistently applied procedures established by the Board of Trustees (the Board). A security traded on a securities exchange or in an over-the-counter market in which transaction prices are reported is valued at the last sales price at the time of valuation. A security traded principally on NASDAQ is valued at the NASDAQ official closing price. Mutual funds and exchange traded funds are valued at their closing net asset value as reported to the applicable exchange. A security for which there is no reported sale on the valuation date is valued at the mean of the latest bid and ask quotations.
Short-term investments maturing in 60 days or less are valued at amortized cost, which approximates market value.
Forward foreign currency exchange contracts are marked-to-market based upon foreign currency exchange rates provided by a pricing service.
A security for which a market quotation is not readily available and any other assets are valued at their fair value determined in good faith under consistently applied procedures established by the Board. The Trust has retained an independent statistical fair value pricing service that employs a systematic methodology to assist in the fair valuation process for securities principally traded in a foreign market in order to adjust for possible changes in value that may occur between the close of the foreign market and the time as of which the securities are to be valued. If a security is valued at a fair value, that value may be different from the last quoted market price for the security.
Foreign currency translations
Values of investments denominated in foreign currencies are converted into U.S. dollars using the New York spot market rate of exchange at the time of valuation. Purchases and sales of investments and dividend and interest income are translated into U.S. dollars using the spot market rate of exchange prevailing on the respective dates of such transactions. The gain or loss resulting from changes in foreign exchange rates is included with net realized and unrealized gain or loss from investments, as appropriate.
Restricted securities
Restricted securities are securities that may only be resold upon registration under federal securities laws or in transactions exempt from registration. In some cases, the issuer of restricted securities has agreed to register such securities for resale at the issuer's expense either upon demand by the Fund or in connection with another registered offering of the securities. Many restricted securities may be resold in the secondary market in transactions exempt from registration. Such restricted securities may be determined to be liquid under criteria established by the Board.
Derivative Instruments
The Fund invests in forward foreign currency exchange contracts, on a very limited basis, as detailed below, to hedge the currency exposure associated with some of the Fund's securities. Forward foreign currency exchange contracts are derivative instruments whose values depend on, or are derived from, in whole or in part, the value of one or more other assets, in this case, currencies. Derivatives may involve various risks, including the potential inability of the counterparty to fulfill its obligation under the terms of the contract and the potential for market movements, which may expose the Fund to gains or losses in excess of the amount shown in the Statement of Assets and Liabilities.
For financial reporting purposes, the Fund does not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statement of Assets and Liabilities.
Forward Foreign Currency Exchange Contracts
Forward foreign currency exchange contracts are agreements between two parties to buy and sell a currency at a set price on a future date. The Fund utilized forward foreign currency exchange contracts to hedge the currency exposure associated with some of the Fund's securities. The Fund's use of forward foreign currency exchange contracts was not material to the net assets of the Fund.
The values of forward foreign currency exchange contracts fluctuate with changes in foreign currency exchange rates. The Fund will record a realized gain or loss when the forward foreign currency exchange contract expires or is closed.
The use of forward foreign currency exchange contracts does not eliminate fluctuations in the prices of the Fund's portfolio securities. The risks of forward foreign currency exchange contracts include movement in the values of the foreign currencies relative to the U.S. dollar (or other foreign currencies) and the possibility that counterparties will not complete their contractual obligations, which may be in excess of the amount reflected, if any, in the Statement of Assets and Liabilities.
Offsetting of Derivative Assets and Derivative Liabilities
The following tables present the gross and net amount of assets and liabilities of the Fund available for offset under netting arrangements as well as any related collateral received or pledged by the Fund as of June 30, 2013:
| | Gross Amounts of | | Gross Amounts Offset in the | | Net Amounts of Liabilities Presented in the | | Gross Amounts Not Offset in the Statement of Assets and Liabilities | | | |
| | Recognized Liabilities | | Statement of Assets and Liabilities | | Statement of Assets and Liabilities | | Financial Instruments (a) | | Cash Collateral Pledged | | Securities Collateral Pledged | | Net Amount (b) | |
Forward foreign currency exchange contracts | | $ | 3,474 | | | $ | — | | | $ | 3,474 | | | $ | — | | | $ | — | | | $ | — | | | $ | 3,474 | | |
(a) Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting
or similar agreements that management elects not to offset on the Statement of Assets and Liabilities.
(b) Represents the net amount due to counterparties in the event of default.
16
Wanger International Select 2013 Semiannual Report
Notes to Financial Statements, continued (Unaudited)
Effects of derivative transactions in the financial statements
The following tables are intended to provide additional information about the effect of derivatives on the financial statements of the Fund including: the fair value of derivatives by risk category and the location of those fair values in the Statement of Assets and Liabilities; the impact of derivative transactions on the Fund's operations over the period including realized gains or losses and unrealized gains or losses. The derivative schedules following the Statement of Investments present additional information regarding derivative instruments outstanding at the end of the period, if any.
The following table is a summary of the fair value of derivative instruments at June 30, 2013:
| | Liability Derivatives | |
Risk Exposure Category | | Statement of Assets and Liabilities Location | | Fair Value | |
Foreign exchange risk | | Unrealized depreciation on forward foreign currency exchange contracts | | $ | (3,474 | ) | |
The following table indicates the effect of derivative instruments in the Statement of Operations for the six months ended June 30, 2013:
Amount of Realized Gain (Loss) on Derivatives Recognized in Income
Risk Exposure Category | | Forward Foreign Currency Exchange Contracts | |
Foreign exchange risk | | $ | 88,919 | | |
Change in Unrealized Appreciation (Depreciation) on Derivatives
Recognized in Income
Risk Exposure Category | | Forward Foreign Currency Exchange Contracts | |
Foreign exchange risk | | $ | 25,349 | | |
The following table is a summary of the volume of derivative instruments for the six months ended June 30, 2013:
Derivative Instrument | | Contracts Opened | |
Forward foreign currency exchange contracts | | | 8 | | |
Security transactions and investment income
Security transactions are accounted for on the trade date (date the order to buy or sell is executed) and dividend income is recorded on the ex-dividend date, except that certain dividends from foreign securities are recorded as soon as the information is available to the Fund. Interest income is recorded on the accrual basis and includes amortization of discounts on debt obligations when required for federal income tax
purposes. Realized gains and losses from security transactions are recorded on an identified cost basis.
Awards, if any, from class action litigation related to securities owned may be recorded as a reduction of cost of those securities. If the applicable securities are no longer owned, the proceeds are recorded as realized gains.
The Fund estimates the tax character of distributions from real estate investment trusts (REITs). Distributions received in excess of income are recorded as a reduction of the cost of the related investments. If the applicable securities are no longer owned, any distributions received in excess of income are recorded as realized gains.
Expenses
General expenses of the Trust are allocated to the Fund and the other series of the Trust based upon relative net assets or other expense allocation methodologies determined by the nature of the expense. Expenses directly attributable to the Fund are charged to the Fund.
Fund share valuation
Fund shares are sold and redeemed on a continuing basis at net asset value. Net asset value per share is determined daily as of the close of trading on the New York Stock Exchange (the Exchange) on each day the Exchange is open for trading by dividing the total value of the Fund's investments and other assets, less liabilities, by the number of Fund shares outstanding.
Securities lending
The Fund may lend securities up to one-third of the value of its total assets to certain approved brokers, dealers and other financial institutions to earn additional income. The Fund retains the benefits of owning the securities, including receipt of dividends or interest generated by the security. The Fund also receives a fee for the loan. The Fund has the ability to recall the loans at any time and could do so in order to vote proxies or to sell the loaned securities. Each loan is collateralized by cash that exceeded the value of the securities on loan. The market value of the loaned securities is determined daily at the close of business of the Fund and any additional required collateral is delivered to each Fund on the next business day. The Fund has elected to invest the cash collateral in the Dreyfus Government Cash Management Fund and the income earned is paid to the Fund, net of any fees remitted to Goldman Sachs Agency Lending, the Fund's lending agent and borrower rebates. The Fund's investment manager, Columbia Wanger Asset Management, LLC (CWAM), does not retain any fees earned by the lending program. Generally, in the event of borrower default, the Fund has the right to use the collateral to offset any losses incurred. In the event the Fund is delayed or prevented from exercising its right to dispose of the collateral, there may be a potential loss to the Fund. Some of these losses may be indemnified by the lending agent. The Fund bears the risk of loss with respect to the investment of collateral. The net lending income earned by the Fund as of June 30, 2013, is included in the Statement of Operations.
The following table presents the Fund's gross and net amount of assets available for offset under a securities lending agreement as well as the related collateral received by the Fund as of June 30, 2013:
| | Gross Amounts of | | Gross Amounts Offset in the | | Net Amounts of Assets Presented in the | | Gross Amounts Not Offset in the Statement of Assets and Liabilities | | | |
| | Recognized Assets | | Statement of Assets and Liabilities | | Statement of Assets and Liabilities | | Financial Instruments (a) | | Cash Collateral Received | | Securities Collateral Received | | Net Amount (b) | |
Securities loaned | | $ | 466,218 | | | $ | — | | | $ | 466,218 | | | $ | — | | | $ | 466,218 | | | $ | — | | | $ | — | | |
(a) Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar agreements that management elects not to offset on the Statement of Assets and Liabilities.
(b) Represents the net amount due from counterparties in the event of default.
17
Wanger International Select 2013 Semiannual Report
Notes to Financial Statements, continued (Unaudited)
Federal income taxes
The Fund has complied with the provisions of the Internal Revenue Code available to regulated investment companies and, in the manner provided therein, distributes substantially all its taxable income, as well as any net realized gain on sales of investments and foreign currency transactions reportable for federal income tax purposes. Accordingly, the Fund paid no federal income taxes and no federal income tax provision was required.
Foreign capital gains taxes
Gains in certain countries may be subject to foreign taxes at the fund level. The Fund accrues for such foreign taxes on realized and unrealized gains at the appropriate rate for each jurisdiction. The amount, if any, is disclosed as a liability on the Statement of Assets and Liabilities.
Distributions to shareholders
Distributions to shareholders are recorded on the ex-dividend date.
Indemnification
In the normal course of business, the Trust on behalf of the Fund enters into contracts that contain a variety of representations and warranties and that provide general indemnities. The Fund's maximum exposure under these arrangements is unknown, as this would involve future claims against the Fund. Also under the Trust's organizational documents, the trustees and officers of the Trust are indemnified against certain liabilities that may arise out of their duties to the Trust. However based on experience, the Fund expects the risk of loss due to these warranties and indemnities to be remote.
3. Federal Tax Information
The timing and character of income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. Reclassifications are made to the Fund's capital accounts for permanent tax differences to reflect income and gains available for distribution (or available capital loss carryforwards) under income tax regulations.
The value of capital loss carryforwards that were utilized for the Fund during the year ended December 31, 2012, was $1,870,724.
Management is required to determine whether a tax position of the Fund is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized by the Fund is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Management is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. However, management's conclusions may be subject to review and adjustment at a later date based on factors including, but not limited to, new tax laws, regulations, and administrative interpretations (including relevant court decisions). The Fund's federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
4. Transactions with Affiliates
CWAM is a wholly owned subsidiary of Columbia Management Investment Advisers, LLC (Columbia Management), which in turn is a wholly owned subsidiary of Ameriprise Financial, Inc. (Ameriprise Financial). CWAM furnishes continuing investment supervision to the Fund and is responsible for the overall management of the Fund's business affairs.
CWAM receives a monthly advisory fee based on the Fund's average daily net assets at the following annual rates:
Average Daily Net Assets | | Annual Fee Rate | |
Up to $500 million | | | 0.94 | % | |
$500 million and over | | | 0.89 | % | |
For the six months ended June 30, 2013, the annualized effective investment advisory fee rate was 0.94% of the Fund's average daily net assets.
Through April 30, 2014, CWAM has contractually agreed to reimburse the Fund to the extent that ordinary operating expenses (exclusive of brokerage commissions, interest, taxes and extraordinary expenses, but inclusive of custodian charges relating to overdrafts, if any), after giving effect to any balance credits from the Fund's custodian, exceed an annual percentage of 1.45% of average daily net assets on an annualized basis.
The reimbursement to the Fund for the six months ended June 30, 2013, was $5,377.
CWAM provides administrative services and receives an administration fee from the Fund at the following annual rates:
Wanger Advisors Trust Aggregate Average Daily Net Assets of the Trust | | Annual Fee Rate | |
Up to $4 billion | | | 0.05 | % | |
$4 billion to $6 billion | | | 0.04 | % | |
$6 billion to $8 billion | | | 0.03 | % | |
$8 billion and over | | | 0.02 | % | |
For the six months ended June 30, 2013, the annualized effective administration fee rate was 0.05% of the Fund's average daily net assets. Columbia Management provides certain sub-administrative services to the Fund.
Columbia Management Investment Distributors, Inc. (CMID), a wholly owned subsidiary of Ameriprise Financial, serves as the Fund's distributor and principal underwriter.
Columbia Management Investment Services Corp. (CMIS), a wholly owned subsidiary of Ameriprise Financial, is the transfer agent to the Fund. For its services, the Fund pays CMIS a monthly fee at the annual rate of $21.00 per open account. CMIS also receives reimbursement from the Fund for certain out-of-pocket expenses.
Certain officers and trustees of the Trust are also officers of CWAM. The Trust makes no direct payments to its officers and trustees who are affiliated with CWAM.
The Board has appointed a Chief Compliance Officer of the Trust in accordance with federal securities regulations. The Fund, along with other affiliated funds, pays its pro-rata share of the expenses associated with the Office of the Chief Compliance Officer. These expenses are disclosed separately as "Chief compliance officer expenses" in the Statement of Operations.
The Trust offers a deferred compensation plan for its independent trustees. Under that plan, a trustee may elect to defer all or a portion of his or her compensation. Amounts deferred are retained by the Trust and may represent an unfunded obligation of the Trust. The value of amounts deferred is determined by reference to the change in value of Class Z shares of one or more series of Columbia Acorn Trust or a money market fund as specified by the trustee. Benefits under the deferred compensation plan are payable in accordance with the plan.
5. Borrowing Arrangements
During the six months ended June 30, 2013, the Trust participated in a credit facility with JPMorgan Chase Bank, N.A., along with Columbia Acorn Trust, another trust managed by CWAM, in the amount of $150 million prior to January 11, 2013, and in the amount of $200 million therafter. The credit facility was entered into to facilitate portfolio liquidity. Under the facility, interest is charged to each participating fund based on its borrowings at a rate per annum equal to the Federal Funds Rate plus 1.00%. In addition, a commitment fee of 0.08% per annum of the unutilized line of credit is accrued and apportioned among the participating funds based on their relative net assets. The commitment fee is disclosed separately as "Commitment fee for line of credit" in the Statement of Operations. The Trust renewed the line of credit in July in the amount of $150 million, and will continue to do so each year for one year durations annually in July at then current market rates and terms.
No amounts were borrowed for the benefit of the Fund during the six months ended June 30, 2013.
18
Wanger International Select 2013 Semiannual Report
Notes to Financial Statements, continued (Unaudited)
6. Fund Share Transactions
Proceeds and payments on Fund shares as shown in the Statement of Changes in Net Assets are in respect of the following numbers of shares:
| | (Unaudited) Six months ended June 30, 2013 | | Year ended December 31, 2012 | |
Shares sold | | | 49,454 | | | | 77,088 | | |
Shares issued in reinvestment of dividend distributions | | | 115,648 | | | | 14,145 | | |
Less shares redeemed | | | (122,631 | ) | | | (301,238 | ) | |
Net increase (decrease)in shares outstanding | | | 42,471 | | | | (210,005 | ) | |
7. Investment Transactions
The aggregate cost of purchases and proceeds from sales other than short-term obligations for the six months ended June 30, 2013, were $10,899,590 and $12,457,637, respectively.
8. Shareholder Concentration
At June 30, 2013, two unaffiliated shareholder accounts owned an aggregate of 93.7% of the outstanding shares of the Fund. The Fund has no knowledge about whether any portion of those shares was owned beneficially by such accounts. Subscription and redemption activity by concentrated accounts may have a significant effect on the operations of the Fund.
9. Subsequent Events
Management has evaluated the events and transactions that have occurred through the date the financial statements were issued and noted no items requiring adjustment of the financial statements or additional disclosure.
10. Information Regarding Pending and Settled Legal Proceedings
Ameriprise Financial and certain of its affiliates have historically been involved in a number of legal, arbitration and regulatory proceedings, including routine litigation, class actions, and governmental actions, concerning matters arising in connection with the conduct of their business activities. Ameriprise Financial believes that the Funds are not currently the subject of, and that neither Ameriprise Financial nor any of its affiliates are the subject of, any pending legal, arbitration or regulatory proceedings that are likely to have a material adverse effect on the Funds or the ability of Ameriprise Financial or its affiliates to perform under their contracts with the Funds. Ameriprise Financial is required to make 10-Q, 10-K and, as necessary, 8-K filings with the Securities and Exchange Commission on legal and regulatory matters that relate to Ameriprise Financial and its affiliates. Copies of these filings may be obtained by accessing the SEC website at www.sec.gov.
There can be no assurance that these matters, or the adverse publicity associated with them, will not result in increased fund redemptions, reduced sale of fund shares or other adverse consequences to the Funds. Further, although we believe proceedings are not likely to have a material adverse effect on the Funds or the ability of Ameriprise Financial or its affiliates to perform under their contracts with the Funds, these proceedings are subject to uncertainties and, as such, we are unable to estimate the possible loss or range of loss that may result. An adverse outcome in one or more of these proceedings could result in adverse judgments, settlements, fines, penalties or other relief that could have a material adverse effect on the consolidated financial condition or results of operations of Ameriprise Financial.
19
Wanger International Select 2013 Semiannual Report
Board Approval of the Advisory Agreement
Wanger Advisors Trust (the "Trust") has an investment advisory agreement (the "Advisory Agreement") with Columbia Wanger Asset Management, LLC ("Columbia WAM") under which Columbia WAM manages Wanger International Select (the "Fund"). More than 75% of the trustees of the Trust (the "Trustees") are persons who have no direct or indirect interest in the Advisory Agreement and are not "interested persons" (as defined in the Investment Company Act of 1940, as amended (the "1940 Act")) of the Trust (the "Independent Trustees"). The Trustees oversee the management of the Fund and, as required by law, determine at least annually whether to continue the Advisory Agreement for the Fund.
The Contract Committee (the "Committee") of the Board of Trustees (the "Board"), which is comprised solely of Independent Trustees, makes recommendations to the Board regarding any proposed continuation of the Advisory Agreement. After the Committee has made its recommendations, the full Board determines whether to approve continuation of the Advisory Agreement. The Board also considers matters bearing on the Advisory Agreement at its various meetings throughout the year, meets at least quarterly with Columbia WAM's portfolio managers (the Board's Investment Performance Analysis Committee meets frequently with them as well), and receives monthly reports from Columbia WAM on the performance of the Fund.
In connection with their most recent consideration of the Advisory Agreement for the Fund, the Committee and all Trustees received and reviewed a substantial amount of information provided by Columbia WAM, Columbia Management Investment Advisers, LLC ("Columbia Management") and Ameriprise Financial, Inc. ("Ameriprise") in response to written requests from the Independent Trustees and their independent legal counsel. In addition, the Trustees reviewed the Management Fee Evaluation dated June 2013 (the "Fee Evaluation") prepared by the Trust's chief compliance officer, senior vice president and general counsel, at the request of the Board. Throughout the process, the Trustees had numerous opportunities to ask questions of and request additional materials from Columbia WAM, Columbia Management and Ameriprise.
During each meeting at which the Committee or the Independent Trustees considered the Advisory Agreement, they met in executive session with their independent legal counsel. The Committee also met with representatives of Columbia WAM, Columbia Management and Ameriprise on several occasions. In all, the Committee convened formally on four separate occasions to consider the continuation of the Advisory Agreement. The Board and/or some or all of the Independent Trustees met on other occasions to receive the Committee's status reports, receive presentations from Columbia WAM, Columbia Management and Ameriprise representatives, and to discuss outstanding issues. In addition, the Investment Performance Analysis Committee of the Board, also comprised exclusively of Independent Trustees, reviewed the performance of the Fund, met in a joint meeting with the Committee, and presented its findings to the Board and the Committee throughout the year. The Compliance Committee of the Board also provided information to the Committee with respect to relevant matters.
The materials reviewed by the Committee and the Trustees included, among other items, (i) information on the investment performance of the Fund and of independently selected peer groups of funds and of the Fund's performance benchmark over various time periods, (ii) information on the Fund's advisory fees and other expenses, including information comparing the Fund's fees and expenses to those of peer groups of funds and information about any applicable expense limitations and fee breakpoints, (iii) data on sales and redemptions of Fund shares, and (iv) information on the profitability to Columbia WAM and Ameriprise, as well as potential "fall-out" or ancillary benefits that Columbia WAM and its affiliates may receive as a result of their relationships with the Fund. The Trustees also considered other information such as (i) Columbia WAM's financial condition, (ii) the Fund's investment objective and strategy, (iii) the size, education and experience of Columbia WAM's investment staff and its use of technology, external research and trading cost measurement tools, (iv) the portfolio manager compensation framework, (v) the allocation of the Fund's brokerage, and the use of "soft" commission dollars to pay for research products and services, (vi) Columbia WAM's risk management program, and (vii) the resources devoted to, and the record of compliance with, the Fund's
investment policies and restrictions, policies on personal securities transactions and other compliance policies.
At a meeting held on June 5, 2013, upon the recommendation of the Committee, the Board unanimously approved the continuation of the Advisory Agreement.
In considering the continuation of the Advisory Agreement, the Trustees reviewed and analyzed various factors that they determined were relevant, none of which by itself was considered dispositive. The material factors and conclusions that formed the basis for the Trustees' determination to approve the continuation of the Advisory Agreement are discussed below.
Nature, quality and extent of services. The Trustees reviewed the nature, quality and extent of the services provided by Columbia WAM and its affiliates to the Fund under the Advisory Agreement, taking into account the investment objective and strategy of the Fund, its shareholder base, and knowledge gained from meetings with management, which were held on at least a quarterly basis. In addition, the Trustees reviewed the available resources and key personnel of Columbia WAM and its affiliates, especially those providing investment management services to the Fund. The Trustees also considered other services provided to the Fund by Columbia WAM and its affiliates, including: managing the execution of portfolio transactions and selecting broker-dealers for those transactions; monitoring adherence to the Fund's investment restrictions; producing shareholder reports; providing support services for the Board and committees of the Board; managing the Fund's securities lending program; communicating with shareholders; serving as the Fund's administrator; and overseeing the activities of the Fund's other service providers, including monitoring for compliance with various policies and procedures as well as applicable securities laws and regulations.
The Trustees concluded that the nature, quality and extent of the services provided by Columbia WAM and its affiliates to the Fund under the Advisory Agreement were appropriate for the Fund and that the Fund was likely to benefit from the continued provision of those services by Columbia WAM. They also concluded that Columbia WAM currently had sufficient personnel, with appropriate education and experience, to serve the Fund effectively, and that the firm had demonstrated its continuing ability to attract and retain well-qualified personnel. In addition, they considered the quality of Columbia WAM's compliance record.
Performance of the Fund. The Trustees received and considered detailed performance information at various meetings of the Board, the Committee and the Investment Performance Analysis Committee of the Board throughout the year. They reviewed information comparing the Fund's performance with that of its benchmark(s) and with the performance of comparable funds and peer groups as identified by Lipper Inc. ("Lipper") and Morningstar, Inc. ("Morningstar"). The Trustees evaluated the performance of the Fund over various time periods, including over the one-, three- and five-year periods ending December 31, 2012. The Trustees also considered peer performance rankings for similar time periods, although they generally focused more on the five-year period.
The Trustees considered that the Fund's returns were mixed versus its peer group over the five- and one-year periods ending December 31, 2012 with Morningstar rating the Fund below the median and Lipper rating the Fund above the median for the five-year period, and Lipper rating the Fund below median in the one-year period, while Morningstar rated it above the median. And in the three-year period, both services rated the Fund's performance well above the median. The Trustees also took into account that the Fund outperformed its benchmark for all periods. They also considered that the Fund exposed shareholders to less risk than its peers during these periods.
Costs of Services and Profits Realized by Columbia WAM. At various Committee and Board meetings, the Trustees examined detailed information on the fees and expenses of the Fund in comparison to information for comparable funds provided by Lipper and Morningstar. The Trustees noted that the Fund's net expenses were higher than both the Lipper and Morningstar peer groups. The Trustees also took into account that the actual advisory fees paid by the Fund were higher than the median versus Lipper peers and lower than the median of Morningstar peers.
The Trustees also reviewed the advisory fee rates charged by Columbia WAM for managing other investment companies, sub-advised funds and other institutional
20
Wanger International Select 2013 Semiannual Report
Board Approval of the Advisory Agreement, continued
separate accounts, with similar investment strategies, as detailed in materials provided to the Committee by Columbia WAM and in the Fee Evaluation. The Trustees noted that the the Fund's advisory fees were generally comparable to Columbia Acorn International Select's advisory fees at the same asset levels.
The Trustees concluded that the rate of advisory fees payable to Columbia WAM were reasonable in relation to the nature and quality of the services to be provided and the investment performance of the Fund, taking into account Columbia WAM's recent steps to improve performance of the Fund.
The Trustees reviewed the analysis of the historic profitability of Columbia WAM in serving as the Fund's investment manager and of Columbia WAM and its affiliates in their relationships with the Fund. The Committee and Trustees met with representatives from Ameriprise to discuss its methodologies for calculating profitability and allocating costs. They considered that Ameriprise calculated profitability and allocated costs on a contract-by-contract and Fund-by-Fund basis. The Trustees also considered the methodology used by Columbia WAM and Ameriprise in determining compensation payable to portfolio managers and the competitive market for investment management talent. The Trustees were also provided with profitability information from Lipper, which compared Columbia WAM's profitability to other similar investment managers in the mutual fund industry. The Trustees concluded that Columbia WAM's and its affiliates' profits were within a reasonable range of those of competitors with similar business models. The Trustees discussed, however, that profitability comparisons among fund managers may not always be meaningful due to the lack of consistency in data, small number of publicly-owned managers, and the fact that profitability of any investment manager is affected by numerous factors, including its particular organizational structure, the types of funds and other accounts managed, other lines of business, expense allocation methodology, capital structure and other factors.
Economies of Scale. At various Committee and Board meetings and other informal meetings, the Trustees considered information about the extent to which Columbia WAM realizes economies of scale in connection with an increase in Fund assets. The Trustees noted that the advisory fee schedule for the Fund includes breakpoints in the rate of fees at various asset levels. The Trustees concluded that the fee structure of the Fund was reflective of a sharing of economies of scale between Columbia WAM and the Fund.
Other Benefits to Columbia WAM. The Trustees also reviewed benefits that accrue to Columbia WAM and its affiliates from their relationships with the Fund, based upon information provided to them by Ameriprise and as outlined in the Fee Evaluation. They noted that the Fund's transfer agency services are performed by Columbia Management Investment Services Corp., an affiliate of Ameriprise, which receives compensation from the Fund for its services provided. They considered that an affiliate of Ameriprise, Columbia Management Investment Distributors, Inc. ("CMID"), serves as the Fund's distributor under an underwriting agreement but receives no fees for its services to the Fund. In addition, Columbia Management provides sub-administration services to the Fund. The Committee received information regarding the profitability of the Fund agreement with Columbia WAM affiliates. The Committee and the Board also reviewed information about and discussed the capabilities of each affiliated entity in performing its duties.
The Trustees considered other ways that the Fund and Columbia WAM may potentially benefit from their relationship with each other. For example, the Trustees considered Columbia WAM's use of commissions paid by the Fund on its portfolio brokerage transactions to obtain research products and services benefiting the Fund and/or other clients of Columbia WAM. The Committee reviewed Columbia WAM's annual "soft dollar" report and met with representatives from Columbia WAM to review Columbia WAM's soft dollar spending. The Committee also considered that the Compliance Committee of the Board regularly reviewed third-party prepared reports that evaluated the quality of Columbia WAM's execution of the Fund's portfolio transactions. The Trustees noted that these reports showed that Columbia WAM's execution capabilities were generally better than industry peers. The Trustees determined that Columbia WAM's use of the Fund's "soft" commission dollars to obtain research products and services was consistent with current regulatory requirements and guidance. They also concluded that Columbia WAM benefits from
the receipt of proprietary research products and services acquired through commissions paid on portfolio transactions of the Fund, and that the Fund benefitted from Columbia WAM's receipt of those products and services as well as research products and services acquired through commissions paid by other clients of Columbia WAM.
After full consideration of the above factors, as well as other factors that were instructive in evaluating the Advisory Agreement, the Trustees, including the Independent Trustees by separate vote, concluded that the continuation of the Advisory Agreement was in the best interest of the Fund. On June 5, 2013, the Trustees approved continuation of the Advisory Agreement through July 31, 2014.
21
Wanger International Select 2013 Semiannual Report
Trustees
Laura M. Born
Chair of the Board
Steven N. Kaplan
Vice Chair of the Board
Michelle L. Collins
Maureen M. Culhane
Margaret M. Eisen
John C. Heaton
Charles P. McQuaid
David J. Rudis
David B. Small
Ralph Wanger (Trustee Emeritus)
Officers
Charles P. McQuaid
President
Robert A. Chalupnik
Vice President
Michael G. Clarke
Assistant Treasurer
Joseph F. DiMaria
Assistant Treasurer
P. Zachary Egan
Vice President
Fritz Kaegi
Vice President
John M. Kunka
Assistant Treasurer
Stephen Kusmierczak
Vice President
Joseph C. LaPalm
Vice President
Bruce H. Lauer
Vice President, Secretary and Treasurer
Louis J. Mendes III
Vice President
Robert A. Mohn
Vice President
Christopher J. Olson
Vice President
Christopher O. Petersen
Assistant Secretary
Scott R. Plummer
Assistant Secretary
Linda K. Roth-Wiszowaty
Assistant Secretary
Robert P. Scales
Chief Compliance Officer, Chief Legal Officer, Senior Vice President and
General Counsel
Andreas Waldburg-Wolfegg
Vice President
Investment Manager
Columbia Wanger Asset Management, LLC
227 West Monroe Street, Suite 3000
Chicago, Illinois 60606
1-888-4-WANGER
(1-888-492-6437)
Transfer Agent,
Dividend Disbursing Agent
Columbia Management Investment Services Corp.
P.O.Box 8081
Boston, Massachusetts
02266-8081
Distributor
Columbia Management Investment Distributors, Inc.
225 Franklin Street
Boston, Massachusetts
02110
Legal Counsel to the Funds
Perkins Coie LLP
Washington, DC
Legal Counsel to the Independent Trustees
Drinker Biddle & Reath LLP
Philadelphia, Pennsylvania
Independent Registered Public Accounting Firm
PricewaterhouseCoopers LLP
Chicago, Illinois
This document contains Global Industry Classification Standard data. The Global Industry Classification Standard ("GICS") was developed by and is the exclusive property and a service mark of MSCI Inc. ("MSCI") and Standard & Poor's Financial Services LLC ("S&P") and is licensed for use by Columbia Wanger Asset Management, LLC ("CWAM"). Neither MSCI, S&P, nor any other party involved in making or compiling the GICS or any GICS classifications makes any express or implied warranties or representations with respect to such standard or classification (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability and fitness for a particular purpose with respect to any of such standard or classification. Without limiting any of the foregoing, in no event shall MSCI, S&P, any of their affiliates or any third party involved in making or compiling the GICS or any GICS classifications have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages.
This report, including the schedules of investments and financial statements, is submitted for the general information of the shareholders of the Wanger Advisors Trust.
A description of the Fund's proxy voting policies and procedures and a copy of the Fund's voting record for the most recent 12-month period ended June 30 are available (i) on our website, columbiamanagement.com, (ii) on the Securities and Exchange Commission's website at www.sec.gov, and (iii) without charge, upon request, by calling 888-492-6437.
The Fund files a complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q. The Fund's Form N-Q is available on the SEC's website at www.sec.gov and may be reviewed and copied at the SEC's Public Reference Room in Washington, D.C. Information on the operation of the Pubic Reference Room may be obtained by calling 800-SEC-0330. The Fund's complete portfolio holdings are disclosed at www.columbiamanagement.com approximately 30 to 40 days after each month-end.
© 2013 Columbia Management Investment Advisers, LLC. All rights reserved.
(8/13) 710327
Wanger Select
2013 Semiannual Report
Not FDIC insured • No bank guarantee • May lose value
Columbia Wanger Asset Management, LLC (CWAM) is one of the leading global small- and mid-cap equity managers in the United States with over 40 years of small- and mid-cap investment experience. As of June 30, 2013, CWAM managed $34.9 billion in assets. CWAM is the investment manager to Wanger USA, Wanger International, Wanger Select and Wanger International Select (together, the Columbia Wanger Funds) and the Columbia Acorn Family of Funds.
Investors should consider the investment objectives, risks, charges and expenses of a mutual fund carefully before investing. For a free prospectus, which contains this and other important information about the Fund, contact your financial adviser, insurance company, qualified pension retirement plan sponsor or call 1-888-4-WANGER. Read the prospectus carefully before investing.
An important note: Columbia Wanger Funds are available for purchase through variable annuity contracts and variable life insurance policies offered by the separate accounts of participating insurance companies and qualified pension or retirement plans.
Shares of the Fund may not be purchased or sold directly by individual owners of variable annuity contracts and/or variable life insurance policies (collectively, Contracts) or participants in qualified retirement or other plans (collectively, Qualified Plans). If you are the owner of a Contract or a participant in a Qualified Plan, please refer to the prospectus that describes your Contract or Qualified Plan for information about minimum investment requirements and how to purchase and redeem shares of the Fund.
The views expressed in "Health Care in the United States" and in the Performance Review reflect the current views of the respective authors. These views are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict so actual outcomes and results may differ significantly from those stated. These views are subject to change at any time based upon economic, market or other conditions and the respective parties disclaim any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Columbia Wanger Fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any particular Columbia Wanger Fund. References to specific company securities should not be construed as a recommendation or investment advice.
Wanger Select
2013 Semiannual Report
Table of Contents
| 2 | | | Understanding Your Expenses | |
| 3 | | | Health Care in the United States | |
| 6 | | | Performance Review | |
| 8 | | | Statement of Investments | |
| 13 | | | Statement of Assets and Liabilities | |
| 13 | | | Statement of Operations | |
| 14 | | | Statement of Changes in Net Assets | |
| 15 | | | Financial Highlights | |
| 16 | | | Notes to Financial Statements | |
| 19 | | | Board Approval of the Advisory Agreement | |
Wanger Select 2013 Semiannual Report
Understanding Your Expenses
As an investor, you incur two types of costs. There are transaction costs, which may include redemption fees or exchange fees charged under your contract or qualified plan. There are also ongoing costs, which generally include management fees and other Fund expenses. Lastly, there may be additional fees or charges imposed by the insurance company that sponsors your variable annuity and/or variable life insurance product. The following information is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to help you compare these costs with the ongoing costs of investing in other mutual funds.
Analyzing your Fund's expenses
To illustrate the ongoing costs, we have provided an example and calculated the expenses paid by investors in the Fund during the period. The actual and hypothetical information in the table below is based on an initial investment of $1,000 at the beginning of the period indicated and held for the entire period. Expense information is calculated two ways and each method provides you with different information. The amount listed in the "Actual" column is calculated using the Fund's actual operating expenses and total return for the period. You may use the Actual information, together with the amount invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the results by the expenses paid during the period under the Actual column. The amount listed in the "Hypothetical" column assumes a 5% annual rate of return before expenses (which is not the Fund's actual return) and then applies the Fund's actual expense ratio for the period to the hypothetical return. You should not use the hypothetical account values and expenses to estimate either your actual account balance at the end of the period or the expenses you paid during the period. See "Compare with other funds" below for details on how to use the hypothetical data.
Compare with other funds
Since all mutual funds are required to include the same hypothetical calculations about expenses in shareholder reports, you can use this information to compare the ongoing cost of investing in the Fund with other funds. To do so, compare the hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds. As you compare hypothetical examples of other funds, it is important to note that hypothetical examples are meant to highlight the ongoing cost of investing in a fund only and do not reflect any transaction costs, such as redemption or exchange fees. Therefore, the hypothetical calculations are useful in comparing ongoing costs only, and will not help you determine the relative total costs of investing in different funds. If transaction costs were included in these calculations, your costs would be higher.
January 1, 2013 - June 30, 2013
| | Account value at the beginning of the period ($) | | Account value at the end of the period ($) | | Expenses paid during period ($) | | Fund's annualized expense ratio (%)* | |
| | Actual | | Hypothetical | | Actual | | Hypothetical | | Actual | | Hypothetical | | | |
Wanger Select | | | 1,000.00 | | | | 1,000.00 | | | | 1,124.70 | | | | 1,020.01 | | | | 4.79 | | | | 4.56 | | | | 0.92 | | |
* Expenses paid during the period are equal to the Fund's annualized expense ratio, multiplied by the average account value over the period, then multiplied by the number of days in the Fund's most recent fiscal half-year and divided by 365.
It is important to note that the expense amounts shown in the table are meant to highlight only ongoing costs of investing in the Fund. Expenses paid during the period do not include any insurance charges imposed by your insurance company's separate account.
2
Wanger Select 2013 Semiannual Report
Health Care in the United States
Critics of the U.S. health care system note that the World Health Organization (WHO) ranked the United States thirtieth in the world in life expectancy1 despite the fact that the United States spends more money per capita on health care than any other country. They argue that health care in the United States is inferior to health care in many other developed countries.
Scott W. Atlas's book, In Excellent Health, Setting the Record Straight on America's Health Care,2 analyzes the consequences of poor lifestyle choices made by many Americans and how the U.S. health care system operates compared to health care systems elsewhere. His book cites numerous studies indicating the U.S. health care system does a great job addressing the health concerns of Americans and is likely the best system in the world.
Life Expectancy
The United States is much more violent and accident-prone than other developed countries. Homicide rates in the United States are ten times that of the United Kingdom and five times that of Canada.3 Death rates from transportation accidents in the United States are 250% that of the United Kingdom and 160% that of Canada.4 Murder and accidents account for the majority of deaths among young adults in the United States,5 and deaths at young ages substantially impact life expectancies.
Robert Ohsfeldt's and John Schneider's book, The Business of Health,6 attempts to quantify the impact of fatal injuries on life expectancy. Using linear regression, they calculate that after standardizing for fatal injuries alone, the United States would edge out Switzerland by 0.3 years and have the highest life expectancy of any country in the world.7
Other studies indicate that violence and accidents account for much, but not all, of the life expectancy shortfall in the United States. A National Academy of Sciences panel addressing cross-national health differences issued a paper that indicated 57% of the life expectancy gap for
males under age 50 and 38% for females under 50 is explained by higher violence and accidents in the United States.8
The United States has a much higher incidence of obesity than other developed countries. Atlas notes that in 2010 34% of people in the United States were obese compared to 15% in Canada, 17% in Western Europe and about 24% in the United Kingdom.9 The Organization for Economic Cooperation and Development (OECD) estimates that obesity reduces life spans by up to eight to ten years.10 Sadly, the worst is yet to come for the United States, as obesity rates have increased and there appears to be a 25-year time lag between becoming obese and suffering premature death.11
Cigarette use in the United States is down substantially; smoking rates are now lower than most other OECD countries.12 However, studies have found a time lag of roughly 25 to 30 years between smoking and lung cancer mortality.13 The United States had the highest rate of smoking in the developed world from the 1930s to the mid-1980s and, according to a 2007 study, 53% of Americans were current or former smokers, compared to 43% of Western Europeans.14 Clearly the United States' legacy of smoking continues to impact health. The Surgeon General estimates that cigarette smoking causes 443,000 deaths in the United States yearly, nearly one-fifth of all deaths.15
With respect to neonatal mortality, Atlas writes that the United States has stringent reporting requirements and definitions. Birth registrations in the United States are done by hospitals and health care professionals, while many other countries rely on reporting by families or surveys.16 In the United States, a live birth is tabulated should a newborn breathe, have a beating heart, move voluntary muscles or show any other evidence of life.17 According to WHO, countries representing only 13% of births worldwide had reliable data meeting this definition.18
Elsewhere, definitions for live births vary greatly. Some countries consider births as live only if 28 weeks gestation was achieved, if a baby is 30 centimeters long, or if a baby survives 24 hours.19 Otherwise, the baby is classified as stillborn and is not considered an infant mortality. Atlas states, "... considering that roughly half of all U.S. infant mortality occurs in the first twenty-four hours, the single criterion of omitting deaths within the first twenty-four hours by many European nations generates their falsely superior infant mortality rates."20
Data from 2004 indicated that the United States had 12% of births classified as preterm (under 32 weeks gestation), a rate 50% to 100% higher than most European countries.21 These figures are impacted by the fact the United States has more multiple gestation pregnancies. Since the early 1980s, the incidence of triplets in the United States has more than tripled to over 140 births per 100,000.22 Atlas notes that in 2007, 17% of twins and 40% of triplets in the United States were associated with fertility treatments.
The United States health care system should be applauded for its efforts to save premature babies rather than write them off as stillborn, as many other countries do. Except for a very limited number of abusive cases, fertility treatment should be considered a virtue of the U.S. health care system. Yet, coupled with superior record keeping, these efforts depress the country's life expectancy ranking.
Diagnosis, Treatment and Outcomes
The Centers for Disease Control and Prevention (CDC) lists heart disease as the top killer in the United States, accounting for 25% of deaths, followed by cancer at 23%, and stroke a distant third at 6%.23 Rather than judge a health care system on reported life expectancy, Atlas assesses health care quality in the United States based on actual medical care, especially diagnosis and treatment of important diseases, using objective data.
3
Wanger Select 2013 Semiannual Report
Atlas notes the challenges facing the health care system due to the poor lifestyle choices of many Americans. The CDC estimates that 80% of diabetes, heart disease and stroke, and 40% of cancer, could be eliminated through reduction in obesity and smoking.24 The rate of diabetes in the United States is typically 33% to 100% higher than other developed countries.25 A 2007 study indicated that 12% of Americans over age 50 were diagnosed with cancer, compared to only 5% in a composite of 10 European countries.26
Atlas cites data showing more timely diagnosis and treatment in the United States as compared to other countries. He writes that, "... prolonged wait times are commonly found in health systems with government-controlled nationalized health insurance."27 Numerous countries with single payer systems had to create policies to address prolonged wait times, including Canada, England, Italy, Sweden and Spain.
The United States is among the world's leaders in per capita computerized tomography (CT) and magnetic resonance imaging (MRI) scanners,28 which are crucial to accurately diagnosing leading fatal diseases and guiding lower risk and more effective treatments. In the United States, referring doctors book CT and MRI appointments within days. In other countries, people wait. In 2010, the average wait time in Canada for a CT scan was 4 weeks and for an MRI, 10 weeks.29 A 2011 study in the United Kingdom indicated thousands of people waited over six weeks for an MRI scan. With respect to breast cancer biopsies, another survey indicated that only 1% of U.S. patients waited three weeks or more while 44% of Canadian and 20% of U.K. patients waited that long.30
Treatment of diseases also tends to be very timely in the United States. One study indicated that no elective (non-emergency) cardiac bypass patients in the United States were known to have waited more than three months, while 47% in Canada and 89% in the United Kingdom waited at least that long.31
Furthermore, treatments in the United States tend to be aggressive. A 2009 paper written by
University of Pennsylvania professor Samuel Preston and doctoral candidate Jessica Ho states that 88% of Americans with high cholesterol are being medicated versus 62% of Europeans. Likewise a higher percentage of Americans over age 50 with heart disease receive medication. Among those with hypertension in the United States, 66% were being successfully treated, versus 25% to 49% in other countries.32
With respect to cancer, Preston and Ho cite studies showing that the United States tends to have the highest percentage of screenings for breast, cervical, prostate and colon cancer.33 If cancer is detected, Americans tend to receive more surgery, chemotherapy and advanced cancer drugs. A 2008 study calculated five-year survival rates for breast, colorectal and prostate cancers. Patients in the United States lead the world with a 74% survival rate. Second-best Canada came in at 71% and the United Kingdom was a laggard at 52%.
Atlas adds that new oncology drugs are most often approved and first used in the United States.34 Some 80% of worldwide medical innovation originates in the United States and, since the mid-1970s, U.S. scientists have won more than half of Nobel Prize awards in medicine and physiology.
The statistics are clear. Sick Americans are more likely to receive timely and aggressive health care than citizens of other countries. Atlas writes, "Availability of state-of-the-art medical technology, timely access to specialists, the most effective screening, the shortest wait times for life-changing surgeries, the newest, most effective drugs for more accurate, safer diagnosis and for the most advanced treatment are all superior in the United States."35
Many people appear to agree. In 2008, a McKinsey & Company study estimated that up to 85,000 patients sought in-patient treatment outside their home country. Of that number, 87% traveled to the United States for advanced medical technology, better quality care or quicker access to care. In contrast, critics of the U.S.
health care system don't appear to be traveling to Cuba for treatment. Based on the facts, I agree with Atlas.
Health Care Economics and Investment Implications
Atlas states that the, "... only real crisis in America's health care today is the unsustainable and increasing burden of health care costs..."36 and recommends free market reforms. Health care costs are not the topic of this essay, but world-class health care clearly is expensive, and costs in the United States are exacerbated by detrimental lifestyle choices. I also believe that poor government policies result in few incentives for cost restraint.
Columbia Wanger Asset Management, the investment manager of the Columbia Wanger Funds, strives to provide Columbia Wanger Fund investors with investments in health care companies that are pursuing breakthrough drugs and devices, with the potential to transform treatment of serious and poorly managed diseases. For example, in pivotal studies Seattle Genetics' drug Adcetris delivered 80% response rates in advanced Hodgkin's lymphoma patients who had exhausted all other treatment options.37 In addition, we seek to invest in companies with products and services that we believe increase the cost effectiveness of health care delivery. We attempt to avoid investing in health care companies that may be more likely to be subject to cost cuts or price controls.
Charles P. McQuaid
President and Chief Investment Officer
Columbia Wanger Asset Management, LLC
4
Wanger Select 2013 Semiannual Report
The information and data provided in this analysis are derived from sources that we deem to be reliable and accurate. These views are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict so actual outcomes and results may differ significantly from the views expressed. The views/opinions expressed here are those of the author and not of the Wanger Advisors Trust Board, are subject to change at any time based upon economic, market or other conditions, may differ from views expressed by other Columbia Management associates and the respective parties disclaim any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Columbia Wanger Fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any particular Columbia Wanger Fund.
1 Atlas, Scott W., In Excellent Health, Setting the Record Straight on American's Heath Care, (Stanford, California, Hoover Institution Press), p. 2.
2 Ibid.
3 Ohsfeldt, Robert L., and Schneider, John E., The Business of Health, The Role of Competition, Markets, and Regulation, (Washington, D.C., The AEI Press), p. 19.
4 Atlas, Scott W., op. cit., p. 28.
5 Ibid., p. 28.
6 Ohsfeldt, Robert L., and Schneider, John E., op. cit.
7 Ibid., p. 22.
8 Steven H. Woolf and Laudan Aron, Editors; Panel on Understanding Cross-National Health Differences Among High-Income Countries; Committee on Population; Division of Behavioral and Social Sciences and Education; National Research Council; Board on Population Health and Public Health Practice; Institute of Medicine, www.nap.edu.
9 Atlas, Scott W., op. cit., p. 105.
10 Ibid., p. 31.
11 Ibid., p. 107.
12 Ibid., p. 40.
13 Ibid., p. 41.
14 Ibid., p. 111.
15 Ibid., p. 108.
16 Ibid., p. 60.
17 Ibid., p. 67.
18 Ibid., p. 71.
19 Ibid., p. 68.
20 Ibid., p. 70.
21 Ibid., p. 73.
22 Ibid., p. 89.
23 Ibid., p. 119.
24 Ibid., p. 103.
25 Ibid., p. 113.
26 Preston, Samuel H., and Ho, Jessica Y., "Low Life Expectancy in the United States: Is the Health Care System at Fault?" University of Pennsylvania Scholarly Commons Working Paper Series, July 1, 2009, p. 4, http://repository.upenn.edu/psc_working_papers/13/. Accessed July 24, 2013.
27 Atlas, Scott W., op. cit., p. 159.
28 Ibid., p. 192-193.
29 Ibid., p. 194.
30 Ibid., p. 175.
31 Ibid., p. 187.
32 Preston, Samuel H., and Ho, Jessica Y., op. cit., p. 6.
33 Ibid., p. 3.
34 Atlas, Scott W., op. cit., p. 222.
35 Ibid., p. 233.
36 Ibid., p. 245.
37 Seattle Genetics is held in the following Columbia Wanger Funds: Wanger USA, 1.2%; Wanger Select, 1.3%.
5
Wanger Select 2013 Semiannual Report
Performance Review Wanger Select
| |
Robert A. Chalupnik Portfolio Manager | |
Performance data shown represents past performance and is not a guarantee of future results. The investment return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data shown. Please visit columbiamanagement.com for most recent month-end performance updates.
Wanger Select finished the semiannual period ended June 30, 2013, up 12.47%, underperforming the 14.59% gain of its primary benchmark, the S&P MidCap 400 Index. Poor stock performance in the energy sector dampened relative returns. The Fund was underweight in energy versus the benchmark and its investments in smaller energy companies lagged the sector.
U.S. car rental company Hertz gained 52% for the six-month period. The rental car industry is benefiting from consolidation and its ability to quickly adjust capacity. WNS, an offshore business process outsourcing company, ended the half up 60% on solid revenue growth. Insurance provider CNO Financial gained 39% during the period, as an increase in interest rates sparked investor interest in life insurance companies.
Other strong performers included Sanmina, a provider of electronic manufacturing services, which bounced with the tech sector and gained 29%. Globalstar, a satellite mobile voice and data carrier, provided an 82% gain for the Fund during the period. Real Goods Solar, a residential solar energy installer, rose 583% in the Fund on positive press suggesting it was a good buy. We sold Globalstar and Real Goods Solar during the period, capturing the surge in their stock prices. Both stocks dropped after we sold them. Removing these two holdings from the portfolio was also in keeping with our effort to reposition the portfolio away from riskier, micro-cap names.
On the downside, Petrodorado Energy, an oil and gas exploration company, fell 53% during the period. Petrodorado hit oil in Colombia, but uncertainty as to whether the find would be commercially viable caused investors to move away from the stock. Also in the oil exploration sector, Pacific Rubiales Energy was down 24% for the half year due to delays caused by a slow environmental licensing process in Colombia. Outside the energy sector, F5 Networks, a provider of Internet traffic management equipment, fell 30% on a slight earnings miss and lowered guidance.
In addition to the two sales mentioned above, we also sold teen apparel retailer Abercrombie & Fitch due to disappointing sales data. We sold Canadian Solar, a Chinese solar cell and module manufacturer, as our thesis for investment did not pan out. We also sold designer accessories retailer Coach, biotech company NPS Pharmaceuticals, drilling rig contractor Tuscany International Drilling and utility company Wisconsin Energy.
Six new names were added to the portfolio during the period including PVH, an apparel wholesaler and retailer with global mega-brands including Calvin Klein and Tommy Hilfiger. Another new holding, Blackhawk Network, is a third-party distributor of prepaid content like gift cards. Blackhawk was spun out of former Fund holding Safeway grocery stores. Since we have covered Safeway for years, we know this piece of their business well and we believe it has growth potential. Trimble Navigation, a manufacturer of global positioning satellites (GPS) instruments, was also
added during the period. We believe increased use of GPS technology in many areas including agriculture, engineering and construction provides a nice runway of growth for Trimble. Consumer electronics specialty retailer Best Buy was added as a turnaround opportunity driven by new company management. Specialty beauty product retailer ULTA and sport and fitness club operator Lifetime Fitness were also added during the period.
The stock market rally continued during the period while gold and bond prices retreated on concerns that the Federal Reserve will taper off its bond buying program. Although we think about macro issues including global growth rates, government deficits and interest rate changes, our primary focus is on finding companies that have strong prospects for growing sales and earnings through product innovation, market share gains and manufacturing efficiencies, while paying a reasonable price for that outlook. The trades we made during the period continue to focus the Fund on this strategy.
Effective May 1, 2013, Wanger Select co-portfolio manager Robert Chalupnik was named lead portfolio manager of the Fund. Former lead portfolio manager Ben Andrews resigned as portfolio manager but will continue to work with the Fund's investment manager, Columbia Wanger Asset Management, LLC, as an analyst. There are no current plans to add a co-manager to the Fund. These changes will not alter the Fund's investment objective or policies.
Risks include stock market fluctuations due to economic and business developments. The Fund also has potentially greater price volatility due to the Fund's concentration in a limited number of stocks of mid-size companies. International investing involves special risks, including foreign taxation, currency risks, risks associated with possible differences in financial standards, operational and settlement risks and other risks associated with future political and economic developments.
Portfolio holdings are subject to change periodically and may not be representative of current holdings.
Fund's Positions in Mentioned Holdings
As a percentage of net assets, as of 6/30/13
CNO Financial Group | | | 6.2 | % | |
Hertz | | | 5.6 | | |
WNS | | | 4.9 | | |
Sanmina | | | 1.8 | | |
F5 Networks | | | 1.6 | | |
ULTA | | | 1.5 | | |
Lifetime Fitness | | | 1.4 | | |
PVH | | | 1.4 | | |
Pacific Rubiales Energy | | | 1.3 | | |
Blackhawk Network | | | 1.2 | | |
Trimble Navigation | | | 1.0 | | |
Best Buy | | | 0.7 | | |
Petrodorado Energy | | | 0.2 | | |
6
Wanger Select 2013 Semiannual Report
Growth of a $10,000 Investment in Wanger Select
February 1, 1999 (inception date) through June 30, 2013
Performance data shown represents past performance and is not a guarantee of future results. The investment return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data shown. Performance results reflect any fee waivers or reimbursements of Fund expenses by the investment manager and/or any of its affiliates. Absent these fee waivers and/or expense reimbursement arrangements, performance results would have been lower. For daily and most recent month-end performance updates, please call 1-888-4-WANGER.
This graph compares the results of $10,000 invested in Wanger Select on February 1, 1999 (the date the Fund began operations) through June 30, 2013, to the S&P MidCap 400 Index, with dividends and capital gains reinvested. Although the index is provided for use in assessing the Fund's performance, the Fund's holdings may differ significantly from those in the index.
Top 10 Holdings
As a percentage of net assets, as of 6/30/13
1. CNO Financial Group Life, Long-term Care & Medical Supplement Insurance | | | 6.2
| % | |
2. Ametek Aerospace/Industrial Instruments | | | 6.2
| | |
3. Hertz Largest U.S. Rental Car Operator | | | 5.6
| | |
4. WNS — ADR* (India) Offshore Business Process Outsourcing Services | | | 4.9
| | |
5. Discover Financial Services Credit Card Company | | | 4.5
| | |
6. Amphenol Electronic Connectors | | | 4.0
| | |
7. Donaldson Industrial Air Filtration | | | 3.9
| | |
8. Crown Castle International Communications Towers | | | 3.7
| | |
9. City National Bank & Asset Manager | | | 3.3
| | |
10. SBA Communications Communications Towers | | | 3.1
| | |
*ADR=American Depository Receipts
Top 5 Industries
As a percentage of net assets, as of 6/30/13
Industrial Goods & Services | | | 23.8 | % | |
Information | | | 23.8 | | |
Consumer Goods & Services | | | 18.2 | | |
Finance | | | 17.9 | | |
Energy & Minerals | | | 5.9 | | |
Results as of June 30, 2013
| | 2nd quarter* | | Year to date* | | 1 year | | 5 years | | 10 years | |
Wanger Select | | | 1.56 | % | | | 12.47 | % | | | 22.67 | % | | | 4.51 | % | | | 8.56 | % | |
S&P MidCap 400 Index** | | | 1.00 | | | | 14.59 | | | | 25.18 | | | | 8.91 | | | | 10.74 | | |
S&P 500 Index | | | 2.91 | | | | 13.82 | | | | 20.60 | | | | 7.01 | | | | 7.30 | | |
Lipper Variable Underlying Mid-Cap Core Funds Index | | | 1.65 | | | | 14.79 | | | | 24.63 | | | | 7.11 | | | | 9.60 | | |
*Not annualized.
**The Fund's primary benchmark.
NAV as of 6/30/13: $30.43
Performance numbers reflect all Fund expenses but do not include any fees and expenses imposed under your variable annuity or life insurance policy or qualified pension or retirement plan. If performance included the effect of these additional charges, it would be lower.
The Fund's annual operating expense ratio of 0.91% is stated as of the Fund's prospectus dated May 1, 2013, and differences in expense ratios disclosed elsewhere in this report may result from including fee waivers and expense reimbursements as well as different time periods used in calculating the ratios.
All results shown assume reinvestment of distributions.
The S&P MidCap 400 Index is a market value-weighted index that tracks the performance of 400 mid-cap U.S. companies. The S&P 500 Index tracks the performance of 500 widely-held large capitalization U.S. stocks. Although the Fund typically invests in companies with market caps under $20 billion at the time of investment, the comparison to the S&P 500 Index is presented to show performance against a widely recognized market index. The Lipper Variable Underlying Mid-Cap Core Funds Index is an equally weighted representation of the 30 largest variable insurance underlying funds in the Lipper Variable Underlying Mid-Cap Core Funds Classification, and shows how the Fund's performance compares with returns of an index of funds with similar investment objectives. Indexes are not managed and do not incur fees or expenses. It is not possible to invest directly in an index.
Lipper Inc., a widely respected data provider in the industry, calculates an average total return (assuming reinvestment of distributions) for mutual funds with investment objectives similar to those of the Fund.
Portfolio characteristics and holdings are subject to change periodically and may not be representative of current characteristics and holdings.
7
Wanger Select 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Equities – 97.6% | |
| | Industrial Goods & Services – 23.8% | |
| | Machinery – 18.2% | |
| 352,000 | | | Ametek Aerospace/Industrial Instruments | | $ | 14,889,600 | | |
| 260,000 | | | Donaldson Industrial Air Filtration | | | 9,271,600 | | |
| 108,000 | | | Pall Life Science, Water & Industrial Filtration | | | 7,174,440 | | |
| 173,000 | | | Kennametal Consumable Cutting Tools | | | 6,717,590 | | |
| 84,000 | | | Nordson Dispensing Systems for Adhesives & Coatings | | | 5,822,040 | | |
| | | 43,875,270 | | |
| | Outsourcing Services – 2.4% | |
| 221,000 | | | Quanta Services (a) Electrical & Telecom Construction Services | | | 5,847,660 | | |
| | Industrial Materials & Specialty Chemicals – 1.8% | |
| 70,000 | | | FMC Corporation Niche Specialty Chemicals | | | 4,274,200 | | |
| | Other Industrial Services – 0.7% | |
| 42,000 | | | Forward Air Freight Transportation Between Airports | | | 1,607,760 | | |
| | Industrial Distribution – 0.7% | |
| 16,496 | | | Airgas Industrial Gas Distributor | | | 1,574,708 | | |
| | | | Total Industrial Goods & Services | | | 57,179,598 | | |
| | Information – 23.8% | |
| | Mobile Communications – 6.7% | |
| 122,000 | | | Crown Castle International (a) Communications Towers | | | 8,831,580 | | |
| 99,000 | | | SBA Communications (a) Communications Towers | | | 7,337,880 | | |
| | | 16,169,460 | | |
| | Computer Services – 4.9% | |
| 703,000 | | | WNS - ADR (India) (a) Offshore Business Process Outsourcing Services | | | 11,733,070 | | |
Number of Shares | | | | Value | |
| | Computer Hardware & Related Equipment – 4.0% | |
| 125,000 | | | Amphenol Electronic Connectors | | $ | 9,742,500 | | |
| | Instrumentation – 3.4% | |
| 28,000 | | | Mettler-Toledo International (a) Laboratory Equipment | | | 5,633,600 | | |
| 96,000 | | | Trimble Navigation (a) GPS-based Instruments | | | 2,496,960 | | |
| | | 8,130,560 | | |
| | Contract Manufacturing – 1.8% | |
| 300,674 | | | Sanmina-SCI (a) Electronic Manufacturing Services | | | 4,314,672 | | |
| | Telecommunications Equipment – 1.6% | |
| 57,000 | | | F5 Networks (a) Internet Traffic Management Equipment | | | 3,921,600 | | |
| | Business Software – 0.9% | |
| 28,000 | | | Ansys (a) Simulation Software for Engineers & Designers | | | 2,046,800 | | |
| | Semiconductors & Related Equipment – 0.5% | |
| 150,000 | | | Atmel (a) Microcontrollers, Radio Frequency & Memory Semiconductors | | | 1,102,500 | | |
| | | | Total Information | | | 57,161,162 | | |
| | Consumer Goods & Services – 18.2% | |
| | Travel – 10.5% | |
| 545,000 | | | Hertz (a) Largest U.S. Rental Car Operator | | | 13,516,000 | | |
| 129,000 | | | Ryman Hospitality Properties (b) Convention Hotels | | | 5,032,290 | | |
| 68,000 | | | Vail Resorts Ski Resort Operator & Developer | | | 4,183,360 | | |
| 63,000 | | | Choice Hotels Franchisor of Budget Hotel Brands | | | 2,500,470 | | |
| | | 25,232,120 | | |
See accompanying notes to financial statements.
8
Wanger Select 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Other Consumer Services – 2.8% | |
| 65,000 | | | Lifetime Fitness (a) Sport & Fitness Club Operator | | $ | 3,257,150 | | |
| 125,000 | | | Blackhawk Network (a) Third Party Distributer of Prepaid Content, Mostly Gift Cards | | | 2,900,000 | | |
| 253,277
| | | IFM Investments (Century 21 China RE) – ADR (China) (a) Provide Real Estate Services in China | | | 590,135
| | |
| | | 6,747,285 | | |
| | Retail – 2.6% | |
| 36,000 | | | ULTA (a) Specialty Beauty Product Retailer | | | 3,605,760 | | |
| 66,000 | | | Best Buy Consumer Electronic Specialty Retailer | | | 1,803,780 | | |
| 12,000 | | | lululemon athletica (a) (b) Premium Active Apparel Retailer | | | 786,240 | | |
| | | 6,195,780 | | |
| | Apparel – 1.3% | |
| 26,000 | | | PVH Apparel Wholesaler & Retailer | | | 3,251,300 | | |
| | Educational Services – 0.5% | |
| 52,625 | | | ITT Educational Services (a) (b) Postsecondary Degree Services | | | 1,284,050 | | |
| | Casinos & Gaming – 0.4% | |
| 15,475,000 | | | RexLot Holdings (China) Lottery Equipment Supplier in China | | | 1,014,839 | | |
| | Food & Beverage – 0.1% | |
| 307,000 | | | GLG Life Tech (Canada) (a) Produce an All-natural Sweetener Extracted from the Stevia Plant | | | 122,800 | | |
| | | | Total Consumer Goods & Services | | | 43,848,174 | | |
| | Finance – 17.9% | |
| | Insurance – 6.2% | |
| 1,150,000 | | | CNO Financial Group Life, Long-term Care & Medical Supplement Insurance | | | 14,904,000 | | |
Number of Shares | | | | Value | |
| | Banks – 5.1% | |
| 126,000 | | | City National Bank & Asset Manager | | $ | 7,984,620 | | |
| 275,000 | | | Associated Banc-Corp Midwest Bank | | | 4,276,250 | | |
| | | 12,260,870 | | |
| | Credit Cards – 4.5% | |
| 225,000 | | | Discover Financial Services Credit Card Company | | | 10,719,000 | | |
| | Brokerage & Money Management – 2.1% | |
| 181,000 | | | SEI Investments Mutual Fund Administration & Investment Management | | | 5,145,830 | | |
| | | | Total Finance | | | 43,029,700 | | |
| | Energy & Minerals – 5.9% | |
| | Oil & Gas Producers – 3.9% | |
| 182,000 | | | Pacific Rubiales Energy (Colombia) Oil Production & Exploration in Colombia | | | 3,196,292 | | |
| 967,259 | | | Canacol (Colombia) (a) Oil Producer in South America | | | 2,694,750 | | |
| 6,150,000 | | | Shamaran Petroleum (Iraq) (a) Oil Exploration & Production in Kurdistan | | | 2,105,163 | | |
| 3,600,000
| | | Canadian Overseas Petroleum (United Kingdom) (a) (c) | | | 585,338 | | |
| 184,000
| | | Canadian Overseas Petroleum (United Kingdom) (a) | | | 31,492 | | |
| 1,800,000
| | | Canadian Overseas Petroleum – Warrants (United Kingdom) (a) (c) (d) Oil & Gas Exploration/Production in the North Sea | | | 8,674
| | |
| 8,714,000 | | | Petrodorado Energy (Colombia) (a) Oil & Gas Exploration & Production in Colombia, Peru & Paraguay | | | 497,138 | | |
| 2,575,000 | | | Petromanas (Canada) (a) Exploring for Oil in Albania | | | 257,084 | | |
| | | 9,375,931 | | |
| | Agricultural Commodities – 1.1% | |
| 261,363
| | | Union Agriculture Group (Uruguay) (a) (c) (d) Farmland Operator in Uruguay | | | 2,705,107
| | |
See accompanying notes to financial statements.
9
Wanger Select 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Mining – 0.7% | |
| 425,000 | | | Kirkland Lake Gold (Canada) (a) (b) Gold Mining | | $ | 1,786,156 | | |
| | Alternative Energy – 0.2% | |
| 535,000 | | | Synthesis Energy Systems (China) (a) Owner/Operator of Gasification Plants | | | 415,695 | | |
| | | | Total Energy & Minerals | | | 14,282,889 | | |
| | Health Care – 5.0% | |
| | Medical Supplies – 3.7% | |
| 136,000 | | | Cepheid (a) Molecular Diagnostics | | | 4,681,120 | | |
| 43,000 | | | Henry Schein (a) Largest Distributor of Health Care Products | | | 4,117,250 | | |
| | | 8,798,370 | | |
| | Biotechnology & Drug Delivery – 1.3% | |
| 103,000 | | | Seattle Genetics (a) Antibody-based Therapies for Cancer | | | 3,240,380 | | |
| | | | Total Health Care | | | 12,038,750 | | |
| | Other Industries – 3.0% | |
| | Real Estate – 3.0% | |
| 244,000 | | | Biomed Realty Trust Life Science-focused Office Buildings | | | 4,936,120 | | |
| 95,000 | | | Dupont Fabros Technology (b) Data Centers | | | 2,294,250 | | |
| | | 7,230,370 | | |
| | | | Total Other Industries | | | 7,230,370 | | |
Total Equities (Cost: $161,343,257) – 97.6% | | | 234,770,643 | (e) | |
Short-Term Investments – 1.9% | | | |
| 2,847,342
| | | JPMorgan U.S. Government Money Market Fund, Capital Shares (7 day yield of 0.01%) | | | 2,847,342 | | |
| 1,921,806
| | | JPMorgan U.S. Government Money Market Fund, Agency Shares (7 day yield of 0.01%) | | | 1,921,806 | | |
Total Short-Term Investments (Cost: $4,769,148) – 1.9% | | | 4,769,148 | | |
Number of Shares | | | | Value | |
Securities Lending Collateral – 3.3% | |
| 7,866,991 | | | Dreyfus Government Cash Management Fund, Institutional Shares (7 day yield of 0.01%) (f) | | $ | 7,866,991 | | |
Total Securities Lending Collateral (Cost: $7,866,991) | | | 7,866,991 | | |
Total Investments (Cost: $173,979,396) (g) – 102.8% | | | 247,406,782 | | |
Obligation to Return Collateral for Securities Loaned – (3.3)% | | | (7,866,991 | ) | |
Cash and Other Assets Less Liabilities – 0.5% | | | 1,045,058 | | |
Net Assets – 100.0% | | $ | 240,584,849 | | |
ADR = American Depositary Receipts
Notes to Statement of Investments
(a) Non-income producing security.
(b) All or a portion of this security was on loan at June 30, 2013. The total market value of securities on loan at June 30, 2013 was $7,826,597.
(c) Denotes a restricted security, which is subject to restrictions on resale under federal securities laws. These securities are valued at fair value determined in good faith under consistently applied procedures established by the Board of Trustees. At June 30, 2013, the market value of these securities amounted to $3,299,119, which represented 1.37% of total net assets. Additional information on these securities is as follows:
Security | | Acquisition Dates | | Shares | | Cost | | Value | |
Union Agriculture Group | | 12/8/10- 6/27/12 | | | 261,363 | | | $ | 2,999,999 | | | $ | 2,705,107 | | |
Canadian Overseas Petroleum | | 11/24/10 | | | 3,600,000 | | | | 1,539,065 | | | | 585,338 | | |
Canadian Overseas Petroleum – Warrants | | 11/24/10 | | | 1,800,000 | | | | 225,295 | | | | 8,674 | | |
| | | | $4,764,359 | | $3,299,119 | |
(d) Illiquid security.
(e) On June 30, 2013, the market value of foreign securities represented 11.53% of total net assets. The Fund's foreign portfolio was diversified as follows:
Country | | Value | | Percentage of Net Assets | |
India | | $ | 11,733,070 | | | | 4.88 | | |
Colombia | | | 6,388,180 | | | | 2.65 | | |
Uruguay | | | 2,705,107 | | | | 1.12 | | |
Canada | | | 2,166,040 | | | | 0.90 | | |
Iraq | | | 2,105,163 | | | | 0.88 | | |
China | | | 2,020,669 | | | | 0.84 | | |
See accompanying notes to financial statements.
10
Wanger Select 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Country | | Value | | Percentage of Net Assets | |
United Kingdom | | | 625,504 | | | | 0.26 | | |
Total Foreign Portfolio | | $ | 27,743,733 | | | | 11.53 | | |
(f) Investment made with cash collateral received from securities lending activity.
(g) At June 30, 2013, for federal income tax purposes, the cost of investments was $173,979,396 and net unrealized appreciation was $73,427,386 consisting of gross unrealized appreciation of $86,975,892 and gross unrealized depreciation of $13,548,506.
Fair Value Measurements
Various inputs are used in determining the value of the Fund's investments, following the input prioritization hierarchy established by accounting principles generally accepted in the United States of America (GAAP). These inputs are summarized in the three broad levels listed below:
• Level 1 – quoted prices in active markets for identical securities
• Level 2 – prices determined using other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others)
• Level 3 – prices determined using significant unobservable inputs where quoted prices or observable inputs are unavailable or less reliable (including management's own assumptions about the factors market participants would use in pricing an investment)
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
Examples of the types of securities in which the Fund would typically invest and how they are classified within this hierarchy are as follows. Typical Level 1 securities include exchange traded domestic equities, mutual funds whose NAVs are published each day and exchange traded foreign equities that are not statistically fair valued. Typical Level 2 securities include exchange traded foreign equities that are statistically fair valued, forward foreign currency exchange contracts and short-term investments valued at amortized cost. Additionally, securities fair valued by the Valuation Committee (the Committee) of the Fund's Board of Trustees (the Board) that rely on significant observable inputs are also included in Level 2. Typical Level 3 securities include any security fair valued by the Committee that relies on significant unobservable inputs.
Under the direction of the Board, the Committee is responsible for carrying out the valuation procedures approved by the Board.
The Committee meets as necessary, and no less frequently than quarterly, to determine fair values for securities for which market quotations are not readily available or for which the investment manager believes that available market quotations are unreliable, to review the appropriateness of the Trust's Portfolio Pricing Policy and the pricing procedures of the investment manager (the Policies), and to review the continuing appropriateness of the current value of any security subject to the Policies. The Policies address, among other things: circumstances under which market quotations will be deemed readily available; selection of third party pricing vendors; appropriate pricing methodologies; events that require fair valuation and fair value techniques; and circumstances under which securities will be deemed to pose a potential for stale pricing, including when securities are illiquid, restricted, or in default. The Committee may also meet to discuss additional valuation matters, which may include review of back-testing results, review of time-sensitive information or approval of other valuation related actions, and to review the appropriateness of the Policies.
For investments categorized as Level 3, the significant unobservable inputs used in the fair value measurement of the Funds' securities may include: (i) data specific to the issuer or comparable issuers, (ii) general market or specific sector news and (iii) quoted prices and specific or similar security transactions. The Committee considers this data and any changes from prior periods in order to assess the reasonableness of observable and unobservable inputs, any assumptions or internal models used to value those securities and changes in fair value. Significant changes in any of these factors could result in lower or higher fair value measurements. Various factors impact the frequency of monitoring (which may occur as often as daily), however the Committee may determine that changes to inputs, assumptions and models are not required with the same frequency.
The following table summarizes the inputs used, as of June 30, 2013, in valuing the Fund's assets:
Investment Type | | Quoted Prices (Level 1) | | Other Significant Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Total | |
Equities | |
Industrial Goods & Services | | $ | 57,179,598 | | | $ | — | | | $ | — | | | $ | 57,179,598 | | |
Information | | | 57,161,162 | | | | — | | | | — | | | | 57,161,162 | | |
Consumer Goods & Services | | | 42,833,335 | | | | 1,014,839 | | | | — | | | | 43,848,174 | | |
Finance | | | 43,029,700 | | | | — | | | | — | | | | 43,029,700 | | |
Energy & Minerals | | | 10,983,770 | | | | 594,012 | | | | 2,705,107 | | | | 14,282,889 | | |
Health Care | | | 12,038,750 | | | | — | | | | — | | | | 12,038,750 | | |
Other Industries | | | 7,230,370 | | | | — | | | | — | | | | 7,230,370 | | |
Total Equities | | | 230,456,685 | | | | 1,608,851 | | | | 2,705,107 | | | | 234,770,643 | | |
Total Short-Term Investments | | | 4,769,148 | | | | — | | | | — | | | | 4,769,148 | | |
Total Securities Lending Collateral | | | 7,866,991 | | | | — | | | | — | | | | 7,866,991 | | |
Total Investments | | $ | 243,092,824 | | | $ | 1,608,851 | | | $ | 2,705,107 | | | $ | 247,406,782 | | |
The Fund's assets assigned to the Level 2 input category are generally valued using a market approach, in which a security's value is determined through its correlation to prices and information from observable market transactions for similar or identical assets. Foreign equities are generally valued at the last sale price on the foreign exchange or market on which they trade. The Fund may use a statistical fair valuation model, in accordance with the policy adopted by the Board, provided by an independent third party to value securities principally traded in foreign markets in order to adjust for possible stale pricing that may occur between the close of the foreign exchanges and the time for valuation. These models take into account available market data including intraday index, ADR, and ETF movements. Securities acquired via private placement that have a holding period or an extended settlement period are valued at a discount to the same shares that are trading freely on the market. These discounts are determined by the investment manager's experience with similar securities or situations. Factors may include, but are not limited to, trade volume, shares outstanding and stock price. Warrants which do not trade are valued as a percentage of the actively trading common stock using a model, based on Black Scholes.
The following table shows transfers between Level 1 and Level 2 of the fair value hierarchy:
Transfers In | | Transfers Out | |
Level 1 | | Level 2 | | Level 1 | | Level 2 | |
$ | 80,127 | | | $ | — | | | $ | — | | | $ | 80,127 | | |
Financial assets were transferred from Level 2 to Level 1 as trading resumed during the period.
See accompanying notes to financial statements.
11
Wanger Select 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
The following table reconciles asset balances for the period ending June 30, 2013, in which significant observable and/or unobservable inputs (Level 3) were used in determining value:
Investments in Securities | | Balance as of December 31, 2012 | | Realized Gain/(Loss) | | Change in Unrealized Appreciation (Depreciation) | | Purchases | | Sales | | Transfers into Level 3 | | Transfers out of Level 3 | | Balance as of June 30, 2013 | |
Equities | |
Energy & Materials | | $ | 2,676,357 | | | $ | — | | | $ | 28,750 | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | 2,705,107 | | |
| | $ | 2,676,357 | | | $ | — | | | $ | 28,750 | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | 2,705,107 | | |
The information in the above reconciliation table represents fiscal year to date activity for any securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period.
The change in unrealized appreciation attributed to securities owned at June 30, 2013, which were valued using significant unobservable inputs (Level 3), amounted to $28,750.
Quantitative information pertaining to Level 3 unobservable fair value measurements
| | Fair Value at 6/30/13 | | Valuation Technique(s) | | Unobservable Input(s) | | Range (Weighted Average) | |
Equities | | $ | 2,705,107 | | | Market comparable companies | | Discount for lack of marketability | | | -14 | % to +19% (-10%) | |
Certain common stock classified as Level 3 are valued at fair value, using a market approach, as determined in good faith under consistently applied procedures established by and under the general supervision of the Board. To determine fair value for these securities, for which no market exists, the Committee utilizes the valuation technique it deems most appropriate in the circumstances, using some unobservable inputs, which
may include but, are not limited to, trades of similar securities, estimated earnings of the company, market multiples derived from a set of comparable companies, and the position of the security within the company's capital structure. Significant increases or decreases to any of these inputs could result in a significantly lower or higher fair value measurement.
See accompanying notes to financial statements.
12
Wanger Select 2013 Semiannual Report
Statement of Assets and Liabilities
June 30, 2013 (Unaudited)
Assets: | |
Investments, at cost | | $ | 173,979,396 | | |
Investments, at value (including securities on loan of $7,826,597) | | $ | 247,406,782 | | |
Cash | | | 14,409 | | |
Receivable for: | |
Investments sold | | | 1,217,688 | | |
Fund shares sold | | | 566 | | |
Securities lending income | | | 4,706 | | |
Dividends | | | 192,373 | | |
Foreign tax reclaims | | | 3,003 | | |
Prepaid expenses | | | 1,430 | | |
Total Assets | | | 248,840,957 | | |
Liabilities: | |
Collateral on securities loaned | | | 7,866,991 | | |
Payable for: | |
Fund shares redeemed | | | 310,120 | | |
Investment advisory fee | | | 5,288 | | |
Administration fee | | | 330 | | |
Transfer agent fee | | | 1 | | |
Trustees' fees | | | 29,934 | | |
Custody fee | | | 377 | | |
Reports to shareholders | | | 19,417 | | |
Other liabilities | | | 23,650 | | |
Total Liabilities | | | 8,256,108 | | |
Net Assets | | $ | 240,584,849 | | |
Composition of Net Assets: | |
Paid-in capital | | $ | 160,791,689 | | |
Overdistributed net investment income | | | (314,430 | ) | |
Accumulated net realized gain | | | 6,680,193 | | |
Net unrealized appreciation (depreciation) on: | |
Investments | | | 73,427,386 | | |
Foreign currency translations | | | 11 | | |
Net Assets | | $ | 240,584,849 | | |
Fund Shares Outstanding | | | 7,905,096 | | |
Net asset value, offering price and redemption price per share | | $ | 30.43 | | |
Statement of Operations
For the Six Months Ended June 30, 2013 (Unaudited)
Investment Income: | |
Dividend income (net foreign taxes withheld of $7,508) | | $ | 978,979 | | |
Securities lending income, net | | | 50,976 | | |
Total Investment Income | | | 1,029,955 | | |
Expenses: | |
Investment advisory fee | | | 961,975 | | |
Administration fee | | | 60,123 | | |
Transfer agent fees | | | 113 | | |
Trustees' fees | | | 7,793 | | |
Custody fees | | | 2,988 | | |
Reports to shareholders | | | 31,744 | | |
Audit fees | | | 15,584 | | |
Legal fees | | | 7,827 | | |
Chief compliance officer expenses (See Note 4) | | | 3,449 | | |
Commitment fee for line of credit (See Note 5) | | | 721 | | |
Other expenses | | | 10,262 | | |
Net Expenses | | | 1,102,579 | | |
Net Investment Loss | | | (72,624 | ) | |
Net Realized and Unrealized Gain (Loss) on Investments: | |
Net realized gain (loss) on: | |
Investments | | | 10,230,140 | | |
Foreign currency translations | | | (974 | ) | |
Net realized gain | | | 10,229,166 | | |
Net change in unrealized appreciation (depreciation) on: | |
Investments | | | 18,513,812 | | |
Foreign currency translations | | | 11 | | |
Net change in unrealized appreciation | | | 18,513,823 | | |
Net realized and unrealized gain | | | 28,742,989 | | |
Net Increase in Net Assets from Operations | | $ | 28,670,365 | | |
See accompanying notes to financial statements.
13
Wanger Select 2013 Semiannual Report
Statements of Changes in Net Assets
Increase (Decrease) in Net Assets | | (Unaudited) Six Months Ended June 30, 2013 | | Year Ended December 31, 2012 | |
Operations: | |
Net investment income (loss) | | $ | (72,624 | ) | | $ | 1,520,674 | | |
Net realized gain (loss) on: | |
Investments | | | 10,230,140 | | | | 10,731,550 | | |
Foreign currency translations | | | (974 | ) | | | (1,405 | ) | |
Net change in unrealized appreciation (depreciation) on: | |
Investments | | | 18,513,812 | | | | 29,770,532 | | |
Foreign currency translations | | | 11 | | | | — | | |
Net Increase in Net Assets from Operations | | | 28,670,365 | | | | 42,021,351 | | |
Distributions to Shareholders From: | |
Net investment income | | | (705,314 | ) | | | (1,022,230 | ) | |
Net realized gains | | | (3,568,085 | ) | | | — | | |
Total Distributions to Shareholders | | | (4,273,399 | ) | | | (1,022,230 | ) | |
Share Transactions: | |
Subscriptions | | | 3,048,288 | | | | 7,127,843 | | |
Distributions reinvested | | | 4,273,399 | | | | 1,022,230 | | |
Redemptions | | | (26,288,514 | ) | | | (56,537,891 | ) | |
Net Decrease from Share Transactions | | | (18,966,827 | ) | | | (48,387,818 | ) | |
Total Increase (Decrease) in Net Assets | | | 5,430,139 | | | | (7,388,697 | ) | |
Net Assets: | |
Beginning of period | | | 235,154,710 | | | | 242,543,407 | | |
End of period | | $ | 240,584,849 | | | $ | 235,154,710 | | |
Undistributed (overdistributed) net investment income | | $ | (314,430 | ) | | $ | 463,508 | | |
See accompanying notes to financial statements.
14
Wanger Select 2013 Semiannual Report
The following table is intended to help you understand the Fund's financial performance. Certain information reflects financial results for a single share held for the periods shown. Per share net investment income (loss) amounts are calculated based on average shares outstanding during the period. Total return assumes reinvestment of all dividends and distributions. Total return does not reflect payment of the expenses that apply to the variable accounts or contract charges, if any, and are not annualized for periods of less than one year.
| | (Unaudited) Six Months Ended June 30, | | Year Ended December 31, | |
Selected data for a share outstanding throughout each period | | 2013 | | 2012 | | 2011 | | 2010 | | 2009 | | 2008 | |
Net Asset Value, Beginning of Period | | $ | 27.54 | | | $ | 23.35 | | | $ | 28.99 | | | $ | 23.05 | | | $ | 13.87 | | | $ | 28.08 | | |
Income from Investment Operations: | |
Net investment income (loss) | | | (0.01 | ) | | | 0.16 | | | | (0.06 | ) | | | (0.09 | ) | | | (0.08 | ) | | | (0.10 | ) | |
Net realized and unrealized gain (loss) | | | 3.44 | | | | 4.15 | | | | (4.99 | ) | | | 6.17 | | | | 9.26 | | | | (13.38 | ) | |
Total from Investment Operations | | | 3.43 | | | | 4.31 | | | | (5.05 | ) | | | 6.08 | | | | 9.18 | | | | (13.48 | ) | |
Less Distributions to Shareholders: | |
Net investment income | | | (0.09 | ) | | | (0.12 | ) | | | (0.59 | ) | | | (0.14 | ) | | | — | | | | — | | |
Net realized gains | | | (0.45 | ) | | | — | | | | — | | | | — | | | | — | | | | (0.73 | ) | |
Total Distributions to Shareholders | | | (0.54 | ) | | | (0.12 | ) | | | (0.59 | ) | | | (0.14 | ) | | | — | | | | (0.73 | ) | |
Net Asset Value, End of Period | | $ | 30.43 | | | $ | 27.54 | | | $ | 23.35 | | | $ | 28.99 | | | $ | 23.05 | | | $ | 13.87 | | |
Total Return | | | 12.47 | % | | | 18.46 | % | | | (17.68 | )% | | | 26.57 | % | | | 66.19 | % | | | (49.06 | )% | |
Ratios to Average Net Assets/Supplemental Data: | |
Total gross expenses | | | 0.92 | %(a)(b) | | | 0.92 | %(b) | | | 0.93 | %(b) | | | 0.93 | %(b) | | | 0.95 | %(b) | | | 0.91 | % | |
Total net expenses | | | 0.92 | %(a)(b) | | | 0.91 | %(b)(c) | | | 0.93 | %(b)(c) | | | 0.93 | %(b)(c) | | | 0.95 | %(b)(c) | | | 0.91 | %(c) | |
Net investment income (loss) | | | (0.06 | )%(a) | | | 0.60 | % | | | (0.24 | )% | | | (0.38 | )% | | | (0.44 | )% | | | (0.45 | )% | |
Portfolio turnover rate | | | 13 | % | | | 20 | % | | | 23 | % | | | 30 | % | | | 35 | % | | | 36 | % | |
Net assets, end of period (000s) | | $ | 240,585 | | | $ | 235,155 | | | $ | 242,543 | | | $ | 345,960 | | | $ | 270,368 | | | $ | 156,588 | | |
Notes to Financial Highlights
(a) Annualized.
(b) In addition to the fees and expenses which the Fund bears directly, the Fund indirectly bears a pro rata share of the fees and expenses of the underlying funds in which it invests. Such indirect expenses are not included in the reported expense ratios.
(c) The benefits derived from custody fees paid indirectly had an impact of less than 0.01%.
See accompanying notes to financial statements.
15
Wanger Select 2013 Semiannual Report
Notes to Financial Statements (Unaudited)
1. Nature of Operations
Wanger Select (the Fund), a series of Wanger Advisors Trust (the Trust), is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The investment objective of the Fund is to seek long-term capital appreciation. The Fund is available only for allocation to certain life insurance company separate accounts established for the purpose of funding participating variable annuity contracts and variable life insurance policies and may also be offered directly to certain qualified pension and retirement plans.
2. Significant Accounting Policies
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (GAAP) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Security valuation
Securities of the Fund are valued at market value or, if a market quotation for a security is not readily available or is deemed not to be reliable because of events or circumstances that have occurred between the market quotation and the time as of which the security is to be valued, the security is valued at its fair value determined in good faith under consistently applied procedures established by the Board of Trustees (the Board). A security traded on a securities exchange or in an over-the-counter market in which transaction prices are reported is valued at the last sales price at the time of valuation. A security traded principally on NASDAQ is valued at the NASDAQ official closing price. Mutual funds and exchange traded funds are valued at their closing net asset value as reported to the applicable exchange. A security for which there is no reported sale on the valuation date is valued at the mean of the latest bid and ask quotations.
Short-term investments maturing in 60 days or less are valued at amortized cost, which approximates market value.
A security for which a market quotation is not readily available and any other assets are valued at their fair value determined in good faith under consistently applied procedures established by the Board. The Trust has retained an independent statistical fair value pricing service that employs a systematic methodology to assist in the fair valuation process for securities principally traded in a foreign market in order to adjust for possible changes in value that may occur between the close of the foreign market and the time as of which the securities are to be valued. If a security is valued at a fair value, that value may be different from the last quoted market price for the security.
Foreign currency translations
Values of investments denominated in foreign currencies are converted into U.S. dollars using the New York spot market rate of exchange at the time of valuation. Purchases and sales of investments and dividend and interest income are translated into U.S. dollars using the spot market rate of exchange prevailing on the respective dates of such transactions. The gain or loss resulting from changes in foreign exchange rates is included with net realized and unrealized gain or loss from investments, as appropriate.
Restricted securities
Restricted securities are securities that may only be resold upon registration under federal securities laws or in transactions exempt from registration. In some cases, the issuer of restricted securities has agreed to register such securities for resale at the
issuer's expense either upon demand by the Fund or in connection with another registered offering of the securities. Many restricted securities may be resold in the secondary market in transactions exempt from registration. Such restricted securities may be determined to be liquid under criteria established by the Board.
Security transactions and investment income
Security transactions are accounted for on the trade date (date the order to buy or sell is executed) and dividend income is recorded on the ex-dividend date, except that certain dividends from foreign securities are recorded as soon as the information is available to the Fund. Interest income is recorded on the accrual basis and includes amortization of discounts on debt obligations when required for federal income tax purposes. Realized gains and losses from security transactions are recorded on an identified cost basis.
Awards, if any, from class action litigation related to securities owned may be recorded as a reduction of cost of those securities. If the applicable securities are no longer owned, the proceeds are recorded as realized gains.
The Fund estimates the tax character of distributions from real estate investment trusts (REITs). Distributions received in excess of income are recorded as a reduction of the cost of the related investments. If the applicable securities are no longer owned, any distributions received in excess of income are recorded as realized gains.
Expenses
General expenses of the Trust are allocated to the Fund and the other series of the Trust based upon relative net assets or other expense allocation methodologies determined by the nature of the expense. Expenses directly attributable to the Fund are charged to the Fund.
Fund share valuation
Fund shares are sold and redeemed on a continuing basis at net asset value. Net asset value per share is determined daily as of the close of trading on the New York Stock Exchange (the Exchange) on each day the Exchange is open for trading by dividing the total value of the Fund's investments and other assets, less liabilities, by the number of Fund shares outstanding.
Securities lending
The Fund may lend securities up to one-third of the value of its total assets to certain approved brokers, dealers and other financial institutions to earn additional income. The Fund retains the benefits of owning the securities, including receipt of dividends or interest generated by the security. The Fund also receives a fee for the loan. The Fund has the ability to recall the loans at any time and could do so in order to vote proxies or to sell the loaned securities. Each loan is collateralized by cash that exceeded the value of the securities on loan. The market value of the loaned securities is determined daily at the close of business of the Fund and any additional required collateral is delivered to each Fund on the next business day. The Fund has elected to invest the cash collateral in the Dreyfus Government Cash Management Fund and the income earned is paid to the Fund, net of any fees remitted to Goldman Sachs Agency Lending, the Fund's lending agent and borrower rebates. The Fund's investment manager, Columbia Wanger Asset Management, LLC (CWAM), does not retain any fees earned by the lending program. Generally, in the event of borrower default, the Fund has the right to use the collateral to offset any losses incurred. In the event the Fund is delayed or prevented from exercising its right to dispose of the collateral, there may be a potential loss to the Fund. Some of these losses may be indemnified by the lending agent. The Fund bears the risk of loss with respect to the investment of collateral. The net lending income earned by the Fund as of June 30, 2013, is included in the Statement of Operations.
16
Wanger Select 2013 Semiannual Report
Notes to Financial Statements, continued (Unaudited)
The following table presents the Fund's gross and net amount of assets available for offset under a securities lending agreement as well as the related collateral received by the Fund as of June 30, 2013:
| | Gross Amounts of | | Gross Amounts Offset in the | | Net Amounts of Assets Presented in the | | Gross Amounts Not Offset in the Statement of Assets and Liabilities | |
| | Recognized Assets | | Statement of Assets and Liabilities | | Statement of Assets and Liabilities | | Financial Instruments (a) | | Cash Collateral Received | | Securities Collateral Received | | Net Amount (b) | |
Securities loaned | | $ | 7,826,597.00 | | | $ | — | | | $ | 7,826,597.00 | | | $ | — | | | $ | 7,826,597.00 | | | $ | — | | | $ | — | | |
(a) Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar agreements that management elects not to offset on the Statement of Assets and Liabilities.
(b) Represents the net amount due from counterparties in the event of default.
Federal income taxes
The Fund has complied with the provisions of the Internal Revenue Code available to regulated investment companies and, in the manner provided therein, distributes substantially all its taxable income, as well as any net realized gain on sales of investments and foreign currency transactions reportable for federal income tax purposes. Accordingly, the Fund paid no federal income taxes and no federal income tax provision was required.
Foreign capital gains taxes
Gains in certain countries may be subject to foreign taxes at the fund level. The Fund accrues for such foreign taxes on realized and unrealized gains at the appropriate rate for each jurisdiction. The amount, if any, is disclosed as a liability on the Statement of Assets and Liabilities.
Distributions to shareholders
Distributions to shareholders are recorded on the ex-dividend date.
Indemnification
In the normal course of business, the Trust on behalf of the Fund enters into contracts that contain a variety of representations and warranties and that provide general indemnities. The Fund's maximum exposure under these arrangements is unknown, as this would involve future claims against the Fund. Also under the Trust's organizational documents, the trustees and officers of the Trust are indemnified against certain liabilities that may arise out of their duties to the Trust. However based on experience, the Fund expects the risk of loss due to these warranties and indemnities to be remote.
3. Federal Tax Information
The timing and character of income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. Reclassifications are made to the Fund's capital accounts for permanent tax differences to reflect income and gains available for distribution (or available capital loss carryforwards) under income tax regulations.
The value of capital loss carryforwards that were utilized for the Fund during the year ended December 31, 2012, was $3,446,870.
Management is required to determine whether a tax position of the Fund is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized by the Fund is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Management is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. However, management's conclusions may be subject to review and adjustment at a later date
based on factors including, but not limited to, new tax laws, regulations, and administrative interpretations (including relevant court decisions). The Fund's federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
4. Transactions With Affiliates
CWAM is a wholly owned subsidiary of Columbia Management Investment Advisers, LLC (Columbia Management), which in turn is a wholly owned subsidiary of Ameriprise Financial, Inc. (Ameriprise Financial). CWAM furnishes continuing investment supervision to the Fund and is responsible for the overall management of the Fund's business affairs.
CWAM receives a monthly advisory fee based on the Fund's average daily net assets at the following annual rates:
Average Daily Net Assets | | Annual Fee Rate | |
Up to $500 million | | | 0.80 | % | |
$500 million and over | | | 0.78 | % | |
For the six months ended June 30, 2013, the annualized effective investment advisory fee rate was 0.80% of the Fund's average daily net assets.
Through April 30, 2014, CWAM has contractually agreed to reimburse the Fund to the extent that ordinary operating expenses (exclusive of brokerage commissions, interest, taxes and extraordinary expenses, but inclusive of custodian charges relating to overdrafts, if any), after giving effect to any balance credits from the Fund's custodian, exceed an annual percentage of 1.35% of average daily net assets on an annualized basis. For the six months ended June 30, 2013, the Fund was not reimbursed any expenses by CWAM.
CWAM provides administrative services and receives an administration fee from the Fund at the following annual rates:
Wanger Advisors Trust Aggregate Average Daily Net Assets of the Trust | | Annual Fee Rate | |
Up to $4 billion | | | 0.05 | % | |
$4 billion to $6 billion | | | 0.04 | % | |
$6 billion to $8 billion | | | 0.03 | % | |
$8 billion and over | | | 0.02 | % | |
For the six months ended June 30, 2013, the annualized effective administration fee rate was 0.05% of the Fund's average daily net assets. Columbia Management provides certain sub-administrative services to the Fund.
Columbia Management Investment Distributors, Inc. (CMID), a wholly owned subsidiary of Ameriprise Financial, serves as the Fund's distributor and principal underwriter.
Columbia Management Investment Services Corp. (CMIS), a wholly owned subsidiary of Ameriprise Financial, is the transfer agent to the Fund. For its services,
17
Wanger Select 2013 Semiannual Report
Notes to Financial Statements, continued (Unaudited)
the Fund pays CMIS a monthly fee at the annual rate of $21.00 per open account. CMIS also receives reimbursement from the Fund for certain out-of-pocket expenses.
Certain officers and trustees of the Trust are also officers of CWAM. The Trust makes no direct payments to its officers and trustees who are affiliated with CWAM.
The Board has appointed a Chief Compliance Officer of the Trust in accordance with federal securities regulations. The Fund, along with other affiliated funds, pays its pro-rata share of the expenses associated with the Office of the Chief Compliance Officer. These expenses are disclosed separately as "Chief compliance officer expenses" in the Statement of Operations.
The Trust offers a deferred compensation plan for its independent trustees. Under that plan, a trustee may elect to defer all or a portion of his or her compensation. Amounts deferred are retained by the Trust and may represent an unfunded obligation of the Trust. The value of amounts deferred is determined by reference to the change in value of Class Z shares of one or more series of Columbia Acorn Trust or a money market fund as specified by the trustee. Benefits under the deferred compensation plan are payable in accordance with the plan.
For the six months ended June 30, 2013, the Fund engaged in purchase and sales transactions with funds that have a common investment manager (or affiliated investment managers), common directors/trustees, and/or common officers. Those purchase and sale transactions complied with provisions of Rule 17a-7 under the Investment Company Act of 1940 and were $360,128 and $1,965,370, respectively.
5. Borrowing Arrangements
During the six months ended June 30, 2013, the Trust participated in a credit facility with JPMorgan Chase Bank, N.A., along with Columbia Acorn Trust, another trust managed by CWAM, in the amount of $150 million prior to January 11, 2013, and in the amount of $200 million thereafter. The credit facility was entered into to facilitate portfolio liquidity. Under the facility, interest is charged to each participating fund based on its borrowings at a rate per annum equal to the Federal Funds Rate plus 1.00%. In addition, a commitment fee of 0.08% per annum of the unutilized line of credit is accrued and apportioned among the participating funds based on their relative net assets. The commitment fee is disclosed separately as "Commitment fee for line of credit" in the Statement of Operations. The Trust renewed the line of credit in July in the amount of $150 million, and will continue to do so each year at then current market rates and terms.
No amounts were borrowed for the benefit of the Fund during the six months ended June 30, 2013.
6. Fund Share Transactions
Proceeds and payments on Fund shares as shown in the Statement of Changes in Net Assets are in respect of the following numbers of shares:
| | (Unaudited) Six months ended June 30, 2013 | | Year ended December 31, 2012 | |
Shares sold | | | 101,412 | | | | 266,744 | | |
Shares issued in reinvestment of dividend distributions | | | 140,711 | | | | 37,568 | | |
Less shares redeemed | | | (876,139 | ) | | | (2,150,485 | ) | |
Net (decrease) in shares outstanding | | | (634,016 | ) | | | (1,846,173 | ) | |
7. Investment Transactions
The aggregate cost of purchases and proceeds from sales other than short-term obligations for the six months ended June 30, 2013, were $31,340,014 and $52,012,625, respectively.
8. Shareholder Concentration
At June 30, 2013, one unaffiliated shareholder account owned 83.3% of the outstanding shares of the Fund. The Fund has no knowledge about whether any portion of those shares was owned beneficially by such account. Subscription and
redemption activity by concentrated accounts may have a significant effect on the operations of the Fund.
9. Subsequent Events
Management has evaluated the events and transactions that have occurred through the date the financial statements were issued and noted no items requiring adjustment of the financial statements or additional disclosure.
10. Information Regarding Pending and Settled Legal Proceedings
Ameriprise Financial and certain of its affiliates have historically been involved in a number of legal, arbitration and regulatory proceedings, including routine litigation, class actions, and governmental actions, concerning matters arising in connection with the conduct of their business activities. Ameriprise Financial believes that the Funds are not currently the subject of, and that neither Ameriprise Financial nor any of its affiliates are the subject of, any pending legal, arbitration or regulatory proceedings that are likely to have a material adverse effect on the Funds or the ability of Ameriprise Financial or its affiliates to perform under their contracts with the Funds. Ameriprise Financial is required to make 10-Q, 10-K and, as necessary, 8-K filings with the Securities and Exchange Commission on legal and regulatory matters that relate to Ameriprise Financial and its affiliates. Copies of these filings may be obtained by accessing the SEC website at www.sec.gov.
There can be no assurance that these matters, or the adverse publicity associated with them, will not result in increased fund redemptions, reduced sale of fund shares or other adverse consequences to the Funds. Further, although we believe proceedings are not likely to have a material adverse effect on the Funds or the ability of Ameriprise Financial or its affiliates to perform under their contracts with the Funds, these proceedings are subject to uncertainties and, as such, we are unable to estimate the possible loss or range of loss that may result. An adverse outcome in one or more of these proceedings could result in adverse judgments, settlements, fines, penalties or other relief that could have a material adverse effect on the consolidated financial condition or results of operations of Ameriprise Financial.
18
Wanger Select 2013 Semiannual Report
Board Approval of the Advisory Agreement
Wanger Advisors Trust (the "Trust") has an investment advisory agreement (the "Advisory Agreement") with Columbia Wanger Asset Management, LLC ("Columbia WAM") under which Columbia WAM manages Wanger Select (the "Fund"). More than 75% of the trustees of the Trust (the "Trustees") are persons who have no direct or indirect interest in the Advisory Agreement and are not "interested persons" (as defined in the Investment Company Act of 1940, as amended (the "1940 Act")) of the Trust (the "Independent Trustees"). The Trustees oversee the management of the Fund and, as required by law, determine at least annually whether to continue the Advisory Agreement for the Fund.
The Contract Committee (the "Committee") of the Board of Trustees (the "Board"), which is comprised solely of Independent Trustees, makes recommendations to the Board regarding any proposed continuation of the Advisory Agreement. After the Committee has made its recommendations, the full Board determines whether to approve continuation of the Advisory Agreement. The Board also considers matters bearing on the Advisory Agreement at its various meetings throughout the year, meets at least quarterly with Columbia WAM's portfolio managers (the Board's Investment Performance Analysis Committee meets frequently with them as well), and receives monthly reports from Columbia WAM on the performance of the Fund.
In connection with their most recent consideration of the Advisory Agreement for the Fund, the Committee and all Trustees received and reviewed a substantial amount of information provided by Columbia WAM, Columbia Management Investment Advisers, LLC ("Columbia Management") and Ameriprise Financial, Inc. ("Ameriprise") in response to written requests from the Independent Trustees and their independent legal counsel. In addition, the Trustees reviewed the Management Fee Evaluation dated June 2013 (the "Fee Evaluation") prepared by the Trust's chief compliance officer, senior vice president and general counsel, at the request of the Board. Throughout the process, the Trustees had numerous opportunities to ask questions of and request additional materials from Columbia WAM, Columbia Management and Ameriprise.
During each meeting at which the Committee or the Independent Trustees considered the Advisory Agreement, they met in executive session with their independent legal counsel. The Committee also met with representatives of Columbia WAM, Columbia Management and Ameriprise on several occasions. In all, the Committee convened formally on four separate occasions to consider the continuation of the Advisory Agreement. The Board and/or some or all of the Independent Trustees met on other occasions to receive the Committee's status reports, receive presentations from Columbia WAM, Columbia Management and Ameriprise representatives, and to discuss outstanding issues. In addition, the Investment Performance Analysis Committee of the Board, also comprised exclusively of Independent Trustees, reviewed the performance of the Fund, met in a joint meeting with the Committee, and presented its findings to the Board and the Committee throughout the year. The Compliance Committee of the Board also provided information to the Committee with respect to relevant matters.
The materials reviewed by the Committee and the Trustees included, among other items, (i) information on the investment performance of the Fund and of independently selected peer groups of funds and of the Fund's performance benchmark over various time periods, (ii) information on the Fund's advisory fees and other expenses, including information comparing the Fund's fees and expenses to those of peer groups of funds and information about any applicable expense limitations and fee breakpoints, (iii) data on sales and redemptions of Fund shares, and (iv) information on the profitability to Columbia WAM and Ameriprise, as well as potential "fall-out" or ancillary benefits that Columbia WAM and its affiliates may receive as a result of their relationships with the Fund. The Trustees also considered other information such as (i) Columbia WAM's financial condition, (ii) the Fund's investment objective and strategy, (iii) the size, education and experience of Columbia WAM's investment staff and its use of technology, external research and trading cost measurement tools, (iv) the portfolio manager compensation framework, (v) the allocation of the Fund's brokerage, and the use of "soft" commission dollars to pay for research products and services, (vi) Columbia WAM's risk management program, and (vii) the resources devoted to, and the record of compliance with, the Fund's
investment policies and restrictions, policies on personal securities transactions and other compliance policies.
At a meeting held on June 5, 2013, upon the recommendation of the Committee, the Board unanimously approved the continuation of the Advisory Agreement.
In considering the continuation of the Advisory Agreement, the Trustees reviewed and analyzed various factors that they determined were relevant, none of which by itself was considered dispositive. The material factors and conclusions that formed the basis for the Trustees' determination to approve the continuation of the Advisory Agreement are discussed below.
Nature, quality and extent of services. The Trustees reviewed the nature, quality and extent of the services provided by Columbia WAM and its affiliates to the Fund under the Advisory Agreement, taking into account the investment objective and strategy of the Fund, its shareholder base, and knowledge gained from meetings with management, which were held on at least a quarterly basis. In addition, the Trustees reviewed the available resources and key personnel of Columbia WAM and its affiliates, especially those providing investment management services to the Fund. The Trustees also considered other services provided to the Fund by Columbia WAM and its affiliates, including: managing the execution of portfolio transactions and selecting broker-dealers for those transactions; monitoring adherence to the Fund's investment restrictions; producing shareholder reports; providing support services for the Board and committees of the Board; managing the Fund's securities lending program; communicating with shareholders; serving as the Fund's administrator; and overseeing the activities of the Fund's other service providers, including monitoring for compliance with various policies and procedures as well as applicable securities laws and regulations.
The Trustees concluded that the nature, quality and extent of the services provided by Columbia WAM and its affiliates to the Fund under the Advisory Agreement were appropriate for the Fund and that the Fund was likely to benefit from the continued provision of those services by Columbia WAM. They also concluded that Columbia WAM currently had sufficient personnel, with appropriate education and experience, to serve the Fund effectively, and that the firm had demonstrated its continuing ability to attract and retain well-qualified personnel. In addition, they considered the quality of Columbia WAM's compliance record.
Performance of the Fund. The Trustees received and considered detailed performance information at various meetings of the Board, the Committee and the Investment Performance Analysis Committee of the Board throughout the year. They reviewed information comparing the Fund's performance with that of its benchmark(s) and with the performance of comparable funds and peer groups as identified by Lipper Inc. ("Lipper") and Morningstar, Inc. ("Morningstar"). The Trustees evaluated the performance of the Fund over various time periods, including over the one-, three- and five-year periods ending December 31, 2012. The Trustees also considered peer performance rankings for similar time periods, although they generally focused more on the five-year period.
The Trustees considered that the Fund had underperformed its peers and benchmark over the three- and five-year periods ending December 31, 2012 and exposed investors to more risk versus its peers. The Trustees considered, however, that the Fund had performed better over the one-year period against both its peers and benchmark, and that Columbia WAM had instituted a performance remediation plan during the year to correct underperformance. In addition, the Trustees noted that there had been a portfolio manager change during the past quarter. The Trustees believed that Columbia WAM was devoting appropriate resources to addressing the Fund's underperformance.
Costs of Services and Profits Realized by Columbia WAM. At various Committee and Board meetings, the Trustees examined detailed information on the fees and expenses of the Fund in comparison to information for comparable funds provided by Lipper and Morningstar. The Trustees noted that the Fund's net expenses were higher than the Lipper peer group expenses, but even with the Morningstar peer group. The Trustees also took into account that the actual advisory fees paid by the Fund were higher than the median versus Lipper and Morningstar peers.
The Trustees also reviewed the advisory fee rates charged by Columbia WAM for managing other investment companies, sub-advised funds and other institutional
19
Wanger Select 2013 Semiannual Report
Board Approval of the Advisory Agreement
separate accounts with similar investment strategies, as detailed in materials provided to the Committee by Columbia WAM and in the Fee Evaluation. The Trustees noted that the Fund's advisory fees were generally comparable to Columbia Acorn Select's advisory fees at the same asset levels.
The Trustees concluded that the rate of advisory fees payable to Columbia WAM were reasonable in relation to the nature and quality of the services to be provided and the investment performance of the Fund, taking into account Columbia WAM's recent steps to improve performance of the Fund.
The Trustees reviewed the analysis of the historic profitability of Columbia WAM in serving as the Fund's investment manager and of Columbia WAM and its affiliates in their relationships with the Fund. The Committee and Trustees met with representatives from Ameriprise to discuss its methodologies for calculating profitability and allocating costs. They considered that Ameriprise calculated profitability and allocated costs on a contract-by-contract and Fund-by-Fund basis. The Trustees also considered the methodology used by Columbia WAM and Ameriprise in determining compensation payable to portfolio managers and the competitive market for investment management talent. The Trustees were also provided with profitability information from Lipper, which compared Columbia WAM's profitability to other similar investment managers in the mutual fund industry. The Trustees concluded that Columbia WAM's and its affiliates' profits were within a reasonable range of those of competitors with similar business models. The Trustees discussed, however, that profitability comparisons among fund managers may not always be meaningful due to the lack of consistency in data, small number of publicly-owned managers, and the fact that profitability of any investment manager is affected by numerous factors, including its particular organizational structure, the types of funds and other accounts managed, other lines of business, expense allocation methodology, capital structure and other factors.
Economies of Scale. At various Committee and Board meetings and other informal meetings, the Trustees considered information about the extent to which Columbia WAM realizes economies of scale in connection with an increase in Fund assets. The Trustees noted that the advisory fee schedule for the Fund includes breakpoints in the rate of fees at various asset levels. The Trustees concluded that the fee structure of the Fund was reflective of a sharing of economies of scale between Columbia WAM and the Fund.
Other Benefits to Columbia WAM. The Trustees also reviewed benefits that accrue to Columbia WAM and its affiliates from their relationships with the Fund, based upon information provided to them by Ameriprise and as outlined in the Fee Evaluation. They noted that the Fund's transfer agency services are performed by Columbia Management Investment Services Corp., an affiliate of Ameriprise, which receives compensation from the Fund for its services provided. They considered that an affiliate of Ameriprise, Columbia Management Investment Distributors, Inc. ("CMID"), serves as the Fund's distributor under an underwriting agreement but receives no fees for its services to the Fund. In addition, Columbia Management provides sub-administration services to the Fund. The Committee received information regarding the profitability of the Fund agreement with Columbia WAM affiliates. The Committee and the Board also reviewed information about and discussed the capabilities of each affiliated entity in performing its duties.
The Trustees considered other ways that the Fund and Columbia WAM may potentially benefit from their relationship with each other. For example, the Trustees considered Columbia WAM's use of commissions paid by the Fund on its portfolio brokerage transactions to obtain research products and services benefiting the Fund and/or other clients of Columbia WAM. The Committee reviewed Columbia WAM's annual "soft dollar" report and met with representatives from Columbia WAM to review Columbia WAM's soft dollar spending. The Committee also considered that the Compliance Committee of the Board regularly reviewed third-party prepared reports that evaluated the quality of Columbia WAM's execution of the Fund's portfolio transactions. The Trustees noted that these reports showed that Columbia WAM's execution capabilities were generally better than industry peers. The Trustees determined that Columbia WAM's use of the Fund's "soft" commission dollars to obtain research products and services was consistent with current regulatory requirements and guidance. They also concluded that Columbia WAM benefits from
the receipt of proprietary research products and services acquired through commissions paid on portfolio transactions of the Fund, and that the Fund benefitted from Columbia WAM's receipt of those products and services as well as research products and services acquired through commissions paid by other clients of Columbia WAM.
After full consideration of the above factors, as well as other factors that were instructive in evaluating the Advisory Agreement, the Trustees, including the Independent Trustees by separate vote, concluded that the continuation of the Advisory Agreement was in the best interest of the Fund. On June 5, 2013, the Trustees approved continuation of the Advisory Agreement through July 31, 2014.
20
Wanger Select 2013 Semiannual Report
Trustees
Laura M. Born
Chair of the Board
Steven N. Kaplan
Vice Chair of the Board
Michelle L. Collins
Maureen M. Culhane
Margaret M. Eisen
John C. Heaton
Charles P. McQuaid
David J. Rudis
David B. Small
Ralph Wanger (Trustee Emeritus)
Officers
Charles P. McQuaid
President
Robert A. Chalupnik
Vice President
Michael G. Clarke
Assistant Treasurer
Joseph F. DiMaria
Assistant Treasurer
P. Zachary Egan
Vice President
Fritz Kaegi
Vice President
John M. Kunka
Assistant Treasurer
Stephen Kusmierczak
Vice President
Joseph C. LaPalm
Vice President
Bruce H. Lauer
Vice President, Secretary and Treasurer
Louis J. Mendes III
Vice President
Robert A. Mohn
Vice President
Christopher J. Olson
Vice President
Christopher O. Petersen
Assistant Secretary
Scott R. Plummer
Assistant Secretary
Linda K. Roth-Wiszowaty
Assistant Secretary
Robert P. Scales
Chief Compliance Officer, Chief Legal Officer, Senior Vice President and
General Counsel
Andreas Waldburg-Wolfegg
Vice President
Investment Manager
Columbia Wanger Asset Management, LLC
227 West Monroe Street, Suite 3000
Chicago, Illinois 60606
1-888-4-WANGER
(1-888-492-6437)
Transfer Agent,
Dividend Disbursing Agent
Columbia Management Investment Services Corp.
P.O. Box 8081
Boston, Massachusetts
02266-8081
Distributor
Columbia Management Investment Distributors, Inc.
225 Franklin Street
Boston, Massachusetts
02110
Legal Counsel to the Funds
Perkins Coie LLP
Washington, DC
Legal Counsel to the Independent Trustees
Drinker Biddle & Reath LLP
Philadelphia, Pennsylvania
Independent Registered Public Accounting Firm
PricewaterhouseCoopers LLP
Chicago, Illinois
This document contains Global Industry Classification Standard data. The Global Industry Classification Standard ("GICS") was developed by and is the exclusive property and a service mark of MSCI Inc. ("MSCI") and Standard & Poor's Financial Services LLC ("S&P") and is licensed for use by Columbia Wanger Asset Management, LLC ("CWAM"). Neither MSCI, S&P, nor any other party involved in making or compiling the GICS or any GICS classifications makes any express or implied warranties or representations with respect to such standard or classification (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability and fitness for a particular purpose with respect to any of such standard or classification. Without limiting any of the foregoing, in no event shall MSCI, S&P, any of their affiliates or any third party involved in making or compiling the GICS or any GICS classifications have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages.
This report, including the schedules of investments and financial statements, is submitted for the general information of the shareholders of the Wanger Advisors Trust.
A description of the Fund's proxy voting policies and procedures and a copy of the Fund's voting record for the most recent 12-month period ended June 30 are available (i) on our website, columbiamanagement.com, (ii) on the Securities and Exchange Commission's website at www.sec.gov, and (iii) without charge, upon request, by calling 888-492-6437.
The Fund files a complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q. The Fund's Form N-Q is available on the SEC's website at www.sec.gov and may be reviewed and copied at the SEC's Public Reference Room in Washington, D.C. Information on the operation of the Pubic Reference Room may be obtained by calling 800-SEC-0330. The Fund's complete portfolio holdings are disclosed at www.columbiamanagement.com approximately 30 to 40 days after each month-end.
21
© 2013 Columbia Management Investment Advisers, LLC. All rights reserved.
Wanger USA
2013 Semiannual Report
Not FDIC insured • No bank guarantee • May lose value
Columbia Wanger Asset Management, LLC (CWAM) is one of the leading global small- and mid-cap equity managers in the United States with over 40 years of small- and mid-cap investment experience. As of June 30, 2013, CWAM managed $34.9 billion in assets. CWAM is the investment manager to Wanger USA, Wanger International, Wanger Select and Wanger International Select (together, the Columbia Wanger Funds) and the Columbia Acorn Family of Funds.
Investors should consider the investment objectives, risks, charges and expenses of a mutual fund carefully before investing. For a free prospectus, which contains this and other important information about the Fund, contact your financial adviser, insurance company, qualified pension or retirement plan sponsor or call 1-888-4-WANGER. Read the prospectus carefully before investing.
An important note: Columbia Wanger Funds are available for purchase through variable annuity contracts and variable life insurance policies offered by the separate accounts of participating insurance companies and qualified pension or retirement plans.
Shares of the Fund may not be purchased or sold directly by individual owners of variable annuity contracts and/or variable life insurance policies (collectively, Contracts) or participants in qualified retirement or other plans (collectively, Qualified Plans). If you are the owner of a Contract or a participant in a Qualified Plan, please refer to the prospectus that describes your Contract or Qualified Plan for information about minimum investment requirements and how to purchase and redeem shares of the Fund.
The views expressed in "Health Care in the United States" and in the Performance Review reflect the current views of the respective authors. These views are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict so actual outcomes and results may differ significantly from those stated. These views are subject to change at any time based upon economic, market or other conditions and the respective parties disclaim any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Columbia Wanger Fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any particular Columbia Wanger Fund. References to specific company securities should not be construed as a recommendation or investment advice.
Wanger USA
2013 Semiannual Report
Table of Contents
| 2 | | | Understanding Your Expenses | |
| 3 | | | Health Care in the United States | |
| 6 | | | Performance Review | |
| 8 | | | Statement of Investments | |
| 15 | | | Statement of Assets and Liabilities | |
| 15 | | | Statement of Operations | |
| 16 | | | Statement of Changes in Net Assets | |
| 17 | | | Financial Highlights | |
| 18 | | | Notes to Financial Statements | |
| 21 | | | Board Approval of the Advisory Agreement | |
Wanger USA 2013 Semiannual Report
Understanding Your Expenses
As an investor, you incur two types of costs. There are transaction costs, which may include redemption fees or exchange fees charged under your contract or qualified plan. There are also ongoing costs, which generally include management fees and other Fund expenses. Lastly, there may be additional fees or charges imposed by the insurance company that sponsors your variable annuity and/or variable life insurance product. The following information is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to help you compare these costs with the ongoing costs of investing in other mutual funds.
Analyzing your Fund's expenses
To illustrate the ongoing costs, we have provided an example and calculated the expenses paid by investors in the Fund during the period. The actual and hypothetical information in the table below is based on an initial investment of $1,000 at the beginning of the period indicated and held for the entire period. Expense information is calculated two ways and each method provides you with different information. The amount listed in the "Actual" column is calculated using the Fund's actual operating expenses and total return for the period. You may use the Actual information, together with the amount invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the results by the expenses paid during the period under the Actual column. The amount listed in the "Hypothetical" column assumes a 5% annual rate of return before expenses (which is not the Fund's actual return) and then applies the Fund's actual expense ratio for the period to the hypothetical return. You should not use the hypothetical account values and expenses to estimate either your actual account balance at the end of the period or the expenses you paid during the period. See "Compare with other funds" below for details on how to use the hypothetical data.
Compare with other funds
Since all mutual funds are required to include the same hypothetical calculations about expenses in shareholder reports, you can use this information to compare the ongoing cost of investing in the Fund with other funds. To do so, compare the hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds. As you compare hypothetical examples of other funds, it is important to note that hypothetical examples are meant to highlight the ongoing cost of investing in a fund only and do not reflect any transaction costs, such as redemption or exchange fees. Therefore, the hypothetical calculations are useful in comparing ongoing costs only, and will not help you determine the relative total costs of investing in different funds. If transaction costs were included in these calculations, your costs would be higher.
January 1, 2013 – June 30, 2013
| | Account value at the beginning of the period ($) | | Account value at the end of the period ($) | | Expenses paid during period ($) | | Fund's annualized expense ratio (%)* | |
| | Actual | | Hypothetical | | Actual | | Hypothetical | | Actual | | Hypothetical | | | |
Wanger USA | | | 1,000.00 | | | | 1,000.00 | | | | 1,122.20 | | | | 1,019.81 | | | | 5.00 | | | | 4.75 | | | | 0.96 | | |
*Expenses paid during the period are equal to the Fund's annualized expense ratio, multiplied by the average account value over the period, then multiplied by the number of days in the Fund's most recent fiscal half-year and divided by 365.
It is important to note that the expense amounts shown in the table are meant to highlight only ongoing costs of investing in the Fund. Expenses paid during the period do not include any insurance charges imposed by your insurance company's separate account.
2
Wanger USA 2013 Semiannual Report
Health Care in the United States
Critics of the U.S. health care system note that the World Health Organization (WHO) ranked the United States thirtieth in the world in life expectancy1 despite the fact that the United States spends more money per capita on health care than any other country. They argue that health care in the United States is inferior to health care in many other developed countries.
Scott W. Atlas's book, In Excellent Health, Setting the Record Straight on America's Health Care,2 analyzes the consequences of poor lifestyle choices made by many Americans and how the U.S. health care system operates compared to health care systems elsewhere. His book cites numerous studies indicating the U.S. health care system does a great job addressing the health concerns of Americans and is likely the best system in the world.
Life Expectancy
The United States is much more violent and accident-prone than other developed countries. Homicide rates in the United States are ten times that of the United Kingdom and five times that of Canada.3 Death rates from transportation accidents in the United States are 250% that of the United Kingdom and 160% that of Canada.4 Murder and accidents account for the majority of deaths among young adults in the United States,5 and deaths at young ages substantially impact life expectancies.
Robert Ohsfeldt's and John Schneider's book, The Business of Health,6 attempts to quantify the impact of fatal injuries on life expectancy. Using linear regression, they calculate that after standardizing for fatal injuries alone, the United States would edge out Switzerland by 0.3 years and have the highest life expectancy of any country in the world.7
Other studies indicate that violence and accidents account for much, but not all, of the life expectancy shortfall in the United States. A National Academy of Sciences panel addressing cross-national health differences issued a paper that indicated 57% of the life expectancy gap for
males under age 50 and 38% for females under 50 is explained by higher violence and accidents in the United States.8
The United States has a much higher incidence of obesity than other developed countries. Atlas notes that in 2010 34% of people in the United States were obese compared to 15% in Canada, 17% in Western Europe and about 24% in the United Kingdom.9 The Organization for Economic Cooperation and Development (OECD) estimates that obesity reduces life spans by up to eight to ten years.10 Sadly, the worst is yet to come for the United States, as obesity rates have increased and there appears to be a 25-year time lag between becoming obese and suffering premature death.11
Cigarette use in the United States is down substantially; smoking rates are now lower than most other OECD countries.12 However, studies have found a time lag of roughly 25 to 30 years between smoking and lung cancer mortality.13 The United States had the highest rate of smoking in the developed world from the 1930s to the mid-1980s and, according to a 2007 study, 53% of Americans were current or former smokers, compared to 43% of Western Europeans.14 Clearly the United States' legacy of smoking continues to impact health. The Surgeon General estimates that cigarette smoking causes 443,000 deaths in the United States yearly, nearly one-fifth of all deaths.15
With respect to neonatal mortality, Atlas writes that the United States has stringent reporting requirements and definitions. Birth registrations in the United States are done by hospitals and health care professionals, while many other countries rely on reporting by families or surveys.16 In the United States, a live birth is tabulated should a newborn breathe, have a beating heart, move voluntary muscles or show any other evidence of life.17 According to WHO, countries representing only 13% of births worldwide had reliable data meeting this definition.18
Elsewhere, definitions for live births vary greatly. Some countries consider births as live only if 28 weeks gestation was achieved, if a baby is 30 centimeters long, or if a baby survives 24 hours.19 Otherwise, the baby is classified as stillborn and is not considered an infant mortality. Atlas states, "... considering that roughly half of all U.S. infant mortality occurs in the first twenty-four hours, the single criterion of omitting deaths within the first twenty-four hours by many European nations generates their falsely superior infant mortality rates."20
Data from 2004 indicated that the United States had 12% of births classified as preterm (under 32 weeks gestation), a rate 50% to 100% higher than most European countries.21 These figures are impacted by the fact the United States has more multiple gestation pregnancies. Since the early 1980s, the incidence of triplets in the United States has more than tripled to over 140 births per 100,000.22 Atlas notes that in 2007, 17% of twins and 40% of triplets in the United States were associated with fertility treatments.
The United States health care system should be applauded for its efforts to save premature babies rather than write them off as stillborn, as many other countries do. Except for a very limited number of abusive cases, fertility treatment should be considered a virtue of the U.S. health care system. Yet, coupled with superior record keeping, these efforts depress the country's life expectancy ranking.
Diagnosis, Treatment and Outcomes
The Centers for Disease Control and Prevention (CDC) lists heart disease as the top killer in the United States, accounting for 25% of deaths, followed by cancer at 23%, and stroke a distant third at 6%.23 Rather than judge a health care system on reported life expectancy, Atlas assesses health care quality in the United States based on actual medical care, especially diagnosis and treatment of important diseases, using objective data.
3
Wanger USA 2013 Semiannual Report
Atlas notes the challenges facing the health care system due to the poor lifestyle choices of many Americans. The CDC estimates that 80% of diabetes, heart disease and stroke, and 40% of cancer, could be eliminated through reduction in obesity and smoking.24 The rate of diabetes in the United States is typically 33% to 100% higher than other developed countries.25 A 2007 study indicated that 12% of Americans over age 50 were diagnosed with cancer, compared to only 5% in a composite of 10 European countries.26
Atlas cites data showing more timely diagnosis and treatment in the United States as compared to other countries. He writes that, "... prolonged wait times are commonly found in health systems with government-controlled nationalized health insurance."27 Numerous countries with single payer systems had to create policies to address prolonged wait times, including Canada, England, Italy, Sweden and Spain.
The United States is among the world's leaders in per capita computerized tomography (CT) and magnetic resonance imaging (MRI) scanners,28 which are crucial to accurately diagnosing leading fatal diseases and guiding lower risk and more effective treatments. In the United States, referring doctors book CT and MRI appointments within days. In other countries, people wait. In 2010, the average wait time in Canada for a CT scan was 4 weeks and for an MRI, 10 weeks.29 A 2011 study in the United Kingdom indicated thousands of people waited over six weeks for an MRI scan. With respect to breast cancer biopsies, another survey indicated that only 1% of U.S. patients waited three weeks or more while 44% of Canadian and 20% of U.K. patients waited that long.30
Treatment of diseases also tends to be very timely in the United States. One study indicated that no elective (non-emergency) cardiac bypass patients in the United States were known to have waited more than three months, while 47% in Canada and 89% in the United Kingdom waited at least that long.31
Furthermore, treatments in the United States tend to be aggressive. A 2009 paper written by
University of Pennsylvania professor Samuel Preston and doctoral candidate Jessica Ho states that 88% of Americans with high cholesterol are being medicated versus 62% of Europeans. Likewise a higher percentage of Americans over age 50 with heart disease receive medication. Among those with hypertension in the United States, 66% were being successfully treated, versus 25% to 49% in other countries.32
With respect to cancer, Preston and Ho cite studies showing that the United States tends to have the highest percentage of screenings for breast, cervical, prostate and colon cancer.33 If cancer is detected, Americans tend to receive more surgery, chemotherapy and advanced cancer drugs. A 2008 study calculated five-year survival rates for breast, colorectal and prostate cancers. Patients in the United States lead the world with a 74% survival rate. Second-best Canada came in at 71% and the United Kingdom was a laggard at 52%.
Atlas adds that new oncology drugs are most often approved and first used in the United States.34 Some 80% of worldwide medical innovation originates in the United States and, since the mid-1970s, U.S. scientists have won more than half of Nobel Prize awards in medicine and physiology.
The statistics are clear. Sick Americans are more likely to receive timely and aggressive health care than citizens of other countries. Atlas writes, "Availability of state-of-the-art medical technology, timely access to specialists, the most effective screening, the shortest wait times for life-changing surgeries, the newest, most effective drugs for more accurate, safer diagnosis and for the most advanced treatment are all superior in the United States."35
Many people appear to agree. In 2008, a McKinsey & Company study estimated that up to 85,000 patients sought in-patient treatment outside their home country. Of that number, 87% traveled to the United States for advanced medical technology, better quality care or quicker access to care. In contrast, critics of the U.S.
health care system don't appear to be traveling to Cuba for treatment. Based on the facts, I agree with Atlas.
Health Care Economics and Investment Implications
Atlas states that the, "... only real crisis in America's health care today is the unsustainable and increasing burden of health care costs..."36 and recommends free market reforms. Health care costs are not the topic of this essay, but world-class health care clearly is expensive, and costs in the United States are exacerbated by detrimental lifestyle choices. I also believe that poor government policies result in few incentives for cost restraint.
Columbia Wanger Asset Management, the investment manager of the Columbia Wanger Funds, strives to provide Columbia Wanger Fund investors with investments in health care companies that are pursuing breakthrough drugs and devices, with the potential to transform treatment of serious and poorly managed diseases. For example, in pivotal studies Seattle Genetics' drug Adcetris delivered 80% response rates in advanced Hodgkin's lymphoma patients who had exhausted all other treatment options.37 In addition, we seek to invest in companies with products and services that we believe increase the cost effectiveness of health care delivery. We attempt to avoid investing in health care companies that may be more likely to be subject to cost cuts or price controls.
Charles P. McQuaid
President and Chief Investment Officer
Columbia Wanger Asset Management, LLC
4
Wanger USA 2013 Semiannual Report
The information and data provided in this analysis are derived from sources that we deem to be reliable and accurate. These views are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict so actual outcomes and results may differ significantly from the views expressed. The views/opinions expressed here are those of the author and not of the Wanger Advisors Trust Board, are subject to change at any time based upon economic, market or other conditions, may differ from views expressed by other Columbia Management associates and the respective parties disclaim any responsibility to update such views. These views may not be relied on as investment advice and, because investment decisions for a Columbia Wanger Fund are based on numerous factors, may not be relied on as an indication of trading intent on behalf of any particular Columbia Wanger Fund.
1 Atlas, Scott W., In Excellent Health, Setting the Record Straight on American's Heath Care, (Stanford, California, Hoover Institution Press), p. 2.
2 Ibid.
3 Ohsfeldt, Robert L., and Schneider, John E., The Business of Health, The Role of Competition, Markets, and Regulation, (Washington, D.C., The AEI Press), p. 19.
4 Atlas, Scott W., op. cit., p. 28.
5 Ibid., p. 28.
6 Ohsfeldt, Robert L., and Schneider, John E., op. cit.
7 Ibid., p. 22.
8 Steven H. Woolf and Laudan Aron, Editors; Panel on Understanding Cross-National Health Differences Among High-Income Countries; Committee on Population; Division of Behavioral and Social Sciences and Education; National Research Council; Board on Population Health and Public Health Practice; Institute of Medicine, www.nap.edu.
9 Atlas, Scott W., op. cit., p. 105.
10 Ibid., p. 31.
11 Ibid., p. 107.
12 Ibid., p. 40.
13 Ibid., p. 41.
14 Ibid., p. 111.
15 Ibid., p. 108.
16 Ibid., p. 60.
17 Ibid., p. 67.
18 Ibid., p. 71.
19 Ibid., p. 68.
20 Ibid., p. 70.
21 Ibid., p. 73.
22 Ibid., p. 89.
23 Ibid., p. 119.
24 Ibid., p. 103.
25 Ibid., p. 113.
26 Preston, Samuel H., and Ho, Jessica Y., "Low Life Expectancy in the United States: Is the Health Care System at Fault?" University of Pennsylvania Scholarly Commons Working Paper Series, July 1, 2009, p. 4, http://repository.upenn.edu/psc_working_papers/13/. Accessed July 24, 2013.
27 Atlas, Scott W., op. cit., p. 159.
28 Ibid., p. 192-193.
29 Ibid., p. 194.
30 Ibid., p. 175.
31 Ibid., p. 187.
32 Preston, Samuel H., and Ho, Jessica Y., op. cit., p. 6.
33 Ibid., p. 3.
34 Atlas, Scott W., op. cit., p. 222.
35 Ibid., p. 233.
36 Ibid., p. 245.
37 Seattle Genetics is held in the following Columbia Wanger Funds: Wanger USA, 1.2%; Wanger Select, 1.3%.
5
Wanger USA 2013 Semiannual Report
Performance Review Wanger USA
Robert A. Mohn
Portfolio Manager
Performance data shown represents past performance and is not a guarantee of future results. The investment return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data shown. Please visit columbiamanagement.com for most recent month-end performance updates.
Wanger USA finished the semiannual period ended June 30, 2013, up 12.22%. This compares to a 15.86% gain for the Fund's primary benchmark, the Russell 2000 Index. While we are pleased with the Fund's double-digit gain for the period, the Fund underperformed its benchmark due, in part, to our growth-at-a-reasonable-price (GARP) style of investing. This style tends to lag the benchmark during a strong market spurt like that experienced during the first half of 2013.
Top contributors in the six-month period included car rental companies Avis Budget Group and Hertz, up 45% and 52%, respectively. The rental car industry has benefited from consolidation and positive trends in rental car pricing. Internet photo-centric retailer Shutterfly ended the half year up 87% after reporting solid market share gains. Bally Technologies, a slot machine manufacturer and software developer, gained 26% in the half after reporting a strong first quarter fueled by increased demand for replacement slot machines.
Other winners included NPS Pharmaceuticals, a developer of orphan drugs, up 66% on the successful launch of its new drug to treat short bowel syndrome. SPS Commerce, a provider of supply chain management software delivered via the web, gained 48% for the period on strong growth in revenue.
Laggards for the period included premium active apparel retailer lululemon athletica, down 14% for the six months as investors reacted negatively to the resignation of the company's CEO. Early in the period, the company suffered from a much-publicized yoga pant recall and holiday same-store-sales growth that met management's guidance but not Wall Street expectations. Fiber laser manufacturer IPG Photonics was off 9% for the first half of the year on weaker-than-expected revenue growth and concerns about China, the source of 17% of the company's revenue. Plagued by a number of project delays, ESCO Technologies, a manufacturer of automatic electric meter readers, fell 13% for the half year. Polypore International, a manufacturer of battery separators and filtration media, fell 13% in the period. Polypore's battery separators are used in lithium
batteries found in electric automobiles and its sales declined along with sales of these cars.
As mentioned above, our GARP style was somewhat out of favor for the semiannual period, as stocks at the top and bottom of the valuation spectrum brought top gains. Investing styles ebb and flow during market cycles, but our GARP approach has historically worked very well over the long term.
Stocks of small- and mid-cap companies pose special risks, including possible illiquidity and greater price volatility than stocks of larger, more established companies.
Portfolio holdings are subject to change periodically and may not be representative of current holdings.
Fund's Positions in Mentioned Holdings
As a percentage of net assets, as of 6/30/13
Avis Budget Group | | | 2.3 | % | |
IPG Photonics | | | 2.1 | | |
Bally Technologies | | | 1.8 | | |
Hertz | | | 1.2 | | |
ESCO Technologies | | | 1.2 | | |
SPS Commerce | | | 1.1 | | |
Shutterfly | | | 0.8 | | |
lululemon athletica | | | 0.8 | | |
NPS Pharmaceuticals | | | 0.7 | | |
Polypore International | | | 0.3 | | |
6
Wanger USA 2013 Semiannual Report
Growth of a $10,000 Investment in Wanger USA
May 3, 1995 (inception date) through June 30, 2013
Performance data shown represents past performance and is not a guarantee of future results. The investment return and principal value will fluctuate so that shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data shown. Performance results reflect any fee waivers or reimbursements of Fund expenses by the investment manager and/or any of its affiliates. Absent these fee waivers and/or expense reimbursement arrangements, performance results would have been lower. For daily and most recent month-end performance updates, please call 1-888-4-WANGER.
This graph compares the results of $10,000 invested in Wanger USA on May 3, 1995 (the date the Fund began operations) through June 30, 2013, to the Russell 2000 Index, with dividends and capital gains reinvested. Although the index is provided for use in assessing the Fund's performance, the Fund's holdings may differ significantly from those in the index.
Top 10 Holdings
As a percentage of net assets, as of 6/30/13
1. Nordson Dispensing Systems for Adhesives & Coatings | | | 3.8 | % | |
2. Ametek Aerospace/Industrial Instruments | | | 3.3 | | |
3. tw telecom Fiber Optic Telephone/Data Services | | | 2.8 | | |
4. Mettler-Toledo International Laboratory Equipment | | | 2.7 | | |
5. Extra Space Storage Self Storage Facilities | | | 2.6 | | |
6. Donaldson Industrial Air Filtration | | | 2.5 | | |
7. Avis Budget Group Second Largest Car Rental Company | | | 2.3 | | |
8. Atwood Oceanics Offshore Drilling Contractor | | | 2.3 | | |
9. IPG Photonics Fiber Lasers | | | 2.1 | | |
10. Informatica Enterprise Data Integration Software | | | 1.9 | | |
Top 5 Industries
As a percentage of net assets, as of 6/30/13
Information | | | 28.1 | % | |
Industrial Goods & Services | | | 18.7 | | |
Consumer Goods & Services | | | 16.2 | | |
Finance | | | 15.1 | | |
Health Care | | | 9.1 | | |
Results as of June 30, 2013
| | 2nd quarter* | | Year to date* | | 1 year | | 5 years | | 10 years | |
Wanger USA | | | 0.92 | % | | | 12.22 | % | | | 22.03 | % | | | 8.41 | % | | | 9.71 | % | |
Russell 2000 Index** | | | 3.08 | | | | 15.86 | | | | 24.21 | | | | 8.77 | | | | 9.53 | | |
Lipper Variable Underlying Small-Cap Growth Funds Index | | | 3.11 | | | | 15.79 | | | | 22.17 | | | | 8.54 | | | | 9.37 | | |
* Not annualized.
** The Fund's primary benchmark.
NAV as of 6/30/13: $34.51
Performance numbers reflect all Fund expenses but do not include any fees and expenses imposed under your variable annuity or life insurance policy or qualified pension or retirement plan. If performance included the effect of these additional charges, it would be lower.
The Fund's annual operating expense ratio of 0.96% is stated as of the Fund's prospectus dated May 1, 2013, and differences in expense ratios disclosed elsewhere in this report may result from including fee waivers and expense reimbursements as well as different time periods used in calculating the ratios.
All results shown assume reinvestment of distributions.
The Russell 2000 Index measures the performance of the 2,000 smallest companies in the Russell 3000 Index, which represents approximately 10% of the total market capitalization of the Russell 3000 Index. The Lipper Variable Underlying Small-Cap Growth Funds Index is an equally weighted representation of the 30 largest variable insurance underlying funds in the Lipper Variable Underlying Small-Cap Growth Funds Classification, and shows how the Fund's performance compares with returns of an index of funds with similar investment objectives. Indexes are not managed and do not incur fees or expenses. It is not possible to invest directly in an index.
Lipper Inc., a widely respected data provider in the industry, calculates an average total return (assuming reinvestment of distributions) for mutual funds with investment objectives similar to those of the Fund.
Portfolio characteristics and holdings are subject to change periodically and may not be representative of current characteristics and holdings.
7
Wanger USA 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Equities – 98.7% | |
| | Information – 28.1% | |
| | Business Software – 9.5% | |
| 448,000 | | | Informatica (a) Enterprise Data Integration Software | | $ | 15,671,040 | | |
| 198,000 | | | Ansys (a) Simulation Software for Engineers & Designers | | | 14,473,800 | | |
| 307,000 | | | Micros Systems (a) Information Systems for Hotels, Restaurants & Retailers | | | 13,247,050 | | |
| 163,000 | | | SPS Commerce (a) Supply Chain Management Software Delivered Via the Web | | | 8,965,000 | | |
| 95,000 | | | NetSuite (a) End-to-end IT Systems Solution Delivered Over the Web | | | 8,715,300 | | |
| 83,000 | | | Concur Technologies (a) (b) Web Enabled Cost & Expense Management Software | | | 6,754,540 | | |
| 165,000 | | | RealPage (a) (b) Software for Managing Rental Properties Delivered Via the Web | | | 3,026,100 | | |
| 42,000 | | | DemandWare (a) (b) eCommerce Website Solution for Retailers & Apparel Manufacturers | | | 1,781,220 | | |
| 150,000 | | | Exa (a) Simulation Software | | | 1,545,000 | | |
| 68,140 | | | E2Open (a) (b) Supply Chain Management Software & Supplier/Partner Network | | | 1,192,450 | | |
| 44,099 | | | Webgroup.com (a) Website Creation & Management for Small Businesses | | | 1,128,934 | | |
| 43,000 | | | Envestnet (a) Technology Platform for Investment Advisors | | | 1,057,800 | | |
| 81,780 | | | InContact (a) Call Center Systems Delivered Via the Web & Telecommunication Services | | | 672,232 | | |
| 195,000 | | | Velti (a) (b) Mobile Marketing Software Platform | | | 273,000 | | |
| 11,724 | | | ChannelAdvisor (a) eCommerce Software | | | 184,419 | | |
| 624 | | | SciQuest (a) Procurement Management Software & Vendor Network | | | 15,631 | | |
| | | 78,703,516 | | |
| | Instrumentation – 4.8% | |
| 109,750 | | | Mettler-Toledo International (a) Laboratory Equipment | | | 22,081,700 | | |
| 291,000 | | | IPG Photonics (b) Fiber Lasers | | | 17,672,430 | | |
| | | 39,754,130 | | |
Number of Shares | | | | Value | |
| | Telephone & Data Services – 3.0% | |
| 830,000 | | | tw telecom (a) Fiber Optic Telephone/Data Services | | $ | 23,356,200 | | |
| 197,000 | | | Boingo Wireless (a) Wholesale & Retail WiFi Networks | | | 1,223,370 | | |
| | | 24,579,570 | | |
| | Semiconductors & Related Equipment – 2.5% | |
| 281,000 | | | Monolithic Power Systems High Performance Analog & Mixed Signal Integrated Circuits | | | 6,774,910 | | |
| 790,000 | | | Atmel (a) Microcontrollers, Radio Frequency & Memory Semiconductors | | | 5,806,500 | | |
| 86,000 | | | Ultratech (a) Semiconductor Equipment | | | 3,157,920 | | |
| 64,000 | | | Semtech (a) Analog Semiconductors | | | 2,241,920 | | |
| 25,000 | | | Hittite Microwave (a) Radio Frequency, Microwave & Millimeterwave Semiconductors | | | 1,450,000 | | |
| 167,000 | | | ON Semiconductor (a) Mixed Signal & Power Management Semiconductors | | | 1,349,360 | | |
| | | 20,780,610 | | |
| | Computer Services – 2.0% | |
| 333,000 | | | ExlService Holdings (a) Business Process Outsourcing | | | 9,843,480 | | |
| 175,000 | | | WNS – ADR (India) (a) Offshore Business Process Outsourcing Services | | | 2,920,750 | | |
| 405,000 | | | RCM Technologies Technology & Engineering Services | | | 2,199,150 | | |
| 297,522 | | | Hackett Group IT Integration & Best Practice Research | | | 1,544,139 | | |
| | | 16,507,519 | | |
| | Gaming Equipment & Services – 1.8% | |
| 264,000 | | | Bally Technologies (a) (b) Slot Machines & Software | | | 14,894,880 | | |
| | Telecommunications Equipment – 1.3% | |
| 275,800 | | | Finisar (a) Optical Subsystems & Components | | | 4,674,810 | | |
| 235,000 | | | Ixia (a) Telecom Network Test Equipment | | | 4,324,000 | | |
See accompanying notes to financial statements.
8
Wanger USA 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Telecommunications Equipment – 1.3% (cont) | |
| 135,000 | | | Infinera (a) Optical Networking Equipment | | $ | 1,440,450 | | |
| | | 10,439,260 | | |
| | Computer Hardware & Related Equipment – 1.2% | |
| 397,000 | | | II-VI (a) Laser Optics & Specialty Materials | | | 6,455,220 | | |
| 66,000 | | | Netgear (a) Networking Products for Small Business & Home | | | 2,015,640 | | |
| 33,000 | | | Rogers (a) Printed Circuit Materials & High-performance Foams | | | 1,561,560 | | |
| | | 10,032,420 | | |
| | Financial Processors – 0.9% | |
| 91,000 | | | Global Payments Credit Card Processor | | | 4,215,120 | | |
| 80,000 | | | Liquidity Services (a) (b) E-Auctions for Surplus & Salvage Goods | | | 2,773,600 | | |
| | | 6,988,720 | | |
| | Contract Manufacturing – 0.7% | |
| 122,000 | | | Plexus (a) Electronic Manufacturing Services | | | 3,646,580 | | |
| 165,000 | | | Sanmina-SCI (a) Electronic Manufacturing Services | | | 2,367,750 | | |
| | | 6,014,330 | | |
| | Business Information & Marketing Services – 0.4% | |
| 291,200 | | | Navigant Consulting (a) Financial Consulting Firm | | | 3,494,400 | | |
| | | | Total Information | | | 232,189,355 | | |
| | Industrial Goods & Services – 18.7% | |
| | Machinery – 15.1% | |
| 457,200 | | | Nordson Dispensing Systems for Adhesives & Coatings | | | 31,688,532 | | |
| 640,000 | | | Ametek Aerospace/Industrial Instruments | | | 27,072,000 | | |
| 580,000 | | | Donaldson Industrial Air Filtration | | | 20,682,800 | | |
| 187,000 | | | Moog (a) Motion Control Products for Aerospace, Defense & Industrial Markets | | | 9,636,110 | | |
Number of Shares | | | | Value | |
| 297,300 | | | ESCO Technologies Automatic Electric Meter Readers | | $ | 9,626,574 | | |
| 124,000 | | | Kennametal Consumable Cutting Tools | | | 4,814,920 | | |
| 124,000 | | | HEICO FAA-approved Aircraft Replacement Parts | | | 4,576,840 | | |
| 24,000 | | | Middleby (a) Manufacturer of Cooking Equipment | | | 4,082,160 | | |
| 88,736 | | | Toro Turf Maintenance Equipment | | | 4,029,502 | | |
| 100,000 | | | Oshkosh Corporation (a) Specialty Truck Manufacturer | | | 3,797,000 | | |
| 57,000 | | | Polypore International (a) (b) Battery Separators & Filtration Media | | | 2,297,100 | | |
| 48,000 | | | Dorman Products Aftermarket Auto Parts Distributor | | | 2,190,240 | | |
| 15,000 | | | Generac Standby Power Generators | | | 555,150 | | |
| | | 125,048,928 | | |
| | Industrial Materials & Specialty Chemicals – 1.6% | |
| 234,000 | | | Drew Industries RV & Manufactured Home Components | | | 9,200,880 | | |
| 157,000 | | | Polyone Intermediate Stage Chemicals Producer | | | 3,890,460 | | |
| | | 13,091,340 | | |
| | Electrical Components – 0.9% | |
| 64,000 | | | Acuity Brands Commercial Lighting Fixtures | | | 4,833,280 | | |
| 134,000 | | | Thermon (a) Global Engineered Thermal Solutions | | | 2,733,600 | | |
| | | 7,566,880 | | |
| | Other Industrial Services – 0.6% | |
| 80,000 | | | KAR Auction Services Auto Auctions | | | 1,829,600 | | |
| 47,000 | | | Forward Air Freight Transportation Between Airports | | | 1,799,160 | | |
| 80,000 | | | TrueBlue (a) Temporary Industrial Labor | | | 1,684,000 | | |
| | | 5,312,760 | | |
See accompanying notes to financial statements.
9
Wanger USA 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Construction – 0.3% | |
| 58,000 | | | Fortune Brands Home & Security Home Building Supplies & Small Locks | | $ | 2,246,920 | | |
| | Industrial Distribution – 0.2% | |
| 60,000 | | | MRC Global (a) Industrial Distributor | | | 1,657,200 | | |
| | | | Total Industrial Goods & Services | | | 154,924,028 | | |
| | Consumer Goods & Services – 16.2% | |
| | Travel – 5.8% | |
| 659,500 | | | Avis Budget Group (a) Second Largest Car Rental Company | | | 18,960,625 | | |
| 337,038 | | | Ryman Hospitality Properties (b) Convention Hotels | | | 13,147,853 | | |
| 400,000 | | | Hertz (a) Largest U.S. Rental Car Operator | | | 9,920,000 | | |
| 85,000 | | | Choice Hotels Franchisor of Budget Hotel Brands | | | 3,373,650 | | |
| 72,000 | | | HomeAway (a) Vacation Rental Online Marketplace | | | 2,328,480 | | |
| | | 47,730,608 | | |
| | Retail – 4.0% | |
| 382,000 | | | Pier 1 Imports Home Furnishing Retailer | | | 8,973,180 | | |
| 120,500 | | | Shutterfly (a) Internet Photo-centric Retailer | | | 6,722,695 | | |
| 102,000 | | | lululemon athletica (a) (b) Premium Active Apparel Retailer | | | 6,683,040 | | |
| 93,000 | | | Abercrombie & Fitch Teen Apparel Retailer | | | 4,208,250 | | |
| 61,000 | | | Casey's General Stores Owner/Operator of Convenience Stores | | | 3,669,760 | | |
| 176,000 | | | Saks (a) Luxury Department Store Retailer | | | 2,400,640 | | |
| 116,229 | | | Gaiam (a) Healthy Living Catalogs & E-Commerce, Non-theatrical Media | | | 518,381 | | |
| | | 33,175,946 | | |
| | Furniture & Textiles – 2.1% | |
| 474,000 | | | Knoll Office Furniture | | | 6,735,540 | | |
Number of Shares | | | | Value | |
| 178,561 | | | Caesarstone (Israel) (a) Quartz Countertops | | $ | 4,862,216 | | |
| 125,000 | | | Herman Miller Office Furniture | | | 3,383,750 | | |
| 135,000 | | | Interface Modular Carpet | | | 2,290,950 | | |
| | | 17,272,456 | | |
| | Other Consumer Services – 1.4% | |
| 163,000 | | | Lifetime Fitness (a) Sport & Fitness Club Operator | | | 8,167,930 | | |
| 132,500 | | | Blackhawk Network (a) Third Party Distributer of Prepaid Content, Mostly Gift Cards | | | 3,074,000 | | |
| | | 11,241,930 | | |
| | Consumer Goods Distribution – 1.2% | |
| 194,000 | | | Pool Swimming Pool Supplies & Equipment Distributor | | | 10,167,540 | | |
| | Casinos & Gaming – 0.5% | |
| 208,156 | | | Pinnacle Entertainment (a) Regional Casino Operator | | | 4,094,428 | | |
| 2,342 | | | Churchill Downs Owner/Operator of Horse Racing Tracks & Regional Casinos | | | 184,667 | | |
| | | 4,279,095 | | |
| | Nondurables – 0.3% | |
| 73,931 | | | Helen of Troy (a) Personal Care, Housewares, Health Care & Home Environment Products | | | 2,836,733 | | |
| | Food & Beverage – 0.3% | |
| 37,504 | | | B&G Foods Acquiror of Small Food Brands | | | 1,277,011 | | |
| 73,000 | | | Boulder Brands (a) Healthy Food Products | | | 879,650 | | |
| | | 2,156,661 | | |
| | Other Durable Goods – 0.2% | |
| 70,000 | | | Select Comfort (a) Specialty Mattresses | | | 1,754,200 | | |
| | Restaurants – 0.2% | |
| 49,000 | | | Fiesta Restaurant Group (a) Owns/Operates Two Restaurant Chains: Pollo Tropical & Taco Cabana | | | 1,685,110 | | |
See accompanying notes to financial statements.
10
Wanger USA 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Apparel – 0.2% | |
| 250,000 | | | Quiksilver (a) Action Sports Lifestyle Branded Apparel & Footwear | | $ | 1,610,000 | | |
| | | | Total Consumer Goods & Services | | | 133,910,279 | | |
| | Finance – 15.1% | |
| | Banks – 7.7% | |
| 373,000 | | | MB Financial Chicago Bank | | | 9,996,400 | | |
| 107,000 | | | SVB Financial Group (a) Bank to Venture Capitalists | | | 8,915,240 | | |
| 485,000 | | | Associated Banc-Corp Midwest Bank | | | 7,541,750 | | |
| 253,000 | | | Lakeland Financial Indiana Bank | | | 7,020,750 | | |
| 103,000 | | | City National Bank & Asset Manager | | | 6,527,110 | | |
| 368,000 | | | TCF Financial Great Lakes Bank | | | 5,218,240 | | |
| 161,194 | | | Hancock Holding Gulf Coast Bank | | | 4,847,104 | | |
| 504,000 | | | Valley National Bancorp (b) New Jersey/New York Bank | | | 4,772,880 | | |
| 666,200 | | | First Busey Illinois Bank | | | 2,997,900 | | |
| 400,000 | | | First Commonwealth Western Pennsylvania Bank | | | 2,948,000 | | |
| 97,700 | | | Sandy Spring Bancorp Baltimore & Washington, D.C. Bank | | | 2,112,274 | | |
| 100,890 | | | Guaranty Bancorp Colorado Bank | | | 1,145,101 | | |
| | | 64,042,749 | | |
| | Finance Companies – 3.8% | |
| 101,000 | | | World Acceptance (a) Personal Loans | | | 8,780,940 | | |
| 339,400 | | | CAI International (a) International Container Leasing | | | 7,999,658 | | |
| 174,900 | | | McGrath Rentcorp Temporary Space & IT Rentals | | | 5,974,584 | | |
| 115,000 | | | Textainer Group Holdings (b) Top International Container Leasor | | | 4,420,600 | | |
Number of Shares | | | | Value | |
| 195,040 | | | H & E Equipment Services Heavy Equipment Leasing | | $ | 4,109,493 | | |
| | | 31,285,275 | | |
| | Savings & Loans – 1.6% | |
| 408,600 | | | ViewPoint Financial Texas Thrift | | | 8,502,966 | | |
| 142,000 | | | Berkshire Hills Bancorp Northeast Thrift | | | 3,941,920 | | |
| 52,011 | | | Simplicity Bancorp Los Angeles Savings & Loan | | | 754,159 | | |
| | | 13,199,045 | | |
| | Brokerage & Money Management – 0.9% | |
| 206,000 | | | SEI Investments Mutual Fund Administration & Investment Management | | | 5,856,580 | | |
| 109,000 | | | Kennedy-Wilson Holdings Global Distressed Real Estate | | | 1,813,760 | | |
| | | 7,670,340 | | |
| | Insurance – 0.6% | |
| 19,000 | | | Enstar Group (a) Insurance/Reinsurance & Related Services | | | 2,526,620 | | |
| 27,000 | | | Allied World Holdings Commerical Lines Insurance/Reinsurance | | | 2,470,770 | | |
| | | 4,997,390 | | |
| | Diversified Financial Companies – 0.5% | |
| 146,500 | | | Leucadia National Holding Company | | | 3,841,230 | | |
| | | | Total Finance | | | 125,036,029 | | |
| | Health Care – 9.1% | |
| | Biotechnology & Drug Delivery – 5.3% | |
| 311,000 | | | Seattle Genetics (a) Antibody-based Therapies for Cancer | | | 9,784,060 | | |
| 397,000 | | | NPS Pharmaceuticals (a) Orphan Drugs & Healthy Royalties | | | 5,994,700 | | |
| 136,801 | | | Synageva Biopharma (a) Biotech Focused on Orphan Diseases | | | 5,745,642 | | |
| 102,000 | | | BioMarin Pharmaceutical (a) Biotech Focused on Orphan Diseases | | | 5,690,580 | | |
See accompanying notes to financial statements.
11
Wanger USA 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Biotechnology & Drug Delivery – 5.3% (cont) | |
| 50,000 | | | Onyx Pharmaceuticals (a) Commercial-stage Biotech Focused on Cancer | | $ | 4,341,000 | | |
| 101,000 | | | Sarepta Therapeutics (a) (b) Biotech Focused on Rare Diseases | | | 3,843,050 | | |
| 211,000 | | | ARIAD Pharmaceuticals (a) Biotech Focused on Cancer | | | 3,690,390 | | |
| 73,000 | | | Alnylam Pharmaceuticals (a) Biotech Developing Drugs for Rare Diseases | | | 2,263,730 | | |
| 201,000 | | | InterMune (a) Drugs for Pulmonary Fibrosis & Hepatitis C | | | 1,933,620 | | |
| 91,000 | | | Coronado Biosciences (a) (b) Development-stage Biotech | | | 782,600 | | |
| | | 44,069,372 | | |
| | Medical Supplies – 1.7% | |
| 314,600 | | | Cepheid (a) Molecular Diagnostics | | | 10,828,532 | | |
| 47,000 | | | Techne Cytokines, Antibodies & Other Reagents for Life Science | | | 3,246,760 | | |
| | | 14,075,292 | | |
| | Medical Equipment & Devices – 1.0% | |
| 121,000 | | | Sirona Dental Systems (a) Manufacturer of Dental Equipment | | | 7,971,480 | | |
| | Pharmaceuticals – 0.7% | |
| 385,000 | | | Akorn (a) Develops, Manufactures & Sells Specialty Generic Drugs | | | 5,205,200 | | |
| 116,100 | | | Alimera Sciences (a) (b) Ophthalmology-focused Pharmaceutical Company | | | 566,568 | | |
| | | 5,771,768 | | |
| | Health Care Services – 0.4% | |
| 226,000 | | | Allscripts Healthcare Solutions (a) Health Care IT | | | 2,924,440 | | |
| | | | Total Health Care | | | 74,812,352 | | |
| | Other Industries – 6.3% | |
| | Real Estate – 5.5% | |
| 503,000 | | | Extra Space Storage Self Storage Facilities | | | 21,090,790 | | |
| 295,600 | | | Biomed Realty Trust Life Science-focused Office Buildings | | | 5,979,988 | | |
Number of Shares | | | | Value | |
| 935,000 | | | Kite Realty Group Community Shopping Centers | | $ | 5,638,050 | | |
| 411,900 | | | EdR Student Housing | | | 4,213,737 | | |
| 119,000 | | | Coresite Realty Data Centers | | | 3,785,390 | | |
| 341,000 | | | DCT Industrial Trust Industrial Properties | | | 2,438,150 | | |
| 119,000 | | | Associated Estates Realty Multi-family Properties | | | 1,913,520 | | |
| 22,500 | | | American Residential Properties (a) (b) Single-family Rental Properties | | | 387,000 | | |
| | | 45,446,625 | | |
| | Transportation – 0.8% | |
| 184,487 | | | Rush Enterprises, Class A (a) Truck Sales & Service | | | 4,566,053 | | |
| 50,000 | | | World Fuel Services Global Fuel Broker | | | 1,999,000 | | |
| | | 6,565,053 | | |
| | | | Total Other Industries | | | 52,011,678 | | |
| | Energy & Minerals – 5.2% | |
| | Oil Services – 2.6% | |
| 360,100 | | | Atwood Oceanics (a) Offshore Drilling Contractor | | | 18,743,205 | | |
| 58,000 | | | Hornbeck Offshore (a) Supply Vessel Operator in U.S. Gulf of Mexico | | | 3,103,000 | | |
| | | 21,846,205 | | |
| | Oil & Gas Producers – 1.5% | |
| 89,000 | | | SM Energy Oil & Gas Producer | | | 5,338,220 | | |
| 58,000 | | | PDC Energy (a) Oil & Gas Producer in U.S. | | | 2,985,840 | | |
| 62,000 | | | Rosetta Resources (a) Oil & Gas Producer Exploring in Texas | | | 2,636,240 | | |
| 47,000 | | | Approach Resources (a) Oil & Gas Producer in West Texas Permian | | | 1,154,790 | | |
| | | 12,115,090 | | |
See accompanying notes to financial statements.
12
Wanger USA 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
Number of Shares | | | | Value | |
| | Mining – 1.1% | |
| 56,000 | | | Core Labs (Netherlands) Oil & Gas Reservoir Consulting | | $ | 8,492,960 | | |
| 100,000 | | | Augusta Resource (a) US Copper/Molybdenum Mine | | | 210,000 | | |
| | | 8,702,960 | | |
| | | | Total Energy & Minerals | | | 42,664,255 | | |
Total Equities (Cost: $435,407,268) – 98.7% | | | 815,547,976 | (c) | |
Short-Term Investments – 1.2% | | | |
| 10,231,516
| | | JPMorgan U.S. Government Money Market Fund, Agency Shares (7 day yield of 0.01%) | | | 10,231,516 | | |
Total Short-Term Investments (Cost: $10,231,516) – 1.2% | | | 10,231,516 | | |
Securities Lending Collateral – 5.6% | | | |
| 46,000,356
| | | Dreyfus Government Cash Management Fund, Institutional Shares (7 day yield of 0.01%) (d) | | | 46,000,356 | | |
Total Securities Lending Collateral (Cost: $46,000,356) | | | 46,000,356 | | |
Total Investments (Cost: $491,639,140) (e) – 105.5% | | | 871,779,848 | | |
Obligation to Return Collateral for Securities Loaned – (5.6)% | | | (46,000,356 | ) | |
Cash and Other Assets Less Liabilities – 0.1% | | | 283,979 | | |
Net Assets – 100.0% | | $ | 826,063,471 | | |
ADR = American Depositary Receipts
Notes to Statement of Investments
(a) Non-income producing security.
(b) All or a portion of this security was on loan at June 30, 2013. The total market value of securities on loan at June 30, 2013 was $45,473,233.
(c) On June 30, 2013, the market value of foreign securities represented 1.97% of total net assets. The Fund's foreign portfolio was diversified as follows:
Country | | Value | | Percentage of Net Assets | |
Netherlands | | $ | 8,492,960 | | | | 1.03 | | |
Israel | | | 4,862,216 | | | | 0.59 | | |
India | | | 2,920,750 | | | | 0.35 | | |
Total Foreign Portfolio | | $ | 16,275,926 | | | | 1.97 | | |
(d) Investment made with cash collateral received from securities lending activity.
(e) At June 30, 2013, for federal income tax purposes, the cost of investments was $491,639,140 and net unrealized appreciation was $380,140,708 consisting of gross unrealized appreciation of $394,519,168 and gross unrealized depreciation of $14,378,460.
Fair Value Measurements
Various inputs are used in determining the value of the Fund's investments, following the input prioritization hierarchy established by accounting principles generally accepted in the United States of America (GAAP). These inputs are summarized in the three broad levels listed below:
• Level 1 – quoted prices in active markets for identical securities
• Level 2 – prices determined using other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others)
• Level 3 – prices determined using significant unobservable inputs where quoted prices or observable inputs are unavailable or less reliable (including management's own assumptions about the factors market participants would use in pricing an investment)
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
Examples of the types of securities in which the Fund would typically invest and how they are classified within this hierarchy are as follows. Typical Level 1 securities include exchange traded domestic equities, mutual funds whose NAVs are published each day and exchange traded foreign equities that are not statistically fair valued. Typical Level 2 securities include exchange traded foreign equities that are statistically fair valued, forward foreign currency exchange contracts and short-term investments valued at amortized cost. Additionally, securities fair valued by the Valuation Committee (the Committee) of the Fund's Board of Trustees (the Board) that rely on significant observable inputs are also included in Level 2. Typical Level 3 securities include any security fair valued by the Committee that relies on significant unobservable inputs.
Under the direction of the Board, the Committee is responsible for carrying out the valuation procedures approved by the Board.
The Committee meets as necessary, and no less frequently than quarterly, to determine fair values for securities for which market quotations are not readily available or for which the investment manager believes that available market quotations are unreliable, to review the appropriateness of the Trust's Portfolio Pricing Policy and the pricing procedures of the investment manager (the Policies), and to review the continuing appropriateness of the current value of any security subject to the Policies. The Policies address, among other things: circumstances under which market quotations will be deemed readily available;
See accompanying notes to financial statements.
13
Wanger USA 2013 Semiannual Report
Statement of Investments (Unaudited), June 30, 2013
selection of third party pricing vendors; appropriate pricing methodologies; events that require fair valuation and fair value techniques; and circumstances under which securities will be deemed to pose a potential for stale pricing, including when securities are illiquid, restricted, or in default. The Committee may also meet to discuss additional valuation matters, which may include review of back-testing results, review of time-sensitive information or approval of other valuation related actions, and to review the appropriateness of the Policies.
For investments categorized as Level 3, the significant unobservable inputs used in the fair value measurement of the Funds' securities may include: (i) data specific to the issuer or comparable issuers, (ii) general market or specific sector news and (iii) quoted prices and specific or similar security transactions. The Committee considers this data and any changes from prior periods in order to assess the reasonableness of observable and unobservable inputs, any assumptions or internal models used to value those securities and changes in fair value. Significant changes in any of these factors could result in lower or higher fair value measurements. Various factors impact the frequency of monitoring (which may occur as often as daily), however the Committee may determine that changes to inputs, assumptions and models are not required with the same frequency.
The following table summarizes the inputs used, as of June 30, 2013, in valuing the Fund's assets:
Investment Type | |
Quoted Prices (Level 1) | | Other Significant Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | |
Total | |
Equities | |
Information | | $ | 232,189,355 | | | $ | — | | | $ | — | | | $ | 232,189,355 | | |
Industrial Goods & Services | | | 154,924,028 | | | | — | | | | — | | | | 154,924,028 | | |
Consumer Goods & Services | | | 133,910,279 | | | | — | | | | — | | | | 133,910,279 | | |
Finance | | | 125,036,029 | | | | — | | | | — | | | | 125,036,029 | | |
Health Care | | | 74,812,352 | | | | — | | | | — | | | | 74,812,352 | | |
Other Industries | | | 52,011,678 | | | | — | | | | — | | | | 52,011,678 | | |
Energy & Minerals | | | 42,664,255 | | | | — | | | | — | | | | 42,664,255 | | |
Total Equities | | | 815,547,976 | | | | — | | | | — | | | | 815,547,976 | | |
Total Short-Term Investments | | | 10,231,516 | | | | — | | | | — | | | | 10,231,516 | | |
Total Securities Lending Collateral | | | 46,000,356 | | | | — | | | | — | | | | 46,000,356 | | |
Total Investments | | $ | 871,779,848 | | | $ | — | | | $ | — | | | $ | 871,779,848 | | |
There were no transfers of financial assets between levels 1 and 2 during the period.
See accompanying notes to financial statements.
14
Wanger USA 2013 Semiannual Report
Statement of Assets and Liabilities
June 30, 2013 (Unaudited)
Assets: | |
Investments, at cost | | $ | 491,639,140 | | |
Investments, at value (including securities on loan of $45,473,233) | | $ | 871,779,848 | | |
Receivable for: | |
Investments sold | | | 1,369,327 | | |
Fund shares sold | | | 74 | | |
Securities lending income | | | 25,086 | | |
Dividends | | | 451,898 | | |
Trustees' deferred compensation plan | | | 100,638 | | |
Prepaid expenses | | | 4,571 | | |
Total Assets | | | 873,731,442 | | |
Liabilities: | |
Collateral on securities loaned | | | 46,000,356 | | |
Payable for: | |
Investments purchased | | | 552,181 | | |
Fund shares redeemed | | | 860,745 | | |
Investment advisory fee | | | 19,555 | | |
Administration fee | | | 1,136 | | |
Transfer agent fee | | | 2 | | |
Trustees' fees | | | 1,436 | | |
Custody fee | | | 96 | | |
Reports to shareholders | | | 94,369 | | |
Trustees' deferred compensation plan | | | 100,638 | | |
Other liabilities | | | 37,457 | | |
Total Liabilities | | | 47,667,971 | | |
Net Assets | | $ | 826,063,471 | | |
Composition of Net Assets: | |
Paid-in capital | | $ | 407,623,612 | | |
Overdistributed net investment income | | | (460,629 | ) | |
Accumulated net realized gain | | | 38,759,780 | | |
Net unrealized appreciation (depreciation) on: | |
Investments | | | 380,140,708 | | |
Net Assets | | $ | 826,063,471 | | |
Fund Shares Outstanding | | | 23,939,653 | | |
Net asset value, offering price and redemption price per share | | $ | 34.51 | | |
Statement of Operations
For the Six Months Ended June 30, 2013 (Unaudited)
Investment Income: | |
Dividend income (net foreign taxes withheld of $5,376) | | $ | 3,303,006 | | |
Securities lending income, net | | | 255,532 | | |
Total Investment Income | | | 3,558,538 | | |
Expenses: | |
Investment advisory fee | | | 3,507,612 | | |
Administration fee | | | 203,678 | | |
Transfer agent fees | | | 351 | | |
Trustees' fees | | | 15,828 | | |
Custody fees | | | 7,448 | | |
Reports to shareholders | | | 82,785 | | |
Audit fees | | | 21,528 | | |
Legal fees | | | 25,640 | | |
Chief compliance officer expenses (See Note 4) | | | 11,240 | | |
Commitment fee for line of credit (See Note 5) | | | 2,305 | | |
Other expenses | | | 14,401 | | |
Net Expenses | | | 3,892,816 | | |
Net Investment Loss | | | (334,278 | ) | |
Net Realized and Unrealized Gain (Loss) on Investments: | |
Net realized gain (loss) on: | |
Investments | | | 41,257,744 | | |
Net realized gain | | | 41,257,744 | | |
Net change in unrealized appreciation (depreciation) on: | |
Investments | | | 53,282,429 | | |
Net change in unrealized appreciation | | | 53,282,429 | | |
Net realized and unrealized gain | | | 94,540,173 | | |
Net Increase in Net Assets from Operations | | $ | 94,205,895 | | |
See accompanying notes to financial statements.
15
Wanger USA 2013 Semiannual Report
Statements of Changes in Net Assets
Increase (Decrease) in Net Assets | | (Unaudited) Six Months Ended June 30, 2013 | | Year Ended December 31, 2012 | |
Operations: | |
Net investment income (loss) | | $ | (334,278 | ) | | $ | 3,561,029 | | |
Net realized gain (loss) on: | |
Investments | | | 41,257,744 | | | | 75,265,335 | | |
Net change in unrealized appreciation (depreciation) on: | |
Investments | | | 53,282,429 | | | | 65,032,346 | | |
Net Increase in Net Assets from Operations | | | 94,205,895 | | | | 143,858,710 | | |
Distributions to Shareholders From: | |
Net investment income | | | (1,173,697 | ) | | | (2,425,860 | ) | |
Net realized gains | | | (74,442,456 | ) | | | (39,051,960 | ) | |
Total Distributions to Shareholders | | | (75,616,153 | ) | | | (41,477,820 | ) | |
Share Transactions: | |
Subscriptions | | | 14,411,426 | | | | 29,722,426 | | |
Distributions reinvested | | | 75,616,153 | | | | 41,477,820 | | |
Redemptions | | | (64,775,777 | ) | | | (148,920,836 | ) | |
Net Increase (Decrease) from Share Transactions | | | 25,251,802 | | | | (77,720,590 | ) | |
Total Increase in Net Assets | | | 43,841,544 | | | | 24,660,300 | | |
Net Assets: | |
Beginning of period | | | 782,221,927 | | | | 757,561,627 | | |
End of period | | $ | 826,063,471 | | | $ | 782,221,927 | | |
Undistributed (overdistributed) net investment income | | $ | (460,629 | ) | | $ | 1,047,346 | | |
See accompanying notes to financial statements.
16
Wanger USA 2013 Semiannual Report
The following table is intended to help you understand the Fund's financial performance. Certain information reflects financial results for a single share held for the periods shown. Per share net investment income (loss) amounts are calculated based on average shares outstanding during the period. Total return assumes reinvestment of all dividends and distributions. Total return does not reflect payment of the expenses that apply to the variable accounts or contract charges, if any, and are not annualized for periods of less than one year.
| | (Unaudited) Six Months Ended June 30, | | Year Ended December 31, | |
Selected data for a share outstanding throughout each period | | 2013 | | 2012 | | 2011 | | 2010 | | 2009 | | 2008 | |
Net Asset Value, Beginning of Period | | $ | 33.84 | | | $ | 29.80 | | | $ | 33.86 | | | $ | 27.45 | | | $ | 19.30 | | | $ | 36.26 | | |
Income from Investment Operations: | |
Net investment income (loss) | | | (0.01 | ) | | | 0.15 | | | | (0.13 | ) | | | (0.10 | ) | | | (0.06 | ) | | | (0.07 | ) | |
Net realized and unrealized gain (loss) | | | 4.13 | | | | 5.63 | | | | (0.82 | ) | | | 6.51 | | | | 8.21 | | | | (13.16 | ) | |
Total from Investment Operations | | | 4.12 | | | | 5.78 | | | | (0.95 | ) | | | 6.41 | | | | 8.15 | | | | (13.23 | ) | |
Less Distributions to Shareholders: | |
Net investment income | | | (0.06 | ) | | | (0.11 | ) | | | — | | | | — | | | | — | | | | — | | |
Net realized gains | | | (3.39 | ) | | | (1.63 | ) | | | (3.11 | ) | | | — | | | | — | | | | (3.73 | ) | |
Total Distributions to Shareholders | | | (3.45 | ) | | | (1.74 | ) | | | (3.11 | ) | | | — | | | | — | | | | (3.73 | ) | |
Net Asset Value, End of Period | | $ | 34.51 | | | $ | 33.84 | | | $ | 29.80 | | | $ | 33.86 | | | $ | 27.45 | | | $ | 19.30 | | |
Total Return | | | 12.22 | % | | | 20.02 | %(a) | | | (3.49 | )%(a) | | | 23.35 | %(a) | | | 42.23 | % | | | (39.68 | )% | |
Ratios to Average Net Assets/Supplemental Data: (b) | |
Total gross expenses | | | 0.96 | %(c) | | | 0.96 | % | | | 0.94 | % | | | 0.98 | %(d) | | | 0.98 | % | | | 0.96 | % | |
Total net expenses | | | 0.96 | %(c) | | | 0.96 | %(e) | | | 0.93 | %(e) | | | 0.97 | %(d)(e) | | | 0.98 | %(e) | | | 0.96 | %(e) | |
Net investment income (loss) | | | (0.08 | )%(c) | | | 0.45 | % | | | (0.40 | )% | | | (0.35 | )% | | | (0.29 | )% | | | (0.26 | )% | |
Portfolio turnover rate | | | 7 | % | | | 12 | % | | | 10 | % | | | 27 | % | | | 30 | % | | | 22 | % | |
Net assets, end of period (000s) | | $ | 826,063 | | | $ | 782,222 | | | $ | 757,562 | | | $ | 911,424 | | | $ | 1,277,154 | | | $ | 952,249 | | |
Notes to Financial Highlights
(a) Had the investment manager and/or its affiliates not waived a portion of expenses, total return would have been reduced.
(b) In addition to the fees and expenses which the Fund bears directly, the Fund indirectly bears a pro rata share of the fees and expenses of the underlying funds in which it invests. Such indirect expenses are not included in the reported expense ratios.
(c) Annualized.
(d) Includes interest expense which rounds to less than 0.01%.
(e) The benefits derived from custody fees paid indirectly had an impact of less than 0.01%.
See accompanying notes to financial statements.
17
Wanger USA 2013 Semiannual Report
Notes to Financial Statements (Unaudited)
1. Nature of Operations
Wanger USA (the Fund), a series of Wanger Advisors Trust (the Trust), is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The investment objective of the Fund is to seek long-term capital appreciation. The Fund is available only for allocation to certain life insurance company separate accounts established for the purpose of funding participating variable annuity contracts and variable life insurance policies and may also be offered directly to certain qualified pension and retirement plans.
2. Significant Accounting Policies
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (GAAP) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Security valuation
Securities of the Fund are valued at market value or, if a market quotation for a security is not readily available or is deemed not to be reliable because of events or circumstances that have occurred between the market quotation and the time as of which the security is to be valued, the security is valued at its fair value determined in good faith under consistently applied procedures established by the Board of Trustees (the Board). A security traded on a securities exchange or in an over-the-counter market in which transaction prices are reported is valued at the last sales price at the time of valuation. A security traded principally on NASDAQ is valued at the NASDAQ official closing price. Mutual funds and exchange traded funds are valued at their closing net asset value as reported to the applicable exchange. A security for which there is no reported sale on the valuation date is valued at the mean of the latest bid and ask quotations.
Short-term investments maturing in 60 days or less are valued at amortized cost, which approximates market value.
A security for which a market quotation is not readily available and any other assets are valued at their fair value determined in good faith under consistently applied procedures established by the Board. The Trust has retained an independent statistical fair value pricing service that employs a systematic methodology to assist in the fair valuation process for securities principally traded in a foreign market in order to adjust for possible changes in value that may occur between the close of the foreign market and the time as of which the securities are to be valued. If a security is valued at a fair value, that value may be different from the last quoted market price for the security.
Security transactions and investment income
Security transactions are accounted for on the trade date (date the order to buy or sell is executed) and dividend income is recorded on the ex-dividend date, except that certain dividends from foreign securities are recorded as soon as the information
is available to the Fund. Interest income is recorded on the accrual basis and includes amortization of discounts on debt obligations when required for federal income tax purposes. Realized gains and losses from security transactions are recorded on an identified cost basis.
Awards, if any, from class action litigation related to securities owned may be recorded as a reduction of cost of those securities. If the applicable securities are no longer owned, the proceeds are recorded as realized gains.
The Fund estimates the tax character of distributions from real estate investment trusts (REITs). Distributions received in excess of income are recorded as a reduction of the cost of the related investments. If the applicable securities are no longer owned, any distributions received in excess of income are recorded as realized gains.
Expenses
General expenses of the Trust are allocated to the Fund and the other series of the Trust based upon relative net assets or other expense allocation methodologies determined by the nature of the expense. Expenses directly attributable to the Fund are charged to the Fund.
Fund share valuation
Fund shares are sold and redeemed on a continuing basis at net asset value. Net asset value per share is determined daily as of the close of trading on the New York Stock Exchange (the Exchange) on each day the Exchange is open for trading by dividing the total value of the Fund's investments and other assets, less liabilities, by the number of Fund shares outstanding.
Securities lending
The Fund may lend securities up to one-third of the value of its total assets to certain approved brokers, dealers and other financial institutions to earn additional income. The Fund retains the benefits of owning the securities, including receipt of dividends or interest generated by the security. The Fund also receives a fee for the loan. The Fund has the ability to recall the loans at any time and could do so in order to vote proxies or to sell the loaned securities. Each loan is collateralized by cash that exceeded the value of the securities on loan. The market value of the loaned securities is determined daily at the close of business of the Fund and any additional required collateral is delivered to each Fund on the next business day. The Fund has elected to invest the cash collateral in the Dreyfus Government Cash Management Fund and the income earned is paid to the Fund, net of any fees remitted to Goldman Sachs Agency Lending, the Fund's lending agent and borrower rebates. The Fund's investment manager, Columbia Wanger Asset Management, LLC (CWAM), does not retain any fees earned by the lending program. Generally, in the event of borrower default, the Fund has the right to use the collateral to offset any losses incurred. In the event the Fund is delayed or prevented from exercising its right to dispose of the collateral, there may be a potential loss to the Fund. Some of these losses may be indemnified by the lending agent. The Fund bears the risk of loss with respect to the investment of collateral. The net lending income earned by the Fund as of June 30, 2013, is included in the Statement of Operations.
The following table presents the Fund's gross and net amount of assets available for offset under a securities lending agreement as well as the related collateral received by the Fund as of June 30, 2013:
| | Gross Amounts of | | Gross Amounts Offset in the | | Net Amounts of Assets Presented in the | | Gross Amounts Not Offset in the Statement of Assets and Liabilities | | | |
| | Recognized Assets | | Statement of Assets and Liabilities | | Statement of Assets and Liabilities | | Financial Instruments (a) | | Cash Collateral Received | | Securities Collateral Received | | Net Amount (b) | |
Securities loaned | | $ | 45,743,233 | | | $ | — | | | $ | 45,743,233 | | | $ | — | | | $ | 45,743,233 | | | $ | — | | | $ | — | | |
(a) Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar agreements that management elects not to offset on the Statement of Assets and Liabilities.
(b) Represents the net amount due from counterparties in the event of default.
18
Wanger USA 2013 Semiannual Report
Notes to Financial Statements, continued (Unaudited)
Federal income taxes
The Fund has complied with the provisions of the Internal Revenue Code available to regulated investment companies and, in the manner provided therein, distributes substantially all its taxable income, as well as any net realized gain on sales of investments and foreign currency transactions reportable for federal income tax purposes. Accordingly, the Fund paid no federal income taxes and no federal income tax provision was required.
Distributions to shareholders
Distributions to shareholders are recorded on the ex-dividend date.
Indemnification
In the normal course of business, the Trust on behalf of the Fund enters into contracts that contain a variety of representations and warranties and that provide general indemnities. The Fund's maximum exposure under these arrangements is unknown, as this would involve future claims against the Fund. Also under the Trust's organizational documents, the trustees and officers of the Trust are indemnified against certain liabilities that may arise out of their duties to the Trust. However based on experience, the Fund expects the risk of loss due to these warranties and indemnities to be remote.
3. Federal Tax Information
The timing and character of income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP. Reclassifications are made to the Fund's capital accounts for permanent tax differences to reflect income and gains available for distribution (or available capital loss carryforwards) under income tax regulations.
Management is required to determine whether a tax position of the Fund is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The tax benefit to be recognized by the Fund is measured as the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. Management is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. However, management's conclusions may be subject to review and adjustment at a later date based on factors including, but not limited to, new tax laws, regulations, and administrative interpretations (including relevant court decisions). The Fund's federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
4. Transactions With Affiliates
CWAM is a wholly owned subsidiary of Columbia Management Investment Advisers, LLC (Columbia Management), which in turn is a wholly owned subsidiary of Ameriprise Financial, Inc. (Ameriprise Financial). CWAM furnishes continuing investment supervision to the Fund and is responsible for the overall management of the Fund's business affairs.
CWAM receives a monthly advisory fee based on the Fund's average daily net assets at the following annual rates:
Average Daily Net Assets | | Annual Fee Rate | |
Up to $100 million | | | 0.94 | % | |
$100 million to $250 million | | | 0.89 | % | |
$250 million to $2 billion | | | 0.84 | % | |
$2 billion and over | | | 0.80 | % | |
For the six months ended June 30, 2013, the annualized effective investment advisory fee rate was 0.86% of the Fund's average daily net assets.
CWAM provides administrative services and receives an administration fee from the Fund at the following annual rates:
Wanger Advisors Trust Aggregate Average Daily Net Assets of the Trust | | Annual Fee Rate | |
Up to $4 billion | | | 0.05 | % | |
$4 billion to $6 billion | | | 0.04 | % | |
$6 billion to $8 billion | | | 0.03 | % | |
$8 billion and over | | | 0.02 | % | |
For the six months ended June 30, 2013, the annualized effective administration fee rate was 0.05% of the Fund's average daily net assets. Columbia Management provides certain sub-administrative services to the Fund.
Columbia Management Investment Distributors, Inc. (CMID), a wholly owned subsidiary of Ameriprise Financial, serves as the Fund's distributor and principal underwriter.
Columbia Management Investment Services Corp. (CMIS), a wholly owned subsidiary of Ameriprise Financial, is the transfer agent to the Fund. For its services, the Fund pays CMIS a monthly fee at the annual rate of $21.00 per open account. CMIS also receives reimbursement from the Fund for certain out-of-pocket expenses.
Certain officers and trustees of the Trust are also officers of CWAM. The Trust makes no direct payments to its officers and trustees who are affiliated with CWAM.
The Board has appointed a Chief Compliance Officer of the Trust in accordance with federal securities regulations. The Fund, along with other affiliated funds, pays its pro-rata share of the expenses associated with the Office of the Chief Compliance Officer. These expenses are disclosed separately as "Chief compliance officer expenses" in the Statement of Operations.
The Trust offers a deferred compensation plan for its independent trustees. Under that plan, a trustee may elect to defer all or a portion of his or her compensation. Amounts deferred are retained by the Trust and may represent an unfunded obligation of the Trust. The value of amounts deferred is determined by reference to the change in value of Class Z shares of one or more series of Columbia Acorn Trust or a money market fund as specified by the trustee. Benefits under the deferred compensation plan are payable in accordance with the plan.
5. Borrowing Arrangements
During the six months ended June 30, 2013, the Trust participated in a credit facility with JPMorgan Chase Bank, N.A., along with Columbia Acorn Trust, another trust managed by CWAM, in the amount of $150 million prior to January 11, 2013, and in the amount of $200 million thereafter. The credit facility was entered into to facilitate portfolio liquidity. Under the facility, interest is charged to each participating fund based on its borrowings at a rate per annum equal to the Federal Funds Rate plus 1.00%. In addition, a commitment fee of 0.08% per annum of the unutilized line of credit is accrued and apportioned among the participating funds based on their relative net assets. The commitment fee is disclosed separately as "Commitment fee for line of credit" in the Statement of Operations. The Trust renewed the line of credit in July in the amount of $150 million, and will continue to do so each year at then current market rates and terms.
No amounts were borrowed for the benefit of the Fund during the six months ended June 30, 2013.
6. Fund Share Transactions
Proceeds and payments on Fund shares as shown in the Statement of Changes in Net Assets are in respect of the following numbers of shares:
| | (Unaudited) Six months ended June 30, 2013 | | Year ended December 31, 2012 | |
Shares sold | | | 393,816 | | | | 900,062 | | |
Shares issued in reinvestment of dividend distributions | | | 2,203,910 | | | | 1,353,693 | | |
Less shares redeemed | | | (1,772,196 | ) | | | (4,560,981 | ) | |
19
Wanger USA 2013 Semiannual Report
Notes to Financial Statements, continued (Unaudited)
Net increase (decrease) in shares outstanding | | | 825,530 | | | | (2,307,226 | ) | |
7. Investment Transactions
The aggregate cost of purchases and proceeds from sales other than short-term obligations for the six months ended June 30, 2013, were $59,906,242 and $122,622,049, respectively.
8. Shareholder Concentration
At June 30, 2013, one unaffiliated shareholder account owned 19.0% of the outstanding shares of the Fund. The Fund has no knowledge about whether any portion of those shares was owned beneficially by such account. Affiliated shareholder accounts owned 54.6% of the outstanding shares of the Fund. Subscription and redemption activity by concentrated accounts may have a significant effect on the operations of the Fund.
9. Subsequent Events
Management has evaluated the events and transactions that have occurred through the date the financial statements were issued and noted no items requiring adjustment of the financial statements or additional disclosure.
10. Information Regarding Pending and Settled Legal Proceedings
Ameriprise Financial and certain of its affiliates have historically been involved in a number of legal, arbitration and regulatory proceedings, including routine litigation, class actions, and governmental actions, concerning matters arising in connection with the conduct of their business activities. Ameriprise Financial believes that the Funds are not currently the subject of, and that neither Ameriprise Financial nor any of its affiliates are the subject of, any pending legal, arbitration or regulatory proceedings that are likely to have a material adverse effect on the Funds or the ability of Ameriprise Financial or its affiliates to perform under their contracts with the Funds. Ameriprise Financial is required to make 10-Q, 10-K and, as necessary, 8-K filings with the Securities and Exchange Commission on legal and regulatory matters that relate to Ameriprise Financial and its affiliates. Copies of these filings may be obtained by accessing the SEC website at www.sec.gov.
There can be no assurance that these matters, or the adverse publicity associated with them, will not result in increased fund redemptions, reduced sale of fund shares or other adverse consequences to the Funds. Further, although we believe proceedings are not likely to have a material adverse effect on the Funds or the ability of Ameriprise Financial or its affiliates to perform under their contracts with the Funds, these proceedings are subject to uncertainties and, as such, we are unable to estimate the possible loss or range of loss that may result. An adverse outcome in one or more of these proceedings could result in adverse judgments, settlements, fines, penalties or other relief that could have a material adverse effect on the consolidated financial condition or results of operations of Ameriprise Financial.
20
Wanger USA 2013 Semiannual Report
Board Approval of the Advisory Agreement
Wanger Advisors Trust (the "Trust") has an investment advisory agreement (the "Advisory Agreement") with Columbia Wanger Asset Management, LLC ("Columbia WAM") under which Columbia WAM manages Wanger USA (the "Fund"). More than 75% of the trustees of the Trust (the "Trustees") are persons who have no direct or indirect interest in the Advisory Agreement and are not "interested persons" (as defined in the Investment Company Act of 1940, as amended (the "1940 Act")) of the Trust (the "Independent Trustees"). The Trustees oversee the management of the Fund and, as required by law, determine at least annually whether to continue the Advisory Agreement for the Fund.
The Contract Committee (the "Committee") of the Board of Trustees (the "Board"), which is comprised solely of Independent Trustees, makes recommendations to the Board regarding any proposed continuation of the Advisory Agreement. After the Committee has made its recommendations, the full Board determines whether to approve continuation of the Advisory Agreement. The Board also considers matters bearing on the Advisory Agreement at its various meetings throughout the year, meets at least quarterly with Columbia WAM's portfolio managers (the Board's Investment Performance Analysis Committee meets frequently with them as well), and receives monthly reports from Columbia WAM on the performance of the Fund.
In connection with their most recent consideration of the Advisory Agreement for the Fund, the Committee and all Trustees received and reviewed a substantial amount of information provided by Columbia WAM, Columbia Management Investment Advisers, LLC ("Columbia Management") and Ameriprise Financial, Inc. ("Ameriprise") in response to written requests from the Independent Trustees and their independent legal counsel. In addition, the Trustees reviewed the Management Fee Evaluation dated June 2013 (the "Fee Evaluation") prepared by the Trust's chief compliance officer, senior vice president and general counsel, at the request of the Board. Throughout the process, the Trustees had numerous opportunities to ask questions of and request additional materials from Columbia WAM, Columbia Management and Ameriprise.
During each meeting at which the Committee or the Independent Trustees considered the Advisory Agreement, they met in executive session with their independent legal counsel. The Committee also met with representatives of Columbia WAM, Columbia Management and Ameriprise on several occasions. In all, the Committee convened formally on four separate occasions to consider the continuation of the Advisory Agreement. The Board and/or some or all of the Independent Trustees met on other occasions to receive the Committee's status reports, receive presentations from Columbia WAM, Columbia Management and Ameriprise representatives, and to discuss outstanding issues. In addition, the Investment Performance Analysis Committee of the Board, also comprised exclusively of Independent Trustees, reviewed the performance of the Fund, met in a joint meeting with the Committee, and presented its findings to the Board and the Committee throughout the year. The Compliance Committee of the Board also provided information to the Committee with respect to relevant matters.
The materials reviewed by the Committee and the Trustees included, among other items, (i) information on the investment performance of the Fund and of independently selected peer groups of funds and of the Fund's performance benchmark over various time periods, (ii) information on the Fund's advisory fees and other expenses, including information comparing the Fund's fees and expenses to those of peer groups of funds and information about any applicable expense limitations and fee breakpoints, (iii) data on sales and redemptions of Fund shares, and (iv) information on the profitability to Columbia WAM and Ameriprise, as well as potential "fall-out" or ancillary benefits that Columbia WAM and its affiliates may receive as a result of their relationships with the Fund. The Trustees also considered other information such as (i) Columbia WAM's financial condition, (ii) the Fund's investment objective and strategy, (iii) the size, education and experience of Columbia WAM's investment staff and its use of technology, external research and trading cost measurement tools, (iv) the portfolio manager compensation framework, (v) the allocation of the Fund's brokerage, and the use of "soft" commission dollars to pay for research products and services, (vi) Columbia WAM's risk management program, and (vii) the resources devoted to, and the record of compliance with, the Fund's
investment policies and restrictions, policies on personal securities transactions and other compliance policies.
At a meeting held on June 5, 2013, upon the recommendation of the Committee, the Board unanimously approved the continuation of the Advisory Agreement.
In considering the continuation of the Advisory Agreement, the Trustees reviewed and analyzed various factors that they determined were relevant, none of which by itself was considered dispositive. The material factors and conclusions that formed the basis for the Trustees' determination to approve the continuation of the Advisory Agreement are discussed below.
Nature, quality and extent of services. The Trustees reviewed the nature, quality and extent of the services provided by Columbia WAM and its affiliates to the Fund under the Advisory Agreement, taking into account the investment objective and strategy of the Fund, its shareholder base, and knowledge gained from meetings with management, which were held on at least a quarterly basis. In addition, the Trustees reviewed the available resources and key personnel of Columbia WAM and its affiliates, especially those providing investment management services to the Fund. The Trustees also considered other services provided to the Fund by Columbia WAM and its affiliates, including: managing the execution of portfolio transactions and selecting broker-dealers for those transactions; monitoring adherence to the Fund's investment restrictions; producing shareholder reports; providing support services for the Board and committees of the Board; managing the Fund's securities lending program; communicating with shareholders; serving as the Fund's administrator; and overseeing the activities of the Fund's other service providers, including monitoring for compliance with various policies and procedures as well as applicable securities laws and regulations.
The Trustees concluded that the nature, quality and extent of the services provided by Columbia WAM and its affiliates to the Fund under the Advisory Agreement were appropriate for the Fund and that the Fund was likely to benefit from the continued provision of those services by Columbia WAM. They also concluded that Columbia WAM currently had sufficient personnel, with appropriate education and experience, to serve the Fund effectively, and that the firm had demonstrated its continuing ability to attract and retain well-qualified personnel. In addition, they considered the quality of Columbia WAM's compliance record.
Performance of the Fund. The Trustees received and considered detailed performance information at various meetings of the Board, the Committee and the Investment Performance Analysis Committee of the Board throughout the year. They reviewed information comparing the Fund's performance with that of its benchmark(s) and with the performance of comparable funds and peer groups as identified by Lipper Inc. ("Lipper") and Morningstar, Inc. ("Morningstar"). The Trustees evaluated the performance of the Fund over various time periods, including over the one-, three- and five-year periods ending December 31, 2012. The Trustees also considered peer performance rankings for similar time periods, although they generally focused more on the five-year period.
The Trustees considered that the Fund's returns were excellent versus its peer group over the one- and five-year periods ending December 31, 2012. The Trustees also took into account that the Fund outperformed its benchmark for the same periods. The Trustees noted that the Fund underperformed its peers and benchmark for the three-year period, but the Trustees focused more on the improved performance in the one-year period. They also considered that the Fund exposed shareholders to more risk than its peers.
The Trustees concluded that the Fund's performance was satisfactory over the longer term and for the one year.
Costs of Services and Profits Realized by Columbia WAM. At various Committee and Board meetings, the Trustees examined detailed information on the fees and expenses of the Fund in comparison to information for comparable funds provided by Lipper and Morningstar. The Trustees noted that the Fund's net expenses were higher than both the Lipper and Morningstar peer groups. The Trustees also took into account that the actual advisory fees paid by the Fund were higher than the median of Lipper and Morningstar peers.
21
Wanger USA 2013 Semiannual Report
Board Approval of the Advisory Agreement, continued
The Trustees also reviewed the advisory fee rates charged by Columbia WAM for managing other investment companies, sub-advised funds and other institutional separate accounts, as detailed in materials provided to the Committee by Columbia WAM and in the Fee Evaluation. The Trustees noted that the Fund's advisory fees were generally comparable to Columbia Acorn USA's advisory fees at the same asset levels. The Trustees also examined Columbia WAM's institutional separate account fees for parallel investment strategies and determined that institutional account advisory fees tended to be lower than the Fund in most cases. The Trustees noted that Columbia WAM performs significant additional services for the Fund that it does not provide to sub-advised funds or non-mutual fund clients, including administrative services, oversight of the Fund's other service providers, Trustee support, regulatory compliance and numerous other services, and that, in servicing the Fund, Columbia WAM assumes many legal and business risks that it does not assume in servicing many of its non-fund clients.
The Trustees concluded that the rate of advisory fees payable to Columbia WAM were reasonable in relation to the nature and quality of the services to be provided and the investment performance of the Fund, taking into account Columbia WAM's recent steps to improve performance of the Fund.
The Trustees reviewed the analysis of the historic profitability of Columbia WAM in serving as the Fund's investment manager and of Columbia WAM and its affiliates in their relationships with the Fund. The Committee and Trustees met with representatives from Ameriprise to discuss its methodologies for calculating profitability and allocating costs. They considered that Ameriprise calculated profitability and allocated costs on a contract-by-contract and Fund-by-Fund basis. The Trustees also considered the methodology used by Columbia WAM and Ameriprise in determining compensation payable to portfolio managers and the competitive market for investment management talent. The Trustees were also provided with profitability information from Lipper, which compared Columbia WAM's profitability to other similar investment managers in the mutual fund industry. The Trustees concluded that Columbia WAM's and its affiliates' profits were within a reasonable range of those of competitors with similar business models. The Trustees discussed, however, that profitability comparisons among fund managers may not always be meaningful due to the lack of consistency in data, small number of publicly-owned managers, and the fact that profitability of any investment manager is affected by numerous factors, including its particular organizational structure, the types of funds and other accounts managed, other lines of business, expense allocation methodology, capital structure and other factors.
Economies of Scale. At various Committee and Board meetings and other informal meetings, the Trustees considered information about the extent to which Columbia WAM realizes economies of scale in connection with an increase in Fund assets. The Trustees noted that the advisory fee schedule for the Fund includes breakpoints in the rate of fees at various asset levels. The Trustees concluded that the fee structure of the Fund was reflective of a sharing of economies of scale between Columbia WAM and the Fund.
Other Benefits to Columbia WAM. The Trustees also reviewed benefits that accrue to Columbia WAM and its affiliates from their relationships with the Fund, based upon information provided to them by Ameriprise and as outlined in the Fee Evaluation. They noted that the Fund's transfer agency services are performed by Columbia Management Investment Services Corp., an affiliate of Ameriprise, which receives compensation from the Fund for its services provided. They considered that an affiliate of Ameriprise, Columbia Management Investment Distributors, Inc. ("CMID"), serves as the Fund's distributor under an underwriting agreement but receives no fees for its services to the Fund. In addition, Columbia Management provides sub-administration services to the Fund. The Committee received information regarding the profitability of the Fund agreement with Columbia WAM affiliates. The Committee and the Board also reviewed information about and discussed the capabilities of each affiliated entity in performing its duties.
The Trustees considered other ways that the Fund and Columbia WAM may potentially benefit from their relationship with each other. For example, the Trustees considered Columbia WAM's use of commissions paid by the Fund on its portfolio brokerage transactions to obtain research products and services benefiting the Fund
and/or other clients of Columbia WAM. The Committee reviewed Columbia WAM's annual "soft dollar" report and met with representatives from Columbia WAM to review Columbia WAM's soft dollar spending. The Committee also considered that the Compliance Committee of the Board regularly reviewed third-party prepared reports that evaluated the quality of Columbia WAM's execution of the Fund's portfolio transactions. The Trustees noted that these reports showed that Columbia WAM's execution capabilities were generally better than industry peers. The Trustees determined that Columbia WAM's use of the Fund's "soft" commission dollars to obtain research products and services was consistent with current regulatory requirements and guidance. They also concluded that Columbia WAM benefits from the receipt of proprietary research products and services acquired through commissions paid on portfolio transactions of the Fund, and that the Fund benefitted from Columbia WAM's receipt of those products and services as well as research products and services acquired through commissions paid by other clients of Columbia WAM.
After full consideration of the above factors, as well as other factors that were instructive in evaluating the Advisory Agreement, the Trustees, including the Independent Trustees by separate vote, concluded that the continuation of the Advisory Agreement was in the best interest of the Fund. On June 5, 2013, the Trustees approved continuation of the Advisory Agreement through July 31, 2014.
22
Wanger USA 2013 Semiannual Report
This page intentionally left blank.
23
Wanger USA 2013 Semiannual Report
This page intentionally left blank.
24
Wanger USA 2013 Semiannual Report
Trustees
Laura M. Born
Chair of the Board
Steven N. Kaplan
Vice Chair of the Board
Michelle L. Collins
Maureen M. Culhane
Margaret M. Eisen
John C. Heaton
Charles P. McQuaid
David J. Rudis
David B. Small
Ralph Wanger (Trustee Emeritus)
Officers
Charles P. McQuaid
President
Robert A. Chalupnik
Vice President
Michael G. Clarke
Assistant Treasurer
Joseph F. DiMaria
Assistant Treasurer
P. Zachary Egan
Vice President
Fritz Kaegi
Vice President
John M. Kunka
Assistant Treasurer
Stephen Kusmierczak
Vice President
Joseph C. LaPalm
Vice President
Bruce H. Lauer
Vice President, Secretary and Treasurer
Louis J. Mendes III
Vice President
Robert A. Mohn
Vice President
Christopher J. Olson
Vice President
Christopher O. Petersen
Assistant Secretary
Scott R. Plummer
Assistant Secretary
Linda K. Roth-Wiszowaty
Assistant Secretary
Robert P. Scales
Chief Compliance Officer, Chief Legal Officer,
Senior Vice President and
General Counsel
Andreas Waldburg-Wolfegg
Vice President
Investment Manager
Columbia Wanger Asset Management,LLC
227 West Monroe Street, Suite 3000
Chicago, Illinois 60606
1-888-4-WANGER
(1-888-492-6437)
Transfer Agent,
Dividend Disbursing Agent
Columbia Management Investment Services Corp.
P.O.Box 8081
Boston, Massachusetts
02266-8081
Distributor
Columbia Management Investment Distributors, Inc.
225 Franklin Street
Boston, Massachusetts
02110
Legal Counsel to the Funds
Perkins Coie LLP
Washington, DC
Legal Counsel to the Independent Trustees
Drinker Biddle & Reath LLP
Philadelphia, Pennsylvania
Independent Registered Public Accounting Firm
PricewaterhouseCoopers LLP
Chicago, Illinois
This document contains Global Industry Classification Standard data. The Global Industry Classification Standard ("GICS") was developed by and is the exclusive property and a service mark of MSCI Inc. ("MSCI") and Standard & Poor's Financial Services LLC ("S&P") and is licensed for use by Columbia Wanger Asset Management, LLC ("CWAM"). Neither MSCI, S&P, nor any other party involved in making or compiling the GICS or any GICS classifications makes any express or implied warranties or representations with respect to such standard or classification (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability and fitness for a particular purpose with respect to any of such standard or classification. Without limiting any of the foregoing, in no event shall MSCI, S&P, any of their affiliates or any third party involved in making or compiling the GICS or any GICS classifications have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages.
This report, including the schedules of investments and financial statements, is submitted for the general information of the shareholders of the Wanger Advisors Trust.
A description of the Fund's proxy voting policies and procedures and a copy of the Fund's voting record for the most recent 12-month period ended June 30 are available (i) on our website, columbiamanagement.com, (ii) on the Securities and Exchange Commission's website at www.sec.gov, and (iii) without charge, upon request, by calling 888-492-6437.
The Fund files a complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q. The Fund's Form N-Q is available on the SEC's website at www.sec.gov and may be reviewed and copied at the SEC's Public Reference Room in Washington, D.C. Information on the operation of the Pubic Reference Room may be obtained by calling 800-SEC-0330. The Fund's complete portfolio holdings are disclosed at www.columbiamanagement.com approximately 30 to 40 days after each month end.
25
© 2013 Columbia Management Investment Advisers, LLC. All rights reserved.
Item 2. Code of Ethics.
Not applicable for semiannual reports.
Item 3. Audit Committee Financial Expert.
Not applicable for semiannual reports.
Item 4. Principal Accountant Fees and Services.
Not applicable for semiannual reports.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments
(a) The registrant’s “Schedule I — Investments in securities of unaffiliated issuers” (as set forth in 17 CFR 210.12-12) is included in Item 1 of this Form N-CSR.
(b) Not applicable.
Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 8. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10. Submission of Matters to a Vote of Security Holders.
There were no material changes to the procedures by which shareholders may recommend nominees to the registrant’s board of directors.
Item 11. Controls and Procedures.
(a) The registrant’s principal executive officer and principal financial officers, based on their evaluation of the registrant’s disclosure controls and procedures as of a date within 90 days of the filing of this report, have concluded that such controls and procedures are adequately designed to ensure that material information required to be disclosed by the registrant in Form N-CSR is accumulated and communicated to the registrant’s management, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
(b) There was no change in the registrant’s internal control over financial reporting that occurred during the registrant’s second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
Item 12. Exhibits.
(a)(1) Code of ethics required to be disclosed under Item 2 of Form N-CSR: Not applicable for semiannual reports.
(a)(2) Certifications pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) attached hereto as Exhibit 99.CERT.
(a)(3) Not applicable.
(b) Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) attached hereto as Exhibit 99.906CERT.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(registrant) | | Wanger Advisors Trust | |
| | | |
| | | |
By (Signature and Title) | | /s/ Charles P. McQuaid | |
| | Charles P. McQuaid, President | |
| | | |
| | | |
Date | | August 15, 2013 | |
| | | | | |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title) | | /s/ Charles P. McQuaid | |
| | Charles P. McQuaid, President | |
| | | |
| | | |
Date | | August 15, 2013 | |
| | | |
| | | |
By (Signature and Title) | | /s/ Bruce H. Lauer | |
| | Bruce H. Lauer, Treasurer | |
| | | |
| | | |
Date | | August 15, 2013 | |
| | | | |